{
  "block": 95645040,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "shriyala",
      "delegator": "steem",
      "vesting_shares": "5574.000599 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2025-05-17T11:13:48",
  "trx_id": "65fb18d4305b2c93ce1080e245f30f436c7b9e04",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 87083769,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "global-refinery-catalyst-market-2021-2027-growth-trends-and-demands-research-report",
      "voter": "sweethoney1",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2024-07-23T06:29:39",
  "trx_id": "c17e51d83df44fc8611062f49c20caa52dd712d5",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 84147766,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "shriyala",
      "delegator": "steem",
      "vesting_shares": "5741.228230 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2024-04-11T20:55:51",
  "trx_id": "454ca442ddc060fe24c22cee38c57ee696003d78",
  "trx_in_block": 10,
  "virtual_op": 0
}

{
  "block": 81537816,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Pharma marketing is the art and science of promoting and selling pharmaceutical products. Unlike general marketing, it revolves around medications and medical services, targeting healthcare professionals and occasionally reaching out directly to consumers. In this specialized field, navigating stringent regulations and ethical considerations is paramount to ensure the responsible promotion of medical products.\n\nThe Pivotal Role of Marketing in Pharma\n\nIn the pharmaceutical industry, marketing transcends mere sales; it's a crucial tool for educating healthcare providers and patients. Beyond selling drugs, pharma marketing aims to raise awareness about diseases and disseminate information on the latest medical advancements.\n\nEffective marketing strategies are vital in enhancing awareness, improving patient outcomes, and fostering business growth. It serves as the bridge connecting medical innovations with those who need them most.\n\nA Sneak Peek into the Pharma Marketing Guide\n\nOur comprehensive guide will delve into the various facets of pharma marketing, exploring effective strategies and understanding how they help companies navigate the competitive and highly regulated market. Covering both digital and traditional methods, the guide emphasizes effectiveness and ethical practices. Stay tuned for insightful discussions and practical tips on elevating your pharma marketing approach.\n\nUnderstanding Pharma Marketing\n\nPharma marketing is different from your typical advertising gig. It's a specialized branch focusing on promoting and selling pharmaceutical products. Beyond advertising, it involves market research, product development feedback, regulatory compliance, and educating healthcare professionals and consumers. This strategy is crucial for effectively reaching the target audience, including doctors, health workers, and, in some cases, directly engaging with patients.\n\nDistinctive Aspects of Pharma Marketing\n\nPharma marketing sets itself apart from general marketing in several ways. It operates in a strict environment, adhering to ethical and legal rules. Unlike general marketing's persuasive tactics, pharma marketing prioritizes accurate information and patient safety. Additionally, the target audience is more specialized, focusing on healthcare professionals who require detailed, scientific data rather than just persuasive sales pitches.\n\nChallenges in Pharma Marketing\n\nNavigating the complex regulatory environment is one of the primary challenges in pharma marketing. Striking a delicate balance between compliance and effective marketing is crucial. Another challenge lies in adapting to the ever-changing healthcare field, requiring continuous innovation in communication strategies. Building and maintaining trust with healthcare professionals and the public also pose ongoing challenges.\n\nFundamentals of Pharma Marketing\n\nIdentifying the Target Audience\n\nA key aspect of pharma marketing is identifying and understanding the target audience, which includes doctors, patients, and pharmacies. Tailoring approaches to each group is essential. For doctors, focus on providing detailed, scientific data; for patients, offer accessible and easy-to-understand information; and for pharmacies, highlight product benefits and availability.\n\nRegulatory Constraints\n\nUnder stringent regulatory constraints, pharma marketing ensures ethical practices and accurate, non-misleading information. Staying updated with regulations is crucial to avoid legal issues and maintain a stellar reputation. Continuous monitoring and adapting strategies to comply with new guidelines are essential for validation of promotional materials.\n\nRole of Medical Representatives\n\nMedical representatives are a vital part of pharma marketing, acting as a link between companies and healthcare professionals. They provide information, address queries, and collect feedback, contributing to marketing and product development.\n\nEffective Strategies in Pharma Marketing\n\nBuilding Relationships with Healthcare Professionals\n\nRelationship marketing with healthcare professionals is crucial. Fostering long-term connections involves understanding their needs and providing valuable information through regular communication, educational events, and personalized interactions.\n\nEmbracing Digital Marketing\n\nDigital marketing is revolutionizing pharma marketing. Engaging websites, active social media presence, and robust SEO strategies enhance visibility and engagement. Social media channels offer direct engagement, and SEO ensures content reaches the right audience.\n\nLeveraging Educative Marketing\n\nEducation is a powerful tool in pharma marketing. Seminars and webinars provide platforms to discuss new research findings, therapeutic advances, and detailed product information. Webinars, offering convenience and accessibility, are ideal for busy professionals.\n\nAdopting Patient-Centric Approaches\n\nA patient-centric approach involves understanding the patient's journey and addressing their specific needs. Creating patient-friendly materials, supporting advocacy groups, and direct-to-patient marketing enhance patient engagement, improve outcomes, and foster brand loyalty.\n\nUsing Data and Analytics in Pharma Marketing\n\nUnderstanding Market Trends Through Data\n\nData is invaluable for understanding market trends and consumer behavior. Analyzing data provides insights into healthcare professionals' and patients' needs and preferences, allowing tailored marketing strategies.\n\nTools for Analyzing Data\n\nTools like big data analysis software, CRM systems, market research surveys, and feedback forms help study market trends and consumer behavior. Case studies showcase successful data-driven campaigns, improving marketing strategies and enhancing patient care.\n\nEmerging Trends in Pharma Marketing\n\nRise of Online Consultations\n\nTelemedicine and online consultations challenge traditional pharma marketing, making it more accessible and immediate. Online platforms facilitate product launches, medical sessions, and patient education.\n\nPersonalized Medicine and Targeted Therapies\n\nPharma marketing shifts towards educating healthcare providers and patients about personalized treatments, focusing on specific groups with tailored messages.\n\nImpact of AI and Machine Learning\n\nAI and machine learning analyze data, predict customer behavior, and create highly targeted campaigns, making marketing more efficient and personalized.\n\nConclusion\nPharma marketing is a dynamic field, encompassing various strategies, compliance measures, and emerging trends. By combining relationship-building, digital marketing, education, patient-centric approaches, and leveraging data, companies can create powerful and effective marketing strategies. Emphasizing ethics, ensuring compliance, and staying adaptable to new technologies and trends are the keys to success in the evolving landscape of pharma marketing.\n\nTo learn more about all P360’s innovative products, visit P360.com",
      "json_metadata": "{\"tags\":[\"pharma\",\"marketing\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "pharma",
      "permlink": "pharma-marketing-enhancing-care-through-engagement",
      "title": "Pharma Marketing: Enhancing Care Through Engagement"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2024-01-11T18:29:54",
  "trx_id": "f64586fefb23b527188c6d7c94f1daaa4ab86c49",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 80504696,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Compliance in pharmaceutical marketing and sales is crucial to ensure ethical practices, adhere to legal regulations, and maintain public trust. The pharmaceutical industry is heavily regulated to protect the interests of patients and ensure the safety and efficacy of drugs. Pharmaceutical marketing and sales professionals must be familiar with the laws and regulations that govern their activities. This includes guidelines from regulatory bodies like the Food and Drug Administration (FDA) in the United States, the European Medicines Agency (EMA) in Europe, and other relevant authorities in different countries. In the context of pharmaceutical marketing, a \"complaint\" refers to an expression of dissatisfaction or concern raised by individuals, healthcare professionals, or regulatory authorities regarding the marketing practices or promotional materials used by a pharmaceutical company.\n\nCompliance standards are crucial for various reasons, and they play a significant role in several aspects of business and society. In the context of different industries, including pharmaceuticals, compliance standards matter for the following key reasons:\n\nEthical Business Practices: Compliance standards set the foundation for ethical conduct within organizations. They promote integrity, honesty, and fairness in all business activities. Adhering to these standards ensures that companies prioritize the well-being of their customers, employees, and other stakeholders.\n\nPublic Safety and Health: In industries like pharmaceuticals, compliance standards are designed to protect public safety and health. They ensure that products and services meet rigorous quality and safety requirements. Non-compliance could lead to unsafe products entering the market, potentially causing harm to consumers.\n\nRegulatory Requirements: Compliance standards are often based on laws, regulations, and industry guidelines established by government bodies or professional associations. Adhering to these requirements is essential to avoid legal penalties, fines, or other punitive actions.\n\nMaintaining Reputation and Trust: Compliant businesses are more likely to earn the trust of consumers, investors, and partners. A strong reputation for ethical behavior and adherence to regulations can lead to increased customer loyalty and positive brand perception.\n\nRisk Management: Compliance standards help organizations identify and mitigate risks associated with their operations. By following established protocols and best practices, companies can reduce the likelihood of costly mistakes or reputational damage.\n\nInternational Operations: For companies operating globally, compliance standards ensure consistency in business practices across different countries. They help organizations navigate the complexities of diverse legal and regulatory environments.\n\nEmployee Well-Being: Compliance standards often include provisions related to employee rights, workplace safety, and fair labor practices. Complying with these standards fosters a positive work environment and promotes the well-being of employees.\n\nPreventing Fraud and Corruption: In sectors prone to fraud and corruption, compliance standards serve as a deterrent. They establish clear guidelines for ethical behavior, making it more challenging for individuals or groups to engage in illicit activities.\n\nData Protection and Privacy: With the increasing emphasis on data protection and privacy, compliance standards help organizations safeguard sensitive information and adhere to relevant data privacy regulations.\n\nQuality Control and Assurance: Compliance standards often incorporate quality control and assurance measures, ensuring that products and services meet predefined standards of excellence.\n\nSustainability and Environmental Responsibility: Some compliance standards include provisions for environmental sustainability, encouraging businesses to adopt eco-friendly practices and reduce their impact on the environment.\n\nStakeholder Confidence: Complying with standards demonstrates a commitment to responsible and accountable business practices. This, in turn, instills confidence in stakeholders, such as investors, customers, and suppliers.\n\nOverall, compliance standards are vital for maintaining the integrity and sustainability of businesses and ensuring they operate in a manner that respects legal, ethical, and societal obligations. By upholding compliance, organizations can contribute to a more transparent and trustworthy business landscape.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"compliance\",\"in\",\"pharma\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "compliance",
      "permlink": "4mxmdc-compliance-in-pharma-marketing-and-sales-the-path-to-responsible-practices",
      "title": "Compliance in Pharma Marketing and Sales: The Path to Responsible Practices"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-12-06T17:37:12",
  "trx_id": "c9f27338eff7fe2528abf5e8c4636e480d745467",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 79880757,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Pharma Data Analytics refers to the systematic use of advanced analytical techniques on vast datasets within the pharmaceutical industry. This transformative approach harnesses the power of big data and analytics to extract valuable insights, optimize processes, and drive informed decision-making across various facets of the pharmaceutical sector. This article explores how leveraging data analytics can empower pharmaceutical companies to enhance business processes, expedite product development, and achieve sales objectives in today's dynamic market.\n\nKey Components of Pharma Data Analytics:\nData Integration\nSales Optimization\nClinical Trials and Research Efficiency\nRegulatory Compliance\nPrescriptive Analytics\nBenefits of Pharma Data Analytics:\nInformed Decision-Making:\nData analytics empowers pharmaceutical companies to make informed decisions based on real-time insights, reducing reliance on traditional, less precise methods.\nOperational Efficiency:\nBy optimizing sales processes, clinical trials, and research endeavors, data analyticsenhances overall operational efficiency, leading to cost reduction and improved productivity.\nTargeted Marketing:\nAnalytics enables precise targeting in marketing efforts, ensuring that resources are allocated efficiently to reach the right audience.\nRisk Mitigation:\nPredictive analytics helps identify potential risks in research and sales, allowing proactive measures to mitigate challenges and reduce the likelihood of failures.\nRegulatory Compliance:\nReporting analytics ensures that pharmaceutical companies adhere to regulatory requirements, promoting transparency and accountability.\nThe Role of Data Analytics in a Competitive Landscape\nThe evolving competitive landscape necessitates pharmaceutical companies to adapt and deliver patient-centric solutions collaboratively. According to an Accenture survey, key trends include:\n\n25% of pharma marketing is now delivered digitally.\n87% plan to increase analytics usage for targeted spending and improved ROI.\n77% of sales executives already use third-party service providers to augment sales and marketing activities.\nUtilizing pharma CRM and analytics enables companies to meet cost reduction goals, master multichannel marketing, and refine sales delivery models. As data continues to grow exponentially, designing commercial business strategies with big data and advanced analytics becomes imperative for sustained success.\n\nLeveraging Different Data Types for Growth\nVarious data types, including patient surveys, pharma sales programs, call center data, sales visit information, and prescribers' data, hold profound relevance for ongoing sales programs. Pharma data analytics provides early opportunities for upselling and cross-selling, leading to increased profits. Swift decision-making and elimination of implementation delays result from the insights derived from these analytics.\n\nHarnessing the Power of Reporting, Predictive, and Prescriptive Analytics\nReporting Analytics:\nEnhances operational efficiency.\nAssists in understanding sales cycles.\nEnsures regulatory compliance, such as Sunshine Act adherence.\nPredictive Analytics:\nUnderstands payer and prescriber behavioral patterns.\nInforms decision-making to reduce risks and product failures.\nExamples include revenue forecasting and customer lifetime value analysis.\nPrescriptive Analytics:\nTransforms predictive insights into actionable strategies.\nGuides specific business goals, such as marketing strategy planning.\nThe Future of Pharma Data Analytics:\nAs the pharmaceutical industry continues to evolve, the role of data analytics will become increasingly pivotal. Embracing digital transformation, overcoming integration challenges, and fostering a culture of data-driven decision-making will be essential for companies seeking to thrive in a competitive and dynamic healthcare landscape.\n\nOvercoming Challenges in Data Integration\nEffective utilization of pharma analytics solutions relies on consistent, reliable, and linked data. Life sciences companies face challenges in achieving end-to-end data integration, requiring capabilities like trusted data sources, cross-linkages, quality assurance, workflow management, and role-based access.\n\nDespite concerns about investing in big-data analytical capabilities, the immense volume of data generated daily renders this skepticism unfounded. Companies that embrace this change can witness substantial business growth, as demonstrated by peers who have successfully implemented big data in their organizations.\n\nCurious about how you can elevate your pharma sales operations? Get in touch for more insights and guidance.",
      "json_metadata": "{\"tags\":[\"pharma\",\"data\",\"analytics\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "pharma",
      "permlink": "pharma-data-analytics-insights-illuminating-the-path-to-progress",
      "title": "Pharma Data Analytics Insights: Illuminating the Path to Progress"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-11-14T18:32:06",
  "trx_id": "7291be456d1732578c00219405f6d68645da6550",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 79880013,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Pharma Data Analytics refers to the systematic use of advanced analytical techniques on vast datasets within the pharmaceutical industry. This transformative approach harnesses the power of big data and analytics to extract valuable insights, optimize processes, and drive informed decision-making across various facets of the pharmaceutical sector. This article explores how leveraging data analytics can empower pharmaceutical companies to enhance business processes, expedite product development, and achieve sales objectives in today's dynamic market.\n\nKey Components of Pharma Data Analytics:\nData Integration\nSales Optimization\nClinical Trials and Research Efficiency\nRegulatory Compliance\nPrescriptive Analytics\nBenefits of Pharma Data Analytics:\nInformed Decision-Making:\nData analytics empowers pharmaceutical companies to make informed decisions based on real-time insights, reducing reliance on traditional, less precise methods.\nOperational Efficiency:\nBy optimizing sales processes, clinical trials, and research endeavors, data analyticsenhances overall operational efficiency, leading to cost reduction and improved productivity.\nTargeted Marketing:\nAnalytics enables precise targeting in marketing efforts, ensuring that resources are allocated efficiently to reach the right audience.\nRisk Mitigation:\nPredictive analytics helps identify potential risks in research and sales, allowing proactive measures to mitigate challenges and reduce the likelihood of failures.\nRegulatory Compliance:\nReporting analytics ensures that pharmaceutical companies adhere to regulatory requirements, promoting transparency and accountability.\nThe Role of Data Analytics in a Competitive Landscape\nThe evolving competitive landscape necessitates pharmaceutical companies to adapt and deliver patient-centric solutions collaboratively. According to an Accenture survey, key trends include:\n\n25% of pharma marketing is now delivered digitally.\n87% plan to increase analytics usage for targeted spending and improved ROI.\n77% of sales executives already use third-party service providers to augment sales and marketing activities.\nUtilizing pharma CRM and analytics enables companies to meet cost reduction goals, master multichannel marketing, and refine sales delivery models. As data continues to grow exponentially, designing commercial business strategies with big data and advanced analytics becomes imperative for sustained success.\n\nLeveraging Different Data Types for Growth\nVarious data types, including patient surveys, pharma sales programs, call center data, sales visit information, and prescribers' data, hold profound relevance for ongoing sales programs. Pharma data analytics provides early opportunities for upselling and cross-selling, leading to increased profits. Swift decision-making and elimination of implementation delays result from the insights derived from these analytics.\n\nHarnessing the Power of Reporting, Predictive, and Prescriptive Analytics\nReporting Analytics:\nEnhances operational efficiency.\nAssists in understanding sales cycles.\nEnsures regulatory compliance, such as Sunshine Act adherence.\nPredictive Analytics:\nUnderstands payer and prescriber behavioral patterns.\nInforms decision-making to reduce risks and product failures.\nExamples include revenue forecasting and customer lifetime value analysis.\nPrescriptive Analytics:\nTransforms predictive insights into actionable strategies.\nGuides specific business goals, such as marketing strategy planning.\nThe Future of Pharma Data Analytics:\nAs the pharmaceutical industry continues to evolve, the role of data analytics will become increasingly pivotal. Embracing digital transformation, overcoming integration challenges, and fostering a culture of data-driven decision-making will be essential for companies seeking to thrive in a competitive and dynamic healthcare landscape.\n\nOvercoming Challenges in Data Integration\nEffective utilization of pharma analytics solutions relies on consistent, reliable, and linked data. Life sciences companies face challenges in achieving end-to-end data integration, requiring capabilities like trusted data sources, cross-linkages, quality assurance, workflow management, and role-based access.\n\nDespite concerns about investing in big-data analytical capabilities, the immense volume of data generated daily renders this skepticism unfounded. Companies that embrace this change can witness substantial business growth, as demonstrated by peers who have successfully implemented big data in their organizations.\n\nCurious about how you can elevate your pharma sales operations? Get in touch for more insights and guidance.",
      "json_metadata": "{\"tags\":[\"pharma\",\"data\",\"analytics\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "pharma",
      "permlink": "pharma-data-analytics-excellence-pioneering-the-future-of-healthcare",
      "title": "Pharma Data Analytics Excellence: Pioneering the Future of Healthcare"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-11-14T17:54:45",
  "trx_id": "15c80129ddd3bea9a8273ac92af42f633978fad7",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 79878956,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "In today's digital era, the term \"data\" often poses a challenge for many industries, including pharma and biotech, as they grapple with an abundance of raw data but lack a clear understanding of how to leverage it. The pharmaceutical industry is experiencing a significant impact from the growing accessibility of high-quality real-world healthcare data.\n\nRecent findings highlight the importance of applying specific data strategies for innovation optimization, enhanced research and clinical trial efficiency, and transitioning to a patient-centric healthcare approach. Pharma leadership teams consistently prioritize these strategies to stay ahead in the industry.\n\nPharma analytics are deemed crucial, with nearly 40% of industry professionals identifying it as the most significant trend in the upcoming year. Key areas of focus include:\n\nIdentifying potential drug candidates.\nMonitoring clinical trials.\nAnalyzing trends in electronic health records.\nImproving tracking of patient statistics.\nPredicting healthcare outcomes.\nDesigning treatment protocols.\nTo thrive in the evolving field of pharma data, organizations must grasp the relevance of available data sources, understand their unique differences, recognize the importance of the information they provide, and learn how to harness it for company benefit.\n\nPrimary vs. Secondary Data Sources\nIn pharma data analytics, data falls into two main categories: primary and secondary data sources.\n\nPrimary Data Sources: Gathered through direct interactions with end-users, such as physicians, clinical trial participants, or patients involved in treatment generating medical claims.\n\nSecondary Data Sources: Collected through market research, utilizing databases, and registries, including information from sources like social media, websites, the Sunshine Act Database, and FDA databases.\n\nBoth primary and secondary data sources offer timely, relevant information crucial for evaluating strategic opportunities in the global pharma market.\n\nExamples of Primary Data Sources in Pharma\nClinical Trials:\n \nEssential for providing detailed information on the safety and efficacy of pharma products.\nA crucial phase in drug development, with associated costs estimated at over $2.5 billion.\n\nPatient Testimonials:\n\nIncreasingly important for building patient connections.\nResearch shows that inspirational patient stories lead to increased hope and proactive actions.\n\nAdverse Events:\n\nCrucial for legal compliance and improving future trials.\nFDA guidance emphasizes the importance of managing and tracking adverse events.\n\nSales Operations and CRM Software:\n\nEssential for effective sales operations.\nAnalyzes data to develop comprehensive promotion strategies and target audiences.\nExamples of Secondary Data Sources\nSocial Media:\n\nTransforming pharma and healthcare industries.\nOver 80% of social media users actively seek health-related information, with patient testimonials driving engagement.\n\nSunshine Act Database:\n\nPublishes data disclosing payments made to healthcare professionals and organizations.\nValuable for understanding the financial interactions impacting decision-making and healthcare costs.\nIn the current open healthcare information era, access to actionable pharma data is crucial for meeting customer needs, driving innovation, and increasing revenue. P360 proudly serves as a premium pharma data solutions provider, offering streamlined access to primary and secondary data sources. Our advanced pharma analytics and data management platform empower organizations to adapt to customer needs, achieve better results, and enhance overall performance.\n\nIf you have any questions or comments, feel free to post them below in the comment section! Interested in experiencing the power of our platform? Request a free demo today!",
      "json_metadata": "{\"tags\":[\"pharma\",\"data\",\"analytics\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "pharma",
      "permlink": "pharma-analytics-navigating-the-data-landscape",
      "title": "Pharma Analytics: Navigating the Data Landscape"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-11-14T17:01:36",
  "trx_id": "3c8f4a97228208b1717cb3e253637865d6fa2519",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 79875579,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "In today's digital era, the term \"data\" often poses a challenge for many industries, including pharma and biotech, as they grapple with an abundance of raw data but lack a clear understanding of how to leverage it. The pharmaceutical industry is experiencing a significant impact from the growing accessibility of high-quality real-world healthcare data.\n\nRecent findings highlight the importance of applying specific data strategies for innovation optimization, enhanced research and clinical trial efficiency, and transitioning to a patient-centric healthcare approach. Pharma leadership teams consistently prioritize these strategies to stay ahead in the industry.\n\nPharma analytics are deemed crucial, with nearly 40% of industry professionals identifying it as the most significant trend in the upcoming year. Key areas of focus include:\n\nIdentifying potential drug candidates.\nMonitoring clinical trials.\nAnalyzing trends in electronic health records.\nImproving tracking of patient statistics.\nPredicting healthcare outcomes.\nDesigning treatment protocols.\nTo thrive in the evolving field of pharma data, organizations must grasp the relevance of available data sources, understand their unique differences, recognize the importance of the information they provide, and learn how to harness it for company benefit.\n\nPrimary vs. Secondary Data Sources\nIn pharma data analytics, data falls into two main categories: primary and secondary data sources.\n\nPrimary Data Sources: Gathered through direct interactions with end-users, such as physicians, clinical trial participants, or patients involved in treatment generating medical claims.\n\nSecondary Data Sources: Collected through market research, utilizing databases, and registries, including information from sources like social media, websites, the Sunshine Act Database, and FDA databases.\n\nBoth primary and secondary data sources offer timely, relevant information crucial for evaluating strategic opportunities in the global pharma market.\n\nExamples of Primary Data Sources in Pharma\nClinical Trials:\n \nEssential for providing detailed information on the safety and efficacy of pharma products.\nA crucial phase in drug development, with associated costs estimated at over $2.5 billion.\n\nPatient Testimonials:\n\nIncreasingly important for building patient connections.\nResearch shows that inspirational patient stories lead to increased hope and proactive actions.\n\nAdverse Events:\n\nCrucial for legal compliance and improving future trials.\nFDA guidance emphasizes the importance of managing and tracking adverse events.\n\nSales Operations and CRM Software:\n\nEssential for effective sales operations.\nAnalyzes data to develop comprehensive promotion strategies and target audiences.\nExamples of Secondary Data Sources\nSocial Media:\n\nTransforming pharma and healthcare industries.\nOver 80% of social media users actively seek health-related information, with patient testimonials driving engagement.\n\nSunshine Act Database:\n\nPublishes data disclosing payments made to healthcare professionals and organizations.\nValuable for understanding the financial interactions impacting decision-making and healthcare costs.\nIn the current open healthcare information era, access to actionable pharma data is crucial for meeting customer needs, driving innovation, and increasing revenue. P360 proudly serves as a premium pharma data solutions provider, offering streamlined access to primary and secondary data sources. Our advanced pharma analytics and data management platform empower organizations to adapt to customer needs, achieve better results, and enhance overall performance.\n\nIf you have any questions or comments, feel free to post them below in the comment section! Interested in experiencing the power of our platform? Request a free demo today!",
      "json_metadata": "{\"tags\":[\"pharma\",\"analytics\",\"insights\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "pharma",
      "permlink": "pharma-analytics-insights-unveiling-trends-and-transformations",
      "title": "Pharma Analytics Insights: Unveiling Trends and Transformations"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-11-14T14:12:06",
  "trx_id": "a92c695d38adc9a590c25c86d2a9883cac5cfe1c",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 79509553,
  "op": [
    "transfer",
    {
      "amount": "0.010 STEEM",
      "from": "bluesniper",
      "memo": "Hello. Good to see you on Steem. To maximize your rewards, publish your post also on Hive ( https://hive.blog ) and Blurt ( https://blurt.blog ) blockchains",
      "to": "shriyala"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-11-01T18:53:45",
  "trx_id": "15bacd1fb2ff04a2d4cf3415b1b65c6f010975d5",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 79509546,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "pharma-marketing-unleashed-the-future-of-healthcare-promotion",
      "voter": "bluesniper",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-11-01T18:53:24",
  "trx_id": "382ae7120aea88d7b2a5eea84233ee05aac7c033",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 79509443,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The pharmaceutical industry is a vital player in advancing patient care, with its innovative diagnostics and therapeutics enabling medical professionals to treat health disorders and diseases more effectively. However, like any industry, the pharmaceutical sector must adhere to stringent legal and ethical standards, particularly in the context of marketing and sales. Compliance plays a crucial role in ensuring patient care remains a top priority and mitigating risks that can arise from non-compliance.\n\nUnderstanding Compliance in Pharma Marketing:\n\nCompliance in pharma marketing entails adhering to regulatory guidelines and ethical standards set by relevant authorities. It involves conducting marketing and promotional activities transparently, accurately, and with a focus on patient safety.\n\nCompliance in pharmaceutical marketing involves adhering to various laws and regulations, including:\n\n  Disclosing all known risks and side effects of a drug.\n  Promoting a drug only for its approved use(s).\n  Avoiding false or misleading claims about a product's effectiveness or safety.\n  Including all necessary warnings and precautions in promotional materials.\nThe Challenges of Compliance:\n\nCompliance can be challenging for pharmaceutical companies due to various issues, including the need to balance product promotion with risk disclosure, staying updated on evolving laws and regulations, managing global marketing campaigns across different jurisdictions, and ensuring all employees are aligned with compliance requirements.\n\nWhy Compliance Standards Matter in Pharma Marketing:\n\nCompliance standards are crucial in pharmaceutical marketing for several reasons:\n\n  Patient Safety: Compliance prioritizes patient safety by ensuring the accurate and safe promotion of medications, preventing off-label use, and protecting against misleading claims.\n  Regulatory Adherence: Compliance helps pharmaceutical companies meet legal requirements and standards set forth by regulatory agencies, preventing penalties, fines, and legal repercussions.\n  Ethical Standards: Compliance fosters ethical conduct in the industry, promoting transparency, trust, and fairness among healthcare professionals, patients, and the public.\n  Protection against Misleading Practices: Compliance safeguards against misleading marketing practices, providing patients and healthcare professionals with accurate information.\n  Preventing Off-Label Promotion: Compliance prevents off-label promotion, safeguarding patients from potential harm associated with unapproved uses.\n  Reputation and Trust: Compliance enhances a company's reputation and fosters trust among stakeholders, contributing to long-term success.\nRisks of Non-Compliance in Pharma Marketing:\n\nNon-compliance with regulations exposes pharmaceutical companies to several risks, including hefty fines and penalties, legal actions, loss of licenses, reputational damage, ethical implications, and business loss. Ensuring compliance is essential to avoid these consequences.\n\nCompliance Framework in Pharma Marketing and Sales:\n\nTo maintain compliance, pharmaceutical companies should implement a comprehensive compliance framework. Key measures include:\n\n  Adherence to Approved Indications: Marketing and selling products only for approved indications.\n  Truthful and Balanced Information: Providing accurate, balanced, and evidence-based information.\n  Regulatory Approval for Promotional Materials: Ensuring all promotional materials meet regulatory guidelines.\n  Compliance with Advertising Regulations: Following strict regulations governing advertising content.\n  Adverse Event Reporting: Establishing systems to monitor and report adverse events.\n  Transparency in Financial Relationships: Disclosing financial ties and conflicts of interest.\n  Comprehensive Policies and Procedures: Outlining compliance requirements in internal policies.\n  Compliance Training and Education: Providing training programs to educate employees.\n  Monitoring and Auditing: Regularly monitoring activities and conducting internal audits.\nCollaboration with Regulatory Authorities: Cooperating with regulatory authorities to ensure compliance.\nEthical Culture and Values: Cultivating an ethical culture within the organization.\nCompliance with Emerging Technologies:\n\nAs the pharmaceutical industry evolves, compliance remains critical in marketing and advertising. New technologies and communication channels present new challenges. Compliance-enabled solutions like P360's ZING Engagement Suite simplify compliance measures, enabling compliant text messaging with healthcare professionals while maintaining data security and transparency.\n\nConclusion:\n\nCompliance in pharma marketing and sales is essential to prioritize patient safety, adhere to regulations, uphold ethical standards, and protect against the risks of non-compliance. By implementing a robust compliance framework and leveraging innovative solutions, pharmaceutical companies can build trust, ensure public health and safety, and secure long-term success in the industry. Staying proactive, vigilant, and adaptable to evolving legal and regulatory requirements is crucial for sustained compliance and industry reputation.\n\nTo learn more about all of P360’s innovative products, visit P360.com",
      "json_metadata": "{\"tags\":[\"pharma\",\"marketing\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "pharma",
      "permlink": "pharma-marketing-unleashed-the-future-of-healthcare-promotion",
      "title": "Pharma Marketing Unleashed: The Future of Healthcare Promotion"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-11-01T18:48:09",
  "trx_id": "021be9f25b29c7665151a29988a8fbf14ead3904",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 79480042,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "large-language-models-transforming-industry-dynamics",
      "voter": "bluesniper",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-10-31T18:11:51",
  "trx_id": "543a9052910c811c005fa30b78eba3fe2e137566",
  "trx_in_block": 12,
  "virtual_op": 0
}

{
  "block": 79479936,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "In the ever-evolving landscape of technology, Generative AI, Machine Learning (ML), and Artificial Intelligence (AI) are pivotal forces reshaping industries and revolutionizing the way we interact with data. Large Language Models (LLMs) stand at the forefront of this transformation, making their mark as powerful engines of innovation. However, with great power comes great responsibility, and the privacy and security implications of public large language models have led to the emergence of private LLMs, a trend particularly pronounced in the life sciences industry.\n\nThe Impact of Generative AI on Industry\n\nThe advent of Generative AI, Machine Learning, and Artificial Intelligence has marked a paradigm shift in how we leverage technology. These technologies have the potential to understand, generate, and manipulate human language, driving innovation and efficiency across multiple sectors.\n\nLarge Language Models: Driving Transformation\n\nLarge Language Models (LLMs) are at the forefront of this transformation, powered by advanced algorithms and the capabilities of AI and ML. They are catalysts for reshaping industries and enabling new ways of interaction with computers.\n\nExploring the Influence of Large Language Models (LLMs) Across Industries\n\nLLMs have ushered in a new era of business operations. They excel in content generation, automation of customer interactions, and data-driven insights, significantly enhancing efficiency and productivity in various sectors. Notably, the life sciences industry has embraced LLMs for their potential to accelerate research and enhance healthcare. However, the integration of LLMs in this sector presents distinct challenges, with data privacy and security taking center stage.\n\nUnique Challenges in the Life Sciences Industry\n\nThe life sciences industry faces intricate challenges due to its complex research processes and the sensitive nature of patient data. The adoption of LLMs necessitates thoughtful consideration of these challenges. Protecting patient data remains a top priority, making data privacy and security-critical.\n\nPrivate Large Language Models vs. Public Large Language Models: The Critical Distinction\n\nThe distinction between private and public Large Language Models is pivotal, particularly concerning data privacy and the risks associated with Artificial Intelligence hallucination. Private LLMs serve as guardians of data privacy within organizations. They exclusively employ in-house data, ensuring the confidentiality of sensitive information, such as patient records and proprietary business data. The \"need-to-know\" principle is upheld, allowing access only to authorized personnel and preventing unauthorized breaches.\n\nEnsuring Data Security: The \"Walled Garden\" Approach\n\nTo safeguard sensitive data within private LLMs, organizations often employ the \"Walled Garden\" Approach to data protection. This strategy creates a secure environment fortified with stringent security measures to shield data during storage and transit. Robust encryption techniques are utilized to prevent unauthorized access.\n\nThe Menace of Artificial Intelligence Hallucination\n\nArtificial Intelligence hallucination poses a serious threat when LLMs generate content that appears accurate but contains factual inaccuracies. In sectors where accuracy is paramount, such as healthcare, AI hallucinations can have life-threatening consequences. Erroneous medical advice or misinterpretation of symptoms by a healthcare chatbot can jeopardize patient safety.\n\nThe Imperative of Private Large Language Models (LLMs)\n\nPrivate LLMs offer significant potential for organizations seeking to harness the capabilities of Generative AI, ML, and AI securely. They facilitate content creation, customer interaction automation, and extraction of valuable insights from unstructured data. Deploying private LLMs, however, presents a strategic challenge.\n\nBuilding Custom Private Large Language Models\n\nCustom-built private LLMs enable organizations to tailor these models to their specific needs, ensuring alignment with their objectives. This approach grants complete control over the data used for model training, enhancing data security and privacy. Nevertheless, developing custom private LLMs demands substantial financial investment and resources. Data mining, involving data collection, cleaning, and sorting, is time-consuming and requires expertise. Assembling a team of experts in Machine Learning, AI, and Natural Language Processing to create in-house LLMs presents its own challenges.\n\nUsing APIs for Private Large Language Model Development\n\nUtilizing Application Programming Interfaces (APIs) provided by LLM service providers offers a convenient alternative to custom development. This approach saves time by allowing quick integration of private LLMs into existing systems and applications. It also reduces the requirement for in-house expertise, as the service provider manages the underlying technology.\n\nRisks and Concerns in API Deployment\n\nAPI utilization offers convenience but raises concerns about data privacy and scalability. Entrusting data to external providers through third-party APIs can heighten privacy concerns. Scalability limitations stem from the predefined functionality of such APIs, limiting customization according to specific functional requirements.\n\nEnsuring Data Security When Using Third-party APIs\n\nTo mitigate the security challenges associated with third-party APIs for private LLM deployment, organizations must take precautionary measures, including data encryption. Strong encryption methods protect data during both transit and storage. Data handling policies must be implemented to govern how service providers handle data and ensure compliance with privacy regulations. Regular security audits and assessments are necessary to monitor the service provider's data handling practices.\n\nRisks in API-driven LLM Development: Intellectual Property Concerns\n\nAPI-driven private LLM development carries the risk of data exposure and intellectual property compromise. Data exposure can lead to security breaches, enabling unauthorized access or data theft. Reverse engineering, or the discovery of proprietary methods and critical information, is also a potential concern.\n\nSafeguarding Intellectual Property in API Usage\n\nIntellectual property (IP) is a priceless asset for organizations. This includes patents, copyrights, trademarks, and trade secrets that underpin innovation and competitiveness. When using APIs for private LLMs, safeguarding intellectual property becomes paramount. Protecting IP ensures that an organization's unique technology and content remain secure and immune to replication by competitors.\n\nStrategies for Protecting Intellectual Property in API-driven LLMs\n\nOrganizations can adopt several strategies to safeguard intellectual property when using APIs for private LLM development:\n\nEnsuring Data Consistency and Accuracy in API-driven LLMs.\nContinuous Monitoring for Data Consistency.\nRobust Security Measures.\n\nCustomized Solutions: Balancing Needs and Risks\n\nIn the rapidly evolving field of life sciences, custom solutions offer a viable approach to address unique challenges while harnessing the power of LLMs. Customized LLMs provide flexibility to align with precise business objectives and support various functions, such as clinical trial data analysis, sales, patient sentiment analysis, regulatory compliance, and quality standards.\n\nThe Future of Private Large Language Models in the Life Sciences Industry\n\nThe integration of LLMs promises to revolutionize the life sciences industry by accelerating drug discovery, improving clinical trial data analysis, and enhancing patient care. Ethical considerations surrounding LLM deployment remain paramount, emphasizing the significance of patient data privacy and regulatory compliance.\n\nThe Ongoing Evolution of Generative AI in Healthcare\n\nGenerative AI in healthcare continues to advance, transforming diagnosis, drug development, and medical information. Private AI systems play a critical role in harnessing AI's power while ensuring ethical practices within the healthcare sector.\n\nThe Rising Significance of Private Large Language Models\n\nPrivate LLMs are gaining prominence, especially in sensitive industries like healthcare, for their ability to mitigate risks associated with public models while enabling secure and responsible AI deployment. Organizations must carefully choose between APIs, custom LLMs, or customized solutions to ensure data privacy, security, and strategic alignment with their specific needs. As LLMs continue to shape industries and accelerate innovation, their responsible and secure usage remains a top priority.\n\nTo learn more about all P360’s innovative products, visit P360.com",
      "json_metadata": "{\"tags\":[\"large\",\"language\",\"models\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "large",
      "permlink": "large-language-models-transforming-industry-dynamics",
      "title": "Large Language Models: Transforming Industry Dynamics"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-10-31T18:06:33",
  "trx_id": "9e8515955fc813db48d0ef4c45c7023f2c0f97f1",
  "trx_in_block": 4,
  "virtual_op": 0
}

{
  "block": 79363022,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The pharmaceutical industry, dedicated to advancing patient care, must adhere to legal and ethical standards in marketing and sales. Compliance in pharma is of vital importance, as it ensures patient safety and reduces liabilities. This SEO-friendly article will explore the significance of compliance in pharmaceutical marketing, its definition, and the risks associated with non-compliance. Additionally, we'll provide a comprehensive framework for achieving compliance in pharma marketing and sales, emphasizing the importance of patient safety, regulatory adherence, and ethical standards.\n\nWhat Does Compliance in Pharma Marketing Mean? Compliance in pharma marketing entails adhering to regulatory guidelines and ethical standards while conducting marketing and promotional activities. It involves transparent, accurate, and patient-centric marketing practices. Compliance ensures that pharmaceutical companies follow laws and regulations related to drug promotion, including disclosing risks, promoting drugs for approved uses, avoiding false claims, and providing necessary warnings and precautions. However, maintaining compliance can be challenging due to the need to balance promotion with risk disclosure, stay updated on evolving regulations, manage global campaigns, and ensure employee alignment.\n\nWhy Compliance Standards Matter in Pharma Marketing: Compliance standards are essential in pharmaceutical marketing for several key reasons:\n\nPatient Safety: Compliance prioritizes patient safety by ensuring accurate information, approved indications, and prompt adverse event reporting, preventing off-label promotion.\n\nRegulatory Adherence: Compliance helps companies meet the legal requirements set by regulatory bodies like the FDA, EMA, and more, avoiding penalties and reputational damage.\n\nEthical Standards: Compliance fosters trust by promoting transparency, integrity, and fair conduct in promotional activities, maintaining the industry's reputation.\n\nProtection against Misleading Practices: It safeguards against misleading claims and ensures patients receive accurate information for informed decisions.\n\nPreventing Off-Label Promotion: Compliance guidelines prohibit potentially risky off-label drug promotion.\n\nReputation and Trust: Compliance builds and maintains a positive reputation, enhancing trust among stakeholders.\n\nRisks of Non-Compliance in Pharma Marketing : Non-compliance in pharma marketing exposes companies to various risks:\n\nHefty Fines and Penalties: Violations can lead to significant civil and criminal fines imposed by regulatory bodies like the Department of Justice and FDA.\n\nLegal Action and Loss of Licenses: Non-compliant companies face legal repercussions, including license revocation and lawsuits from injured consumers.\n\nReputational Risk: Trust in the industry can be shattered, resulting in a loss of brand value, business, and investor confidence.\n\nEthical Implications: Non-compliance may lead to unethical practices, harming patients, and violating the law.\n\nBusiness Loss: Fines, lawsuits, and reputational damage can affect profitability, market share, and investor confidence.\n\nCompliance Framework in Pharma Marketing and Sales : Pharmaceutical companies must implement a comprehensive compliance framework to ensure adherence to regulations. Key measures include:\n\nAdherence to Approved Indications: Marketing products only for approved indications and avoiding off-label promotion.\n\nTruthful and Balanced Information: Providing accurate, balanced, and evidence-based information.\n\nRegulatory Approval: Ensuring all promotional materials gain regulatory approval.\n\nCompliance with Advertising Regulations: Following advertising content guidelines.\n\nAdverse Event Reporting: Monitoring and reporting adverse events.\n\nTransparency in Financial Relationships: Disclosing financial ties and conflicts of interest.\n\nComprehensive Policies and Procedures: Establishing internal policies covering various compliance aspects.\n\nCompliance Training and Education: Providing regular training to educate employees on regulations and ethical considerations.\n\nMonitoring and Auditing: Assessing adherence and implementing corrective measures.\n\nCollaboration with Regulatory Authorities: Cooperating with regulatory authorities to ensure compliance.\n\nEthical Culture and Values: Fostering an ethical organizational culture.\n\nZING Simplifies Pharma Marketing Compliance: With ZING, pharma teams can achieve compliance in text-based communication. It offers preapproval for messages and digital assets, a user-friendly portal for tracking messages, and data storage for legal reporting. ZING allows compliant two-way messaging with healthcare professionals without the need for app downloads. It ensures a seamless and hassle-free experience for HCPs, improving trust and reliability.\n\nFinal Thoughts on Compliance in Pharma Marketing: To protect public health and safety, compliance remains paramount in the pharmaceutical industry. Staying updated on regulations, investing in compliance resources like ZING, and committing to ethical marketing practices are essential. Companies must remain vigilant, proactive, and adaptable in their compliance programs to align with evolving legal and regulatory requirements. This not only safeguards public health but also ensures the long-term success of pharmaceutical businesses.\n\nTo learn more about all P360’s innovative products, visit P360.com",
      "json_metadata": "{\"tags\":[\"compliance\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "pharma",
      "permlink": "pharma-compliance-audits-from-preparation-to-performance",
      "title": "Pharma Compliance Audits: From Preparation to Performance"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-10-27T16:16:00",
  "trx_id": "82d7ac8f180ca9cae0730aa7169deac8877b3341",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 79277353,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "machine-learning-in-pharma-a-prescription-for-innovation",
      "voter": "bluesniper",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-10-24T16:34:24",
  "trx_id": "72f4fa16c9f0be5998bff8b29e5629c5a7b5613f",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 79277245,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The pharmaceutical industry has long been a cornerstone of global healthcare, consistently pushing the boundaries of innovation and research. In recent years, it has witnessed a dramatic transformation, largely driven by the integration of artificial intelligence (AI) and machine learning (ML) into various facets of drug discovery, development, and patient care. With the sector poised to reach a staggering $1.5 trillion economy by 2023, the adoption of more efficient and automated processes is not only a choice but a necessity.\n\nAI in Pharma: A Paradigm Shift\n\nThe integration of AI in the pharmaceutical industry has been a game-changer, revolutionizing the landscape of drug discovery and development. AI empowers pharmaceutical companies to advance precision medicine, ensuring that healthcare treatments reach the right patients at the right time. This transformative influence of AI extends from the early stages of drug discovery to the improved understanding and utilization of clinical trial data, marking a consistent and progressive integration of AI technologies.\n\nHere Are Four AI & ML Trends in the Pharma Industry\n\nDrug Discovery and Development using AI in Pharma\nThe journey from conceptualizing a new drug to bringing it to market is arduous, taking 7-10 years and costing a staggering $2 billion. Furthermore, the process is fraught with high failure rates at various stages. Companies like Cyclica and Bayer are leading the charge in this sector, collaborating to expedite drug discovery. Cyclica, a biotechnology firm, has harnessed AI and computational biophysics to screen small molecule drugs against existing repositories of proteins, dramatically reducing discovery time. Their algorithms predict ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) to enhance drug efficacy.\n\nVerge Genomics, a neuroscience firm, is partnering with pharmaceutical companies and tissue banks to leverage AI in bringing AI-generated compounds to market for the treatment of neurodegenerative diseases. Through large databases of patient tissues and AI-driven analysis, they discover novel gene targets.\n\nRare Diseases & Personalized Medicine\nHistorically, pharma companies focused on diseases affecting large populations, driven by regulatory requirements and the need for affordable drugs. However, AI has opened doors to drug development for rare diseases. The partnership between Tencent Holdings and Huma exemplifies the power of AI in detecting and diagnosing rare neurological diseases. AI algorithms are also used to create personalized drug treatments based on an individual’s genes, environment, and lifestyle. This shift towards personalized medicine is epitomized by the collaboration between Aprecia and Cycle Pharmaceuticals in the development of orphan drugs.\n\nClinical Trials\nClinical trials are a critical phase in drug development, but they face significant challenges. According to a study, 80% of clinical trials fail to meet enrollment timelines, and 1/3 of phase 3 trials terminate due to enrollment difficulties. Start-ups like Deep and Antidote are addressing these challenges using machine learning algorithms. Deep6's AI software analyzes a wide range of clinical data to streamline patient selection for pharmaceutical firms, while Antidote's AI platform matches patients with suitable trials based on their health conditions.\n\nDrug Adherence and Dosage\nMaintaining patient adherence and precise dosage during clinical trials is essential. AbbVie and AiCure use smartphone technology with machine learning algorithms to monitor drug adherence, particularly in diseases like schizophrenia. Curate.Ai, on the other hand, assists clinicians in identifying the right drug combination and dosing strategy based on individual patient data, especially relevant in complex diseases like cancer.\n\nAI in Pharmaceuticals: A Healthcare Revolution\n\nThe integration of AI in the pharmaceutical industry is drastically altering how medicines are formulated and brought to market. The traditionally prolonged and costly process has evolved into an efficient and collaborative endeavor, thanks to AI. Pharmaceutical companies are partnering with technology firms, resulting in the development of groundbreaking products. AI's influence extends throughout the industry, making it an intelligent assistant for scientists and doctors, enabling the faster and more cost-effective development of superior medicines.\n\nThe expedited introduction of new treatments enhances healthcare for all. BirdzAI, a data management solution that combines AI and ML, empowers the industry with insights and predictions to make data-driven decisions. Data360, another solution, leverages machine learning to predict outcomes more accurately than humans using a multitude of variables.\n\nThe pharmaceutical industry is at the cusp of a transformative era, driven by the power of AI and ML. From drug discovery and development to clinical trials, rare diseases, and drug adherence, AI is changing the game. It's not just about making processes more efficient; it's about improving patient care, enhancing the quality of medicines, and ushering in a new era of healthcare. The integration of AI is not just a trend; it's a revolution that's here to stay. As we move forward, the pharmaceutical industry, in partnership with AI, will continue to unlock new possibilities and reach even greater heights.\n\nTo learn more about all of P360’s innovative products, visit P360.com",
      "json_metadata": "{\"tags\":[\"machine\",\"learning\",\"in\",\"pharma\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "machine",
      "permlink": "machine-learning-in-pharma-a-prescription-for-innovation",
      "title": "Machine Learning in Pharma: A Prescription for Innovation"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-10-24T16:28:57",
  "trx_id": "7daf440f9354d599a23f76166bcf7202fea3f57f",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 79275577,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "In the complex and ever-evolving landscape of healthcare, Effective Healthcare Professional (HCP) Engagement stands as a linchpin for success. Whether you are a pharmaceutical company, a medical device manufacturer, or a healthcare provider, fostering strong and productive relationships with HCPs is not just a strategy; it's a necessity. In this blog, we'll delve into the reasons why effective HCP engagement is of utmost importance.\n\nEnhanced Patient Care:Effective engagement with HCPs directly impacts patient care. When pharmaceutical companies and medical device manufacturers collaborate with healthcare providers, they can provide valuable information about new treatments, drugs, and technologies. Patient care lies at the core of the healthcare industry, and elevating it is a collective responsibility. One of the most pivotal factors contributing to improved patient care is Effective Healthcare Professional (HCP) Engagement. This ensures that patients receive the most up-to-date and effective healthcare options available.\nFostering Innovation:The synergy between pharmaceutical companies and HCPs fosters innovation in the medical field. Through close collaboration, HCPs can share their clinical insights and experiences, which can inform the development of new drugs and medical devices. This collaboration accelerates the pace of medical advancements, benefitting patients worldwide.\nCompliance and Ethical Considerations:Effective HCP engagement goes hand in hand with maintaining compliance and adhering to ethical standards. The healthcare industry is heavily regulated, and maintaining transparency and ethical conduct in relationships with HCPs is essential to avoid legal and reputational issues. Companies that prioritize ethical engagement are more likely to earn trust and credibility.\nMarket Access and Commercial Success:Engaging with HCPs is essential for market access and commercial success. HCPs play a pivotal role in recommending and prescribing medications and treatments. Establishing solid relationships with them can help companies gain market access and succeed in a highly competitive industry.\nEducational Resource:HCPs rely on pharmaceutical companies and medical device manufacturers for valuable educational resources. Effective engagement allows these professionals to stay informed about the latest clinical studies, treatment options, and best practices. This knowledge transfer benefits not only the HCPs but also the patients they serve.\nTailored Solutions:Understanding the needs and preferences of HCPs is crucial for tailoring solutions that align with their clinical practice. Effective engagement enables pharmaceutical and medical device companies to develop products and services that directly address the challenges and requirements of healthcare providers, ultimately improving patient outcomes.\nBuilding Trust and Long-Term Relationships:Trust is the cornerstone of any successful relationship, including those in the healthcare industry. Effective HCP engagement involves building trust over time by delivering on promises, providing accurate information, and prioritizing the well-being of patients. Trustworthy partnerships often lead to long-term collaborations and mutual growth.\nData-Driven Decision-Making:HCPs generate a vast amount of valuable data through their clinical practice. Effective engagement allows companies to access this data ethically and leverage it for data-driven decision-making. This can lead to more targeted research and development efforts, ultimately benefiting patients and the healthcare system as a whole.\nPatient-Centered Care:The shift towards patient-centered care means that HCPs need to be well-informed and equipped to make decisions that align with their patient's best interests. Effective engagement ensures that HCPs access the necessary information and resources to deliver patient-centered care.\nAdaptation to Changing Healthcare Dynamics:Healthcare is constantly evolving, with new technologies, treatment modalities, and regulatory changes. Effective engagement with HCPs allows companies to adapt to these changes more quickly and effectively, ensuring that they remain relevant and valuable to the healthcare ecosystem.\nIn conclusion, the importance of effective HCP engagement cannot be overstated. It serves as a catalyst for advancements in patient care, innovation, and ethical conduct within the healthcare industry. Companies that prioritize meaningful and ethical engagement with healthcare professionals not only contribute to better patient outcomes but also position themselves for long-term success in an ever-changing healthcare landscape.\n\nTo learn more about all P360’s innovative products, visit P360.com",
      "json_metadata": "{\"tags\":[\"effective\",\"hcp\",\"engagement\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "effective",
      "permlink": "effective-hcp-engagement-the-bridge-to-better-healthcare",
      "title": "Effective HCP Engagement: The Bridge to Better Healthcare"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-10-24T15:05:18",
  "trx_id": "dd09c0ee88110e7df9638aa688fe806a09658746",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 79249881,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "3fugrz-pharma-compliance-audits-from-preparation-to-performance",
      "voter": "bluesniper",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-10-23T17:34:18",
  "trx_id": "4670edc59e3f07de8f671bbce64c40e9db50df5f",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 79249774,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The pharmaceutical industry, dedicated to advancing patient care, must adhere to legal and ethical standards in marketing and sales. Compliance in pharma is of vital importance, as it ensures patient safety and reduces liabilities. This SEO-friendly article will explore the significance of compliance in pharmaceutical marketing, its definition, and the risks associated with non-compliance. Additionally, we'll provide a comprehensive framework for achieving compliance in pharma marketing and sales, emphasizing the importance of patient safety, regulatory adherence, and ethical standards.\n\nWhat Does Compliance in Pharma Marketing Mean? Compliance in pharma marketing entails adhering to regulatory guidelines and ethical standards while conducting marketing and promotional activities. It involves transparent, accurate, and patient-centric marketing practices. Compliance ensures that pharmaceutical companies follow laws and regulations related to drug promotion, including disclosing risks, promoting drugs for approved uses, avoiding false claims, and providing necessary warnings and precautions. However, maintaining compliance can be challenging due to the need to balance promotion with risk disclosure, stay updated on evolving regulations, manage global campaigns, and ensure employee alignment.\n\nWhy Compliance Standards Matter in Pharma Marketing: Compliance standards are essential in pharmaceutical marketing for several key reasons:\n\nPatient Safety: Compliance prioritizes patient safety by ensuring accurate information, approved indications, and prompt adverse event reporting, preventing off-label promotion.\n\nRegulatory Adherence: Compliance helps companies meet the legal requirements set by regulatory bodies like the FDA, EMA, and more, avoiding penalties and reputational damage.\n\nEthical Standards: Compliance fosters trust by promoting transparency, integrity, and fair conduct in promotional activities, maintaining the industry's reputation.\n\nProtection against Misleading Practices: It safeguards against misleading claims and ensures patients receive accurate information for informed decisions.\n\nPreventing Off-Label Promotion: Compliance guidelines prohibit potentially risky off-label drug promotion.\n\nReputation and Trust: Compliance builds and maintains a positive reputation, enhancing trust among stakeholders.\n\nRisks of Non-Compliance in Pharma Marketing : Non-compliance in pharma marketing exposes companies to various risks:\n\nHefty Fines and Penalties: Violations can lead to significant civil and criminal fines imposed by regulatory bodies like the Department of Justice and FDA.\n\nLegal Action and Loss of Licenses: Non-compliant companies face legal repercussions, including license revocation and lawsuits from injured consumers.\n\nReputational Risk: Trust in the industry can be shattered, resulting in a loss of brand value, business, and investor confidence.\n\nEthical Implications: Non-compliance may lead to unethical practices, harming patients, and violating the law.\n\nBusiness Loss: Fines, lawsuits, and reputational damage can affect profitability, market share, and investor confidence.\n\nCompliance Framework in Pharma Marketing and Sales : Pharmaceutical companies must implement a comprehensive compliance framework to ensure adherence to regulations. Key measures include:\n\nAdherence to Approved Indications: Marketing products only for approved indications and avoiding off-label promotion.\n\nTruthful and Balanced Information: Providing accurate, balanced, and evidence-based information.\n\nRegulatory Approval: Ensuring all promotional materials gain regulatory approval.\n\nCompliance with Advertising Regulations: Following advertising content guidelines.\n\nAdverse Event Reporting: Monitoring and reporting adverse events.\n\nTransparency in Financial Relationships: Disclosing financial ties and conflicts of interest.\n\nComprehensive Policies and Procedures: Establishing internal policies covering various compliance aspects.\n\nCompliance Training and Education: Providing regular training to educate employees on regulations and ethical considerations.\n\nMonitoring and Auditing: Assessing adherence and implementing corrective measures.\n\nCollaboration with Regulatory Authorities: Cooperating with regulatory authorities to ensure compliance.\n\nEthical Culture and Values: Fostering an ethical organizational culture.\n\nZING Simplifies Pharma Marketing Compliance: With ZING, pharma teams can achieve compliance in text-based communication. It offers preapproval for messages and digital assets, a user-friendly portal for tracking messages, and data storage for legal reporting. ZING allows compliant two-way messaging with healthcare professionals without the need for app downloads. It ensures a seamless and hassle-free experience for HCPs, improving trust and reliability.\n\nFinal Thoughts on Compliance in Pharma Marketing: To protect public health and safety, compliance remains paramount in the pharmaceutical industry. Staying updated on regulations, investing in compliance resources like ZING, and committing to ethical marketing practices are essential. Companies must remain vigilant, proactive, and adaptable in their compliance programs to align with evolving legal and regulatory requirements. This not only safeguards public health but also ensures the long-term success of pharmaceutical businesses.\n\nTo learn more about all P360’s innovative products, visit P360.com",
      "json_metadata": "{\"tags\":[\"pharma\",\"marketing\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "pharma",
      "permlink": "3fugrz-pharma-compliance-audits-from-preparation-to-performance",
      "title": "Pharma Compliance Audits: From Preparation to Performance"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-10-23T17:28:57",
  "trx_id": "6e1ef480ffd19365db1a283f0136e7446ceaed3f",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 79248528,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "pharma-compliance-audits-from-preparation-to-performance",
      "voter": "bluesniper",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-10-23T16:26:18",
  "trx_id": "29d0bf35915e4b616a2d84b42b3c4a0275cb1558",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 79248424,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The pharmaceutical industry, dedicated to advancing patient care, must adhere to legal and ethical standards in marketing and sales. Compliance in pharma is of vital importance, as it ensures patient safety and reduces liabilities. This SEO-friendly article will explore the significance of compliance in pharmaceutical marketing, its definition, and the risks associated with non-compliance. Additionally, we'll provide a comprehensive framework for achieving compliance in pharma marketing and sales, emphasizing the importance of patient safety, regulatory adherence, and ethical standards.\n\nWhat Does Compliance in Pharma Marketing Mean? Compliance in pharma marketing entails adhering to regulatory guidelines and ethical standards while conducting marketing and promotional activities. It involves transparent, accurate, and patient-centric marketing practices. Compliance ensures that pharmaceutical companies follow laws and regulations related to drug promotion, including disclosing risks, promoting drugs for approved uses, avoiding false claims, and providing necessary warnings and precautions. However, maintaining compliance can be challenging due to the need to balance promotion with risk disclosure, stay updated on evolving regulations, manage global campaigns, and ensure employee alignment.\n\nWhy Compliance Standards Matter in Pharma Marketing: Compliance standards are essential in pharmaceutical marketing for several key reasons:\n\nPatient Safety: Compliance prioritizes patient safety by ensuring accurate information, approved indications, and prompt adverse event reporting, preventing off-label promotion.\n\nRegulatory Adherence: Compliance helps companies meet the legal requirements set by regulatory bodies like the FDA, EMA, and more, avoiding penalties and reputational damage.\n\nEthical Standards: Compliance fosters trust by promoting transparency, integrity, and fair conduct in promotional activities, maintaining the industry's reputation.\n\nProtection against Misleading Practices: It safeguards against misleading claims and ensures patients receive accurate information for informed decisions.\n\nPreventing Off-Label Promotion: Compliance guidelines prohibit potentially risky off-label drug promotion.\n\nReputation and Trust: Compliance builds and maintains a positive reputation, enhancing trust among stakeholders.\n\nRisks of Non-Compliance in Pharma Marketing : Non-compliance in pharma marketing exposes companies to various risks:\n\nHefty Fines and Penalties: Violations can lead to significant civil and criminal fines imposed by regulatory bodies like the Department of Justice and FDA.\n\nLegal Action and Loss of Licenses: Non-compliant companies face legal repercussions, including license revocation and lawsuits from injured consumers.\n\nReputational Risk: Trust in the industry can be shattered, resulting in a loss of brand value, business, and investor confidence.\n\nEthical Implications: Non-compliance may lead to unethical practices, harming patients, and violating the law.\n\nBusiness Loss: Fines, lawsuits, and reputational damage can affect profitability, market share, and investor confidence.\n\nCompliance Framework in Pharma Marketing and Sales : Pharmaceutical companies must implement a comprehensive compliance framework to ensure adherence to regulations. Key measures include:\n\nAdherence to Approved Indications: Marketing products only for approved indications and avoiding off-label promotion.\n\nTruthful and Balanced Information: Providing accurate, balanced, and evidence-based information.\n\nRegulatory Approval: Ensuring all promotional materials gain regulatory approval.\n\nCompliance with Advertising Regulations: Following advertising content guidelines.\n\nAdverse Event Reporting: Monitoring and reporting adverse events.\n\nTransparency in Financial Relationships: Disclosing financial ties and conflicts of interest.\n\nComprehensive Policies and Procedures: Establishing internal policies covering various compliance aspects.\n\nCompliance Training and Education: Providing regular training to educate employees on regulations and ethical considerations.\n\nMonitoring and Auditing: Assessing adherence and implementing corrective measures.\n\nCollaboration with Regulatory Authorities: Cooperating with regulatory authorities to ensure compliance.\n\nEthical Culture and Values: Fostering an ethical organizational culture.\n\nZING Simplifies Pharma Marketing Compliance: With ZING, pharma teams can achieve compliance in text-based communication. It offers preapproval for messages and digital assets, a user-friendly portal for tracking messages, and data storage for legal reporting. ZING allows compliant two-way messaging with healthcare professionals without the need for app downloads. It ensures a seamless and hassle-free experience for HCPs, improving trust and reliability.\n\nFinal Thoughts on Compliance in Pharma Marketing: To protect public health and safety, compliance remains paramount in the pharmaceutical industry. Staying updated on regulations, investing in compliance resources like ZING, and committing to ethical marketing practices are essential. Companies must remain vigilant, proactive, and adaptable in their compliance programs to align with evolving legal and regulatory requirements. This not only safeguards public health but also ensures the long-term success of pharmaceutical businesses.\n\nTo learn more about all P360’s innovative products, visit P360.com",
      "json_metadata": "{\"tags\":[\"pharma\",\"compliance\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "pharma",
      "permlink": "pharma-compliance-audits-from-preparation-to-performance",
      "title": "Pharma Compliance Audits: From Preparation to Performance"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-10-23T16:21:06",
  "trx_id": "c18eb464c934061fb55ed2e27e5e9fa7a1a3ce41",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 78246701,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Artificial Intelligence (AI) is revolutionizing the way we live and work. With the ability to learn, reason, and make decisions, AI systems are transforming industries and driving innovation. This article explores the applications, benefits, and challenges of AI, shedding light on the potential it holds for the future.\n\nThe growth of Artificial Intelligence (AI) has been nothing short of remarkable. In recent years, advancements in machine learning and deep learning techniques have propelled AI to the forefront of technological innovation. AI systems can now process vast amounts of data, recognize patterns, and make intelligent decisions with increasing accuracy. This growth has led to significant breakthroughs across industries, from healthcare and finance to manufacturing and transportation. AI has revolutionized the way businesses operate, improving efficiency, productivity, and decision-making. As AI continues to evolve, its potential for further growth is immense, promising new opportunities and challenges in shaping the future of technology and society.\n\nArtificial Intelligence (AI) has found diverse applications across various sectors, transforming industries and improving efficiency. In healthcare, AI algorithms are aiding in disease diagnosis, analyzing medical images, and personalizing treatment plans. Finance benefits from AI-driven chatbots for customer service and fraud detection algorithms. Manufacturing harnesses AI for quality control, predictive maintenance, and supply chain optimization. Transportation utilizes AI in autonomous vehicles, traffic management, and route planning for improved safety and efficiency. AI is also making strides in natural language processing, enabling virtual assistants, language translation, and sentiment analysis. From healthcare to finance, AI applications are revolutionizing industries, enhancing decision-making, and shaping the way we live and work.\n\nMachine Learning (ML) and Neural Networks are integral components of Artificial Intelligence (AI) that have revolutionized the way computers learn and make predictions. Machine Learning involves training algorithms on data to recognize patterns and make informed decisions without explicit programming. It encompasses various techniques such as supervised learning, unsupervised learning, and reinforcement learning. Neural Networks, inspired by the human brain's structure, use interconnected layers of artificial neurons to process complex information. Deep Learning, a subset of ML, employs neural networks with multiple layers to tackle complex tasks like image recognition and natural language processing. Machine Learning and Neural Networks have propelled AI advancements, enabling systems to understand, interpret, and learn from vast amounts of data, leading to breakthroughs across industries.\n\nArtificial Intelligence (AI) is transforming various industries, revolutionizing processes, and delivering significant benefits. Here are some industries that are benefiting from AI:\n\nArtificial Intelligence in Healthcare: Artificial Intelligence (AI) is transforming healthcare by revolutionizing diagnostics, personalized medicine, and patient care. AI algorithms analyze medical images, aiding in disease detection and diagnosis with high accuracy. It enables personalized treatment plans by analyzing patient data and genetic information. AI streamlines the drug discovery process, accelerating the development of new therapies. Wearable devices and remote monitoring systems powered by AI enable continuous patient monitoring and early intervention. AI assists in medical imaging analysis, improving diagnostic accuracy. Virtual assistants and chatbots provide patient support and enhance access to healthcare services.\nArtificial Intelligence in Finance: Artificial Intelligence (AI) is revolutionizing the finance industry by transforming processes, improving decision-making, and enhancing customer experiences. AI-powered algorithms analyze vast amounts of financial data to detect patterns, identify trends, and make accurate predictions for investment decisions. Machine learning models optimize risk management, fraud detection, and credit scoring, improving operational efficiency and reducing financial risks. Chatbots and virtual assistants powered by AI provide personalized customer service, assisting with queries, transactions, and financial advice.\nArtificial Intelligence in Transportation:Artificial Intelligence (AI) is transforming the automotive industry, revolutionizing the way vehicles are designed, manufactured, and operated. AI-powered technologies, such as autonomous driving, enhance vehicle safety, efficiency, and convenience. Machine learning algorithms analyze sensor data, enabling vehicles to perceive their surroundings, make real-time decisions, and navigate complex environments. AI also supports advanced driver-assistance systems (ADAS), improving collision avoidance and adaptive cruise control.\nArtificial Intelligence is transforming the world, opening up new possibilities and driving innovation. From healthcare to finance, manufacturing to transportation, AI is revolutionizing industries and improving the quality of life. As we continue to explore the potential of AI, it is essential to navigate the challenges and ensure ethical implementation to harness its full benefits.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"artificial\",\"intelligence\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "artificial",
      "permlink": "artificial-intelligence-transforming-the-future-with-intelligent-machines",
      "title": "Artificial Intelligence: Transforming the Future with Intelligent Machines"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-09-18T09:15:12",
  "trx_id": "236e015ac3bc9a0cccd044722658612489ca1784",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 78245902,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "In the dynamic landscape of healthcare, effective engagement with healthcare professionals (HCPs) is crucial for the success of pharmaceutical companies, medical device manufacturers, and healthcare organizations. This article explores key strategies to foster meaningful and productive relationships with HCPs, resulting in improved collaboration, knowledge exchange, and ultimately, better patient care.\n\nUnderstanding HCP Needs and Preferences\n\nUnderstanding the needs and preferences of healthcare professionals (HCPs) is a fundamental aspect of effective engagement. Organizations can tailor their strategies to meet those needs and foster meaningful relationships by gaining insights into their specific requirements and challenges. Organizations should invest in research methods such as surveys, interviews, and focus groups to gather data directly from HCPs. This research can help identify their priorities, patient populations, areas of interest, and challenges they face in their daily practice. Recognize that different HCPs have different needs and preferences. Tailor engagement strategies are based on factors like specialty, practice setting, and geographical location. Personalization enhances the relevance and value of interactions with HCPs, leading to increased engagement.\n\nPromoting peer-to-peer collaboration among HCPs can be instrumental in improving healthcare outcomes. Creating forums, both online and offline, where HCPs can share best practices, case studies, and clinical experiences can foster a vibrant community of learning and collaboration. These platforms can also serve as spaces for industry experts and thought leaders to engage with HCPs, providing insights into emerging therapies, technological advancements, and healthcare trends. By facilitating such knowledge exchange, organizations can position themselves as valuable partners invested in advancing the practice of medicine.\n\nFacilitating peer-to-peer collaboration and knowledge exchange among healthcare professionals (HCPs) is an effective strategy for fostering engagement and enhancing the practice of medicine. By creating platforms and opportunities for HCPs to share insights, best practices, and clinical experiences, organizations can promote a culture of continuous learning and collaboration. Develop online platforms, forums, or communities where HCPs can connect and engage with their peers. These platforms can be dedicated websites, social media groups, or professional networking platforms tailored to specific medical specialties or areas of interest. By providing a space for HCPs to interact, share knowledge, ask questions, and discuss emerging trends, organizations can foster a vibrant community of learning and collaboration.\n\nOrganize thought leadership programs that bring together HCPs, industry experts, and opinion leaders. These programs can include conferences, symposiums, or panel discussions, where participants can share their expertise, present research findings, and engage in productive discussions. Thought leadership programs provide a platform for HCPs to learn from each other and stay updated on the latest advancements in their fields. Establish mentoring programs that connect experienced HCPs with early-career professionals or those seeking guidance. Peer mentors can provide valuable support, share their expertise, and offer career advice. Additionally, organizations can facilitate coaching programs where HCPs can receive feedback and guidance from their peers on specific clinical or professional challenges. ZING has been tested, scaled, and evolved over the past several years and Pp360 has the experience to keep going, enabling pharmaceutical companies to have practical, compliant HCP engagement.\n\nFacilitating peer-to-peer collaboration and knowledge exchange among HCPs not only strengthens professional networks but also enhances the overall quality of patient care. By creating platforms and initiatives that encourage HCPs to share their knowledge and experiences, organizations can foster a culture of continuous learning, innovation, and collaboration.\n\nTrust is a cornerstone of effective HCP engagement. Organizations must prioritize transparent communication to build and maintain trust with HCPs. This includes openly sharing information about product efficacy, safety profiles, and clinical trial data. Clear and honest communication regarding any conflicts of interest is also crucial for credibility. By being transparent in their interactions, organizations can foster a foundation of trust with HCPs, which is essential for long-term collaboration and partnership. Provide HCPs with clear and accurate information about products, services, clinical data, and research findings. Avoid exaggerations or misleading claims that may undermine credibility. HCPs rely on accurate information to make informed decisions about patient care, and transparent communication helps foster trust in the organization's integrity.\n\nPharma-to-Physician relationships rely on clear, timely communication that is handled in a compliant manner – something that is difficult to ensure with many measures today. That is why solutions like P360’s ZING Engagement Suite is the way to go. Building trust through transparent communication is an ongoing process that requires consistent effort and a genuine commitment to openness and honesty. By establishing transparent communication practices, organizations can cultivate trust with HCPs, leading to stronger relationships, improved collaboration, and ultimately, better patient outcomes.\n\nConclusion:\n\nIn a rapidly evolving healthcare landscape, effective engagement with HCPs is paramount for the success of organizations operating in the life sciences industry. By understanding HCP needs, providing educational resources, promoting collaboration, and fostering transparent communication, organizations can establish strong relationships that drive better patient care and mutually beneficial outcomes for all stakeholders involved.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"effective\",\"hcp\",\"engagement\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "effective",
      "permlink": "effective-hcp-engagement-building-trust-and-strengthening-relationships",
      "title": "Effective HCP Engagement: Building Trust and Strengthening Relationships"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-09-18T08:35:09",
  "trx_id": "2dc9222d0acf5c89ed6a4f530cc2f1208d58ad41",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 78243982,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Artificial Intelligence (AI) technology refers to the ability of machines and computers to perform tasks that typically require human intelligence. These tasks can include reasoning, perception, and decision-making. AI has become increasingly prevalent in recent years and has the potential to revolutionize many industries, from healthcare to finance manufacturing. AI algorithms are typically designed to analyze large amounts of data and identify patterns or relationships that humans may not be able to discern. This ability to process data quickly and accurately makes AI well-suited for applications such as predictive modeling, image and speech recognition, and natural language processing.\n\nArtificial Intelligence (AI) technology has been making waves in various industries, including pharma. With the help of AI, the pharma industry is poised to revolutionize drug discovery, clinical trials, and patient care. AI technology also has the potential to improve decision-making and provide new insights into complex data. In healthcare, AI can be used to analyze patient data and identify potential health risks, suggest treatment options, and predict patient outcomes.\n\nPharma Artificial Intelligence (AI) technology is a rapidly growing field that is transforming the pharmaceutical industry by improving drug discovery, clinical trials, and patient care. AI is being used in various stages of drug development, from drug discovery to post-market surveillance, to accelerate the process and improve efficiency. Here are some of the ways in which pharma AI technology is being used:\n\nDrug Discovery:AI is being used to identify new drug targets, design new molecules, and predict drug efficacy and toxicity. By analyzing large amounts of data from various sources, such as scientific literature, clinical trials, and genetic databases, AI algorithms can identify patterns and relationships that may not be evident to humans. This can help researchers to discover new drugs and repurpose existing ones for new applications.\nClinical Trials:AI is being used to improve the efficiency of clinical trials by identifying eligible patients, predicting patient outcomes, and optimizing trial design. By analyzing patient data, including genetic and clinical data, AI algorithms can identify patient subgroups that are most likely to respond to a particular drug, thereby reducing the number of patients needed for trials. AI can also help to identify adverse events early in the trial, improving patient safety.\nDrug Development:AI is being used to improve drug development processes by predicting drug efficacy and toxicity, optimizing drug formulations, and predicting manufacturing processes. By analyzing data from preclinical and clinical studies, AI algorithms can identify factors that influence drug efficacy and toxicity, helping to optimize drug formulations and dosages.\nPost-Market Surveillance:AI is being used to monitor drug safety and efficacy in real-time, by analyzing data from electronic health records, social media, and other sources. This can help to identify potential adverse events early and improve patient outcomes.\nPatient Care:AI is being used to personalize patient care by analyzing patient data, including genetic and clinical data, to predict patient outcomes, identify disease risk, and optimize treatment plans. AI-powered tools, such as virtual assistants and chatbots, are also being used to improve patient engagement and adherence to treatment plans.\nWhile pharma AI technology has the potential to transform drug discovery, development, and patient care, there are also challenges associated with its use. One of the primary challenges is data privacy and security. Pharma AI algorithms require access to large amounts of patient data to be effective, but this data must be protected from unauthorized access and misuse. Companies must ensure that patient data is stored securely and that AI algorithms are designed with data privacy and security in mind.\n\nConclusion:\n\nArtificial Intelligence (AI) technology has the potential to transform the pharma industry by speeding up drug discovery, improving clinical trials, and providing personalized patient care. While there are some challenges that need to be addressed, the benefits of AI in pharma are significant. As the use of AI in pharma continues to grow, it will be essential to ensure that patient data is protected, and AI algorithms are developed and used ethically. By addressing these challenges, AI can help create a more efficient, effective, and personalized healthcare system.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"artificial\",\"intelligence\",\"in\",\"pharma\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "artificial",
      "permlink": "41eity-artificial-intelligence-in-pharma-improving-efficiency-and-patient-outcomes",
      "title": "Artificial Intelligence in Pharma: Improving Efficiency and Patient Outcomes"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-09-18T06:58:54",
  "trx_id": "a305451ba5cdd8691c8e96597ace62fde081afc5",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 78228943,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "omnichannel-marketing-integrating-channels-for-impact",
      "voter": "sairazerin",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-09-17T18:24:15",
  "trx_id": "202e16f224fa80d60575ba91902a118e487a7e7b",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 78228860,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Understanding Omnichannel Marketing\n\nOmnichannel marketing goes beyond the multichannel approach by creating a unified experience for customers. Instead of focusing on each channel as a separate entity, omnichannel marketing takes a holistic view, recognizing that customers move fluidly between online and offline environments. The goal is to enable customers to transition seamlessly from one channel to another, with each interaction building upon the previous one. \n\nThe Power of Consistency\n\nConsistency lies at the heart of successful omnichannel marketing. Customers expect a consistent message, branding, and experience regardless of where they engage with a brand. This consistency not only strengthens brand identity but also builds trust. Whether a customer discovers a product on social media, visits the website, or steps into a physical store, the messaging and experience should be cohesive.\n\nPersonalization and Data Integration\n\nOne of the key benefits of omnichannel marketing is the ability to leverage customer data for personalization. By integrating data from various touchpoints, businesses can gain insights into customer preferences, behaviors, and buying patterns. This information allows for the creation of tailored marketing campaigns that resonate with individual customers, increasing the likelihood of conversions.\n\nChallenges and Solutions\n\nImplementing effective omnichannel marketing comes with its challenges. One major hurdle is ensuring that the technology and systems used for different channels can communicate seamlessly. Integration between online and offline systems, social media platforms, customer relationship management (CRM) software, and more is essential. This requires investment in both technology and personnel to manage and analyze data effectively.\n\nAnother challenge is maintaining a consistent brand voice and message across diverse channels. This necessitates a well-defined brand strategy and guidelines that all marketing teams must adhere to. Clear communication and collaboration between teams are crucial to ensure a unified approach.\n\nBenefits for Businesses\n\nOmnichannel marketing offers several advantages to businesses willing to invest time and resources into its implementation. Increased customer engagement and satisfaction are among the most significant benefits. By providing customers with the freedom to interact with a brand in their preferred way, businesses can create a more positive and memorable experience.\n\nMoreover, omnichannel strategies often lead to higher conversion rates and customer retention. When customers receive consistent and personalized interactions, they are more likely to make purchases and remain loyal to the brand. Repeat customers are not only more profitable but also act as brand advocates, spreading positive word-of-mouth and attracting new customers.\n\nThe Mobile Revolution: Powering Omnichannel Engagement to New Heights\n\nIn an era defined by technological advancements and rapidly changing consumer behaviors, mobile devices have emerged as a central force in shaping how businesses engage with their customers across various channels. The integration of mobile technology into the omnichannel marketing landscape has not only transformed the way consumers interact with brands but also elevated the potential for seamless and personalized engagement.\n\nThe Future of Mobile-Driven Omnichannel Engagement\n\nAs technology continues to evolve, the role of mobile devices in omnichannel engagement will only become more profound. Innovations like augmented reality (AR) and virtual reality (VR) have the potential to blend the physical and digital worlds, creating immersive experiences that extend across multiple channels. Voice-activated assistants and smart speakers are also shaping a future where seamless interactions occur through voice commands, further integrating mobile into the omnichannel ecosystem.\n\nIn conclusion, omnichannel marketing has become an essential strategy for businesses aiming to stay relevant and competitive in today's dynamic marketplace. By prioritizing consistency, personalization, and data integration, businesses can create memorable and seamless customer experiences that foster brand loyalty and drive growth. As consumer expectations continue to evolve, the ability to provide a cohesive omnichannel journey will remain a cornerstone of successful marketing strategies.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"omnichannel\",\"marketing\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "omnichannel",
      "permlink": "omnichannel-marketing-integrating-channels-for-impact",
      "title": "Omnichannel Marketing: Integrating Channels for Impact"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-09-17T18:20:06",
  "trx_id": "a984eb165e23bfe767a464fe8d040c96cac4ca63",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 78227914,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The Hippocratic Oath is an ancient pledge that physicians take to uphold ethical standards and practices in medicine. The oath was named after the ancient Greek physician Hippocrates, who is considered the father of Western medicine. The Hippocratic Oath has been a guiding principle for physicians for centuries, and its principles have been adopted by many medical schools around the world.\n\nThe Hippocratic Oath is a solemn promise that physicians make to their patients, colleagues, and society. The oath includes a commitment to uphold the highest ethical standards in medical practice, including confidentiality, honesty, and respect for patient autonomy. The oath also includes a promise to use medical knowledge and skills for the benefit of patients and to avoid any actions that may cause harm.\n\nOne of the key principles of the Hippocratic Oath is the principle of non-maleficence, which means to \"first, do no harm.\" This principle requires physicians to prioritize the well-being of their patients and to avoid any actions that may cause harm or unnecessary suffering. The principle of beneficence, which means to \"do good,\" also requires physicians to act in the best interests of their patients and to promote their well-being.\n\nEffective communication is a crucial aspect of the healthcare industry. Healthcare professionals (HCPs) must communicate effectively with their patients to ensure that they receive the appropriate treatment and care. However, communication in healthcare is not always easy. HCPs must navigate complex medical jargon, emotional patients, and time constraints while conveying important information.\n\nOne of the most important aspects of HCP communication is establishing rapport with patients. Building trust and a positive relationship with patients can help ease their anxiety and improve the effectiveness of treatment. HCPs can establish rapport by using open-ended questions, active listening, and empathy. They should avoid interrupting patients, using medical jargon, or appearing rushed.\n\nHCPs must also ensure that their communication is clear and easily understood. Patients may have limited health literacy or language barriers that can make it difficult for them to understand medical terminology. HCPs should use plain language and avoid medical jargon whenever possible. They can also use visual aids such as diagrams or videos to help explain complex medical concepts.\n\nIn addition to communicating with patients, HCPs must also communicate effectively with their colleagues. Good communication between healthcare providers can prevent errors and improve patient outcomes. HCPs should use standardized communication methods, such as the Situation-Background-Assessment-Recommendation (SBAR) framework, to ensure that everyone involved in a patient's care has the same information.\n\nFinally, HCPs must be aware of cultural differences that may affect communication with patients. Cultural differences can impact how patients understand and respond to medical information. HCPs should strive to understand their patients' cultural backgrounds and adapt their communication styles accordingly.\n\nIn conclusion, effective communication is essential for HCPs to provide high-quality care. By establishing rapport with patients, using clear and understandable language, communicating effectively with colleagues, and being aware of cultural differences, HCPs can improve the effectiveness of treatment and ensure positive outcomes for their patients.\n\nObstacles to Effective HCP Communication\n\nIn the current market, PR confronts numerous obstacles in the way of establishing a relationship with HCP and in optimizing HCP engagement. Beyond the ground-level difficulties, PR, by extension, represents their c-suite executives and the public distrust of the elite. These sentiments, valid or not, ultimately come at the expense of the patient and their best clinical outcome. In my experience, these limitations arise when pharmaceutical companies and PR fail to understand my daily routines when constructing physical and digital touchpoints and misalign products with my patient populations or treatment philosophies. We can do better.\n\nFor More Visit@ p360",
      "json_metadata": "{\"tags\":[\"effective\",\"hcp\",\"engagement\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "effective",
      "permlink": "overcoming-obstacles-challenges-to-effective-hcp-communication",
      "title": "Overcoming Obstacles: Challenges to Effective HCP Communication"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-09-17T17:32:33",
  "trx_id": "e3eea0c6dcb029ae97419ba6c7c89b7f80dcec9c",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 77449645,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Understanding Omnichannel Marketing\n\nOmnichannel marketing goes beyond the multichannel approach by creating a unified experience for customers. Instead of focusing on each channel as a separate entity, omnichannel marketing takes a holistic view, recognizing that customers move fluidly between online and offline environments. The goal is to enable customers to transition seamlessly from one channel to another, with each interaction building upon the previous one. \n\nThe Power of Consistency\n\nConsistency lies at the heart of successful omnichannel marketing. Customers expect a consistent message, branding, and experience regardless of where they engage with a brand. This consistency not only strengthens brand identity but also builds trust. Whether a customer discovers a product on social media, visits the website, or steps into a physical store, the messaging and experience should be cohesive.\n\nPersonalization and Data Integration\n\nOne of the key benefits of omnichannel marketing is the ability to leverage customer data for personalization. By integrating data from various touchpoints, businesses can gain insights into customer preferences, behaviors, and buying patterns. This information allows for the creation of tailored marketing campaigns that resonate with individual customers, increasing the likelihood of conversions.\n\nChallenges and Solutions\n\nImplementing effective omnichannel marketing comes with its challenges. One major hurdle is ensuring that the technology and systems used for different channels can communicate seamlessly. Integration between online and offline systems, social media platforms, customer relationship management (CRM) software, and more is essential. This requires investment in both technology and personnel to manage and analyze data effectively.\n\nAnother challenge is maintaining a consistent brand voice and message across diverse channels. This necessitates a well-defined brand strategy and guidelines that all marketing teams must adhere to. Clear communication and collaboration between teams are crucial to ensure a unified approach.\n\nBenefits for Businesses\n\nOmnichannel marketing offers several advantages to businesses willing to invest time and resources into its implementation. Increased customer engagement and satisfaction are among the most significant benefits. By providing customers with the freedom to interact with a brand in their preferred way, businesses can create a more positive and memorable experience.\n\nMoreover, omnichannel strategies often lead to higher conversion rates and customer retention. When customers receive consistent and personalized interactions, they are more likely to make purchases and remain loyal to the brand. Repeat customers are not only more profitable but also act as brand advocates, spreading positive word-of-mouth and attracting new customers.\n\nThe Mobile Revolution: Powering Omnichannel Engagement to New Heights\n\nIn an era defined by technological advancements and rapidly changing consumer behaviors, mobile devices have emerged as a central force in shaping how businesses engage with their customers across various channels. The integration of mobile technology into the omnichannel marketing landscape has not only transformed the way consumers interact with brands but also elevated the potential for seamless and personalized engagement.\n\nThe Future of Mobile-Driven Omnichannel Engagement\n\nAs technology continues to evolve, the role of mobile devices in omnichannel engagement will only become more profound. Innovations like augmented reality (AR) and virtual reality (VR) have the potential to blend the physical and digital worlds, creating immersive experiences that extend across multiple channels. Voice-activated assistants and smart speakers are also shaping a future where seamless interactions occur through voice commands, further integrating mobile into the omnichannel ecosystem.\n\nIn conclusion, omnichannel marketing has become an essential strategy for businesses aiming to stay relevant and competitive in today's dynamic marketplace. By prioritizing consistency, personalization, and data integration, businesses can create memorable and seamless customer experiences that foster brand loyalty and drive growth. As consumer expectations continue to evolve, the ability to provide a cohesive omnichannel journey will remain a cornerstone of successful marketing strategies.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"omnichannel\",\"marketing\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "omnichannel",
      "permlink": "omnichannel-marketing-evolution-adapting-to-changing-landscapes",
      "title": "Omnichannel Marketing Evolution: Adapting to Changing Landscapes"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-08-21T12:31:03",
  "trx_id": "adc4491f7cd8ec010cc661fd19e7eb52898c2461",
  "trx_in_block": 7,
  "virtual_op": 0
}

{
  "block": 76853861,
  "op": [
    "author_reward",
    {
      "author": "shriyala",
      "permlink": "compliance-in-pharma-marketing-and-sales-the-path-to-responsible-practices",
      "sbd_payout": "0.000 SBD",
      "steem_payout": "0.029 STEEM",
      "vesting_payout": "50.924024 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-07-31T18:08:45",
  "trx_id": "0000000000000000000000000000000000000000",
  "trx_in_block": 4294967295,
  "virtual_op": 3
}

{
  "block": 76653540,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "compliance-in-pharma-marketing-and-sales-the-path-to-responsible-practices",
      "voter": "dorothy213",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-07-24T18:25:00",
  "trx_id": "e22f8c44692d137e491b0212c0661548a477d313",
  "trx_in_block": 7,
  "virtual_op": 0
}

{
  "block": 76653216,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Compliance in pharmaceutical marketing and sales is crucial to ensure ethical practices, adhere to legal regulations, and maintain public trust. The pharmaceutical industry is heavily regulated to protect the interests of patients and ensure the safety and efficacy of drugs. Pharmaceutical marketing and sales professionals must be familiar with the laws and regulations that govern their activities. This includes guidelines from regulatory bodies like the Food and Drug Administration (FDA) in the United States, the European Medicines Agency (EMA) in Europe, and other relevant authorities in different countries. In the context of pharmaceutical marketing, a \"complaint\" refers to an expression of dissatisfaction or concern raised by individuals, healthcare professionals, or regulatory authorities regarding the marketing practices or promotional materials used by a pharmaceutical company.\n\nCompliance standards are crucial for various reasons, and they play a significant role in several aspects of business and society. In the context of different industries, including pharmaceuticals, compliance standards matter for the following key reasons:\n\nEthical Business Practices: Compliance standards set the foundation for ethical conduct within organizations. They promote integrity, honesty, and fairness in all business activities. Adhering to these standards ensures that companies prioritize the well-being of their customers, employees, and other stakeholders.\n\nPublic Safety and Health: In industries like pharmaceuticals, compliance standards are designed to protect public safety and health. They ensure that products and services meet rigorous quality and safety requirements. Non-compliance could lead to unsafe products entering the market, potentially causing harm to consumers.\n\nRegulatory Requirements: Compliance standards are often based on laws, regulations, and industry guidelines established by government bodies or professional associations. Adhering to these requirements is essential to avoid legal penalties, fines, or other punitive actions.\n\nMaintaining Reputation and Trust: Compliant businesses are more likely to earn the trust of consumers, investors, and partners. A strong reputation for ethical behavior and adherence to regulations can lead to increased customer loyalty and positive brand perception.\n\nRisk Management: Compliance standards help organizations identify and mitigate risks associated with their operations. By following established protocols and best practices, companies can reduce the likelihood of costly mistakes or reputational damage.\n\nInternational Operations: For companies operating globally, compliance standards ensure consistency in business practices across different countries. They help organizations navigate the complexities of diverse legal and regulatory environments.\n\nEmployee Well-Being: Compliance standards often include provisions related to employee rights, workplace safety, and fair labor practices. Complying with these standards fosters a positive work environment and promotes the well-being of employees.\n\nPreventing Fraud and Corruption: In sectors prone to fraud and corruption, compliance standards serve as a deterrent. They establish clear guidelines for ethical behavior, making it more challenging for individuals or groups to engage in illicit activities.\n\nData Protection and Privacy: With the increasing emphasis on data protection and privacy, compliance standards help organizations safeguard sensitive information and adhere to relevant data privacy regulations.\n\nQuality Control and Assurance: Compliance standards often incorporate quality control and assurance measures, ensuring that products and services meet predefined standards of excellence.\n\nSustainability and Environmental Responsibility: Some compliance standards include provisions for environmental sustainability, encouraging businesses to adopt eco-friendly practices and reduce their impact on the environment.\nStakeholder Confidence: Complying with standards demonstrates a commitment to responsible and accountable business practices. This, in turn, instills confidence in stakeholders, such as investors, customers, and suppliers.\n\nOverall, compliance standards are vital for maintaining the integrity and sustainability of businesses and ensuring they operate in a manner that respects legal, ethical, and societal obligations. By upholding compliance, organizations can contribute to a more transparent and trustworthy business landscape.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"compliance\",\"in\",\"pharma\",\"sales\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "compliance",
      "permlink": "compliance-in-pharma-marketing-and-sales-the-path-to-responsible-practices",
      "title": "Compliance in Pharma Marketing and Sales: The Path to Responsible Practices"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-07-24T18:08:45",
  "trx_id": "7151c0c0bcbe7ef3cb900fc3f148fcfa401ee951",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 76651384,
  "op": [
    "transfer",
    {
      "amount": "0.001 STEEM",
      "from": "beemengine",
      "memo": "⚡️Supercharge your content's reach and engagement with Beemengine! Boost your visibility, attract a larger audience, and skyrocket your upvotes 🚀 . Join now at just 1 HIVE/STEEM per month for 24/7 auto voting, a thriving 🌐 community of 1.5k+ interactions, up to 100K boosted posts, tens of dedicated curators, and effortless passive earnings 💰 . Don't miss out - subscribe today at beemengine.com or reply 'subscribe' for a one-month subscription for just 1 HIVE/STEEM",
      "to": "shriyala"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-07-24T16:36:45",
  "trx_id": "d5b22b99e7e702723a95c6e837e161e4f2d0b5d4",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 76651367,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "In the ever-evolving landscape of technology and data-driven decision-making, two concepts have emerged as transformative approaches to data management: Data Fabric and Data Mesh. As organizations grapple with increasing data volumes, diverse sources, and the need for faster insights, these paradigms offer innovative solutions to streamline data operations and democratize data access. In this article, we will delve into the core principles of Data Fabric and Data Mesh, understanding their differences, benefits, and potential impact on the future of data management.\n\nData Fabric: Weaving a Unified Data Landscape\n\nData Fabric is a data management framework that aims to create a seamless and interconnected data ecosystem across an organization. Traditional data management practices often suffer from data silos, where different departments and systems hold data independently, leading to duplication, inconsistency, and data governance challenges. Data Fabric seeks to address these issues by weaving together data assets and services into a cohesive fabric, facilitating data discovery, access, and sharing.\n\nAt the core of the Data Fabric lies data virtualization, a technique that enables data consumers to access and query data from various sources without physically moving or duplicating it. This eliminates the need for complex data integration processes and reduces data redundancy. Moreover, data governance policies and security controls can be enforced centrally, ensuring compliance and data privacy.\n\nData Fabric also embraces the use of metadata, which acts as a guiding thread in the fabric. Metadata provides essential information about data assets, including their origins, quality, and usage, making it easier for data consumers to identify and utilize the right data for their analytical needs. This fosters a data-driven culture within the organization and promotes collaborative decision-making.\n\nData Mesh: Decentralizing Data Ownership and Empowering Data Domains\n\nWhile Data Fabric focuses on building a unified data infrastructure, Data Mesh takes a different approach by advocating for the decentralization of data ownership and management. As organizations grow, data complexity escalates, leading to challenges in maintaining a centralized data model effectively. Data Mesh suggests that these complexities can be better managed by treating data as a product and creating self-serve data platforms known as \"data domains.\"\nIn the Data Mesh paradigm, each data domain is a self-contained unit, responsible for its data ingestion, storage, processing, and delivery. Cross-functional teams take ownership of individual data domains, consisting of domain-specific data engineers, data scientists, and domain experts. This approach decentralizes data management, reducing bottlenecks and enabling faster data-driven decision-making within each domain.\n\nThe success of Data Mesh relies on a strong governance model and well-defined data contracts. Data contracts specify the format, quality, and security standards for data exchange between different domains, ensuring consistency and interoperability. Additionally, a Data Mesh implementation requires a robust data infrastructure, including data lakes, data warehouses, and data streaming platforms, that can support the diverse data needs of different domains.\n\nData Fabric and Data Mesh: Complementary or Contradictory?\n\nWhile Data Fabric and Data Mesh appear to have divergent principles, they are not necessarily mutually exclusive. In fact, some organizations are exploring hybrid approaches that combine elements of both paradigms to suit their specific needs. For instance, they might use a Data Fabric to integrate data across the enterprise while implementing Data Mesh principles within specific business units to promote agility and autonomy.\n\nThe choice between Data Fabric and Data Mesh ultimately depends on the organization's scale, structure, and data maturity level. Smaller companies with relatively straightforward data requirements may find a Data Fabric more suitable, as it provides a unified and streamlined data ecosystem. On the other hand, larger organizations dealing with complex and diverse data landscapes might benefit from adopting Data Mesh principles to foster data ownership and innovation at a granular level.\n\nConclusion\nAs data continues to grow exponentially in the digital age, efficient data management becomes paramount for organizations seeking a competitive edge. Data Fabric and Data Mesh represent two revolutionary paradigms, each with its unique strengths and applicability. While Data Fabric emphasizes centralization and cohesion, Data Mesh advocates for decentralization and domain-specific ownership. Organizations must carefully evaluate their data needs and cultural readiness to determine which approach aligns best with their business objectives. Ultimately, embracing these data management paradigms will unlock the true potential of data as a strategic asset in the modern world.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"aata\",\"fabric\",\"and\",\"data\",\"mesh\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "aata",
      "permlink": "data-fabric-or-data-mesh-finding-the-right-fit-for-your-organization",
      "title": "Data Fabric or Data Mesh? Finding the Right Fit for Your Organization"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-07-24T16:35:54",
  "trx_id": "5f15ec0920708cb256f73cc0b6ec0bee22c2277c",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 75278996,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Artificial Intelligence (AI) is revolutionizing the way we live and work. With the ability to learn, reason, and make decisions, AI systems are transforming industries and driving innovation. This article explores the applications, benefits, and challenges of AI, shedding light on the potential it holds for the future.\n\nThe growth of Artificial Intelligence (AI) has been nothing short of remarkable. In recent years, advancements in machine learning and deep learning techniques have propelled AI to the forefront of technological innovation. AI systems can now process vast amounts of data, recognize patterns, and make intelligent decisions with increasing accuracy. This growth has led to significant breakthroughs across industries, from healthcare and finance to manufacturing and transportation. AI has revolutionized the way businesses operate, improving efficiency, productivity, and decision-making. As AI continues to evolve, its potential for further growth is immense, promising new opportunities and challenges in shaping the future of technology and society.\n\nArtificial Intelligence (AI) has found diverse applications across various sectors, transforming industries and improving efficiency. In healthcare, AI algorithms are aiding in disease diagnosis, analyzing medical images, and personalizing treatment plans. Finance benefits from AI-driven chatbots for customer service and fraud detection algorithms. Manufacturing harnesses AI for quality control, predictive maintenance, and supply chain optimization. Transportation utilizes AI in autonomous vehicles, traffic management, and route planning for improved safety and efficiency. AI is also making strides in natural language processing, enabling virtual assistants, language translation, and sentiment analysis. From healthcare to finance, AI applications are revolutionizing industries, enhancing decision-making, and shaping the way we live and work.\n\nMachine Learning (ML) and Neural Networks are integral components of Artificial Intelligence (AI) that have revolutionized the way computers learn and make predictions. Machine Learning involves training algorithms on data to recognize patterns and make informed decisions without explicit programming. It encompasses various techniques such as supervised learning, unsupervised learning, and reinforcement learning. Neural Networks, inspired by the human brain's structure, use interconnected layers of artificial neurons to process complex information. Deep Learning, a subset of ML, employs neural networks with multiple layers to tackle complex tasks like image recognition and natural language processing. Machine Learning and Neural Networks have propelled AI advancements, enabling systems to understand, interpret, and learn from vast amounts of data, leading to breakthroughs across industries.\n\nArtificial Intelligence (AI) is transforming various industries, revolutionizing processes, and delivering significant benefits. Here are some industries that are benefiting from AI:\n1.\tArtificial Intelligence in Healthcare:  Artificial Intelligence (AI) is transforming healthcare by revolutionizing diagnostics, personalized medicine, and patient care. AI algorithms analyze medical images, aiding in disease detection and diagnosis with high accuracy. It enables personalized treatment plans by analyzing patient data and genetic information. AI streamlines the drug discovery process, accelerating the development of new therapies. Wearable devices and remote monitoring systems powered by AI enable continuous patient monitoring and early intervention. AI assists in medical imaging analysis, improving diagnostic accuracy. Virtual assistants and chatbots provide patient support and enhance access to healthcare services.\n\n2.\tArtificial Intelligence in Finance: Artificial Intelligence (AI) is revolutionizing the finance industry by transforming processes, improving decision-making, and enhancing customer experiences. AI-powered algorithms analyze vast amounts of financial data to detect patterns, identify trends, and make accurate predictions for investment decisions. Machine learning models optimize risk management, fraud detection, and credit scoring, improving operational efficiency and reducing financial risks. Chatbots and virtual assistants powered by AI provide personalized customer service, assisting with queries, transactions, and financial advice.\n\n3.\tArtificial Intelligence in Transportation: Artificial Intelligence (AI) is transforming the automotive industry, revolutionizing the way vehicles are designed, manufactured, and operated. AI-powered technologies, such as autonomous driving, enhance vehicle safety, efficiency, and convenience. Machine learning algorithms analyze sensor data, enabling vehicles to perceive their surroundings, make real-time decisions, and navigate complex environments. AI also supports advanced driver-assistance systems (ADAS), improving collision avoidance and adaptive cruise control.\nArtificial Intelligence is transforming the world, opening up new possibilities and driving innovation. From healthcare to finance, manufacturing to transportation, AI is revolutionizing industries and improving the quality of life. As we continue to explore the potential of AI, it is essential to navigate the challenges and ensure ethical implementation to harness its full benefits.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"artificial\",\"intelligence\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "artificial",
      "permlink": "artificial-intelligence-innovations-shaping-the-future",
      "title": "Artificial Intelligence: Innovations Shaping the Future"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-06-06T18:30:00",
  "trx_id": "447539f4adc60420c354028e571f9998bd7bc9b9",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 75248334,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "In the dynamic landscape of healthcare, effective engagement with healthcare professionals (HCPs) is crucial for the success of pharmaceutical companies, medical device manufacturers, and healthcare organizations. This article explores key strategies to foster meaningful and productive relationships with HCPs, resulting in improved collaboration, knowledge exchange, and ultimately, better patient care.\n\nUnderstanding HCP Needs and Preferences\n\nUnderstanding the needs and preferences of healthcare professionals (HCPs) is a fundamental aspect of effective engagement. Organizations can tailor their strategies to meet those needs and foster meaningful relationships by gaining insights into their specific requirements and challenges. Organizations should invest in research methods such as surveys, interviews, and focus groups to gather data directly from HCPs. This research can help identify their priorities, patient populations, areas of interest, and challenges they face in their daily practice. Recognize that different HCPs have different needs and preferences. Tailor engagement strategies are based on factors like specialty, practice setting, and geographical location. Personalization enhances the relevance and value of interactions with HCPs, leading to increased engagement.\n\nPromoting peer-to-peer collaboration among HCPs can be instrumental in improving healthcare outcomes. Creating forums, both online and offline, where HCPs can share best practices, case studies, and clinical experiences can foster a vibrant community of learning and collaboration. These platforms can also serve as spaces for industry experts and thought leaders to engage with HCPs, providing insights into emerging therapies, technological advancements, and healthcare trends. By facilitating such knowledge exchange, organizations can position themselves as valuable partners invested in advancing the practice of medicine.\n\nFacilitating peer-to-peer collaboration and knowledge exchange among healthcare professionals (HCPs) is an effective strategy for fostering engagement and enhancing the practice of medicine. By creating platforms and opportunities for HCPs to share insights, best practices, and clinical experiences, organizations can promote a culture of continuous learning and collaboration. Develop online platforms, forums, or communities where HCPs can connect and engage with their peers. These platforms can be dedicated websites, social media groups, or professional networking platforms tailored to specific medical specialties or areas of interest. By providing a space for HCPs to interact, share knowledge, ask questions, and discuss emerging trends, organizations can foster a vibrant community of learning and collaboration.\n\nOrganize thought leadership programs that bring together HCPs, industry experts, and opinion leaders. These programs can include conferences, symposiums, or panel discussions, where participants can share their expertise, present research findings, and engage in productive discussions. Thought leadership programs provide a platform for HCPs to learn from each other and stay updated on the latest advancements in their fields. Establish mentoring programs that connect experienced HCPs with early-career professionals or those seeking guidance. Peer mentors can provide valuable support, share their expertise, and offer career advice. Additionally, organizations can facilitate coaching programs where HCPs can receive feedback and guidance from their peers on specific clinical or professional challenges. ZING has been tested, scaled, and evolved over the past several years and P360 has the experience to keep going, enabling pharmaceutical companies to have practical, compliant HCP engagement.\n\nFacilitating peer-to-peer collaboration and knowledge exchange among HCPs not only strengthens professional networks but also enhances the overall quality of patient care. By creating platforms and initiatives that encourage HCPs to share their knowledge and experiences, organizations can foster a culture of continuous learning, innovation, and collaboration.\nTrust is a cornerstone of effective HCP engagement. Organizations must prioritize transparent communication to build and maintain trust with HCPs. This includes openly sharing information about product efficacy, safety profiles, and clinical trial data. Clear and honest communication regarding any conflicts of interest is also crucial for credibility. By being transparent in their interactions, organizations can foster a foundation of trust with HCPs, which is essential for long-term collaboration and partnership. Provide HCPs with clear and accurate information about products, services, clinical data, and research findings. Avoid exaggerations or misleading claims that may undermine credibility. HCPs rely on accurate information to make informed decisions about patient care, and transparent communication helps foster trust in the organization's integrity.\n\nPharma-to-Physician relationships rely on clear, timely communication that is handled in a compliant manner – something that is difficult to ensure with many measures today. That is why solutions like P360’s ZING Engagement Suite is the way to go. Building trust through transparent communication is an ongoing process that requires consistent effort and a genuine commitment to openness and honesty. By establishing transparent communication practices, organizations can cultivate trust with HCPs, leading to stronger relationships, improved collaboration, and ultimately, better patient outcomes.\n\nConclusion:\nIn a rapidly evolving healthcare landscape, effective engagement with HCPs is paramount for the success of organizations operating in the life sciences industry. By understanding HCP needs, providing educational resources, promoting collaboration, and fostering transparent communication, organizations can establish strong relationships that drive better patient care and mutually beneficial outcomes for all stakeholders involved.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"hcp\",\"engagement\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "hcp",
      "permlink": "hcp-engagement-nurturing-relationships-for-future-success",
      "title": "HCP Engagement: Nurturing Relationships for Future Success"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-06-05T16:50:27",
  "trx_id": "3ac10f17fb1817160b664dc471193a52d6402005",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 74763388,
  "op": [
    "author_reward",
    {
      "author": "shriyala",
      "permlink": "artificial-intelligence-in-pharma-improving-efficiency-and-patient-outcomes",
      "sbd_payout": "0.000 SBD",
      "steem_payout": "0.186 STEEM",
      "vesting_payout": "330.198411 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-05-19T18:59:00",
  "trx_id": "0000000000000000000000000000000000000000",
  "trx_in_block": 4294967295,
  "virtual_op": 4
}

{
  "block": 74564216,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "artificial-intelligence-in-pharma-improving-efficiency-and-patient-outcomes",
      "voter": "dlike",
      "weight": 1700
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-05-12T20:16:03",
  "trx_id": "62bf808b728736ee37334fac3849ec4d3f97ad3e",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 74563085,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "artificial-intelligence-in-pharma-improving-efficiency-and-patient-outcomes",
      "voter": "riosparada",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-05-12T19:19:21",
  "trx_id": "04d3cb1cdc3349bc2a63569e6bef2ca0c2aee9e8",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 74562679,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "What is Artificial Intelligence (AI)?\n\nArtificial Intelligence (AI) technology refers to the ability of machines and computers to perform tasks that typically require human intelligence. These tasks can include reasoning, perception, and decision-making. AI has become increasingly prevalent in recent years and has the potential to revolutionize many industries, from healthcare to finance to manufacturing. AI algorithms are typically designed to analyze large amounts of data and identify patterns or relationships that humans may not be able to discern. This ability to process data quickly and accurately makes AI well-suited for applications such as predictive modeling, image and speech recognition, and natural language processing.\n\nArtificial Intelligence (AI) technology has been making waves in various industries, including pharma. With the help of AI, the pharma industry is poised to revolutionize drug discovery, clinical trials, and patient care. AI technology also has the potential to improve decision-making and provide new insights into complex data. In healthcare, AI can be used to analyze patient data and identify potential health risks, suggest treatment options, and predict patient outcomes.\n\nPharma Artificial Intelligence (AI) technology is a rapidly growing field that is transforming the pharmaceutical industry by improving drug discovery, clinical trials, and patient care. AI is being used in various stages of drug development, from drug discovery to post-market surveillance, to accelerate the process and improve efficiency. Here are some of the ways in which pharma AI technology is being used:\n\nDrug Discovery: AI is being used to identify new drug targets, design new molecules, and predict drug efficacy and toxicity. By analyzing large amounts of data from various sources, such as scientific literature, clinical trials, and genetic databases, AI algorithms can identify patterns and relationships that may not be evident to humans. This can help researchers to discover new drugs and repurpose existing ones for new applications.\n\nClinical Trials: AI is being used to improve the efficiency of clinical trials by identifying eligible patients, predicting patient outcomes, and optimizing trial design. By analyzing patient data, including genetic and clinical data, AI algorithms can identify patient subgroups that are most likely to respond to a particular drug, thereby reducing the number of patients needed for trials. AI can also help to identify adverse events early in the trial, improving patient safety.\n\nDrug Development: AI is being used to improve drug development processes by predicting drug efficacy and toxicity, optimizing drug formulations, and predicting manufacturing processes. By analyzing data from preclinical and clinical studies, AI algorithms can identify factors that influence drug efficacy and toxicity, helping to optimize drug formulations and dosages.\n\nPost-Market Surveillance: AI is being used to monitor drug safety and efficacy in real-time, by analyzing data from electronic health records, social media, and other sources. This can help to identify potential adverse events early, and improve patient outcomes.\n\nPatient Care: AI is being used to personalize patient care by analyzing patient data, including genetic and clinical data, to predict patient outcomes, identify disease risk, and optimize treatment plans. AI-powered tools, such as virtual assistants and chatbots, are also being used to improve patient engagement and adherence to treatment plans.\n\nWhile pharma AI technology has the potential to transform drug discovery, development, and patient care, there are also challenges associated with its use. One of the primary challenges is data privacy and security. Pharma AI algorithms require access to large amounts of patient data to be effective, but this data must be protected from unauthorized access and misuse. Companies must ensure that patient data is stored securely and that AI algorithms are designed with data privacy and security in mind.\n\nConclusion:\n\nArtificial Intelligence (AI) technology has the potential to transform the pharma industry by speeding up drug discovery, improving clinical trials, and providing personalized patient care. While there are some challenges that need to be addressed, the benefits of AI in pharma are significant. As the use of AI in pharma continues to grow, it will be essential to ensure that patient data is protected, and AI algorithms are developed and used ethically. By addressing these challenges, AI can help create a more efficient, effective, and personalized healthcare system.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"artificial\",\"intelligence\",\"in\",\"pharma\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "artificial",
      "permlink": "artificial-intelligence-in-pharma-improving-efficiency-and-patient-outcomes",
      "title": "Artificial Intelligence in Pharma: Improving Efficiency and Patient Outcomes"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-05-12T18:59:00",
  "trx_id": "3ae2097356f4de08baf7d6314d6e5833c1e923f8",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 74533410,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The healthcare industry has traditionally relied on more traditional marketing strategies, such as direct mail and print advertisements, to reach patients and healthcare providers. However, as technology continues to advance, the industry is starting to embrace omnichannel marketing as a way to reach patients and healthcare providers in more effective and personalized ways. In this article, we will explore how omnichannel marketing can be used in the pharmaceutical industry to improve patient outcomes and increase engagement with healthcare providers.\n\nWhat is omnichannel marketing in pharma?\n\nOmnichannel marketing in pharma refers to the use of multiple channels to connect with patients and healthcare providers. This approach recognizes that patients and healthcare providers may interact with pharmaceutical companies through a variety of channels, from social media to email to in-person interactions. By using an omnichannel marketing strategy, pharmaceutical companies can create a more seamless and integrated experience across all these touchpoints, ensuring that patients and healthcare providers have a consistent experience regardless of where they interact with the company.\n\nWhy is omnichannel marketing important in pharma?\n\nThe use of omnichannel marketing in pharma can provide a number of benefits. For one, it allows pharmaceutical companies to connect with patients and healthcare providers in more personalized and targeted ways. By using data from various touchpoints, companies can create a more complete picture of each patient's journey and use that information to deliver more targeted and relevant marketing messages. This can help to increase engagement with healthcare providers and improve patient outcomes.\n\nAnother benefit of omnichannel marketing in pharma is that it can help to increase patient adherence to medication. By delivering more personalized and targeted messages, companies can provide patients with the information and support they need to stay on track with their medication regimen. This can lead to better health outcomes and reduced healthcare costs over time.\n\nFinally, omnichannel marketing can help to build stronger relationships between pharmaceutical companies and healthcare providers. By delivering more targeted and relevant messages, companies can demonstrate their understanding of the challenges faced by healthcare providers and position themselves as trusted partners in the delivery of healthcare.\n\nHow does omnichannel marketing work in pharma?\n\nAt its core, omnichannel marketing in pharma is all about creating a unified experience across all channels. This requires a deep understanding of patient and healthcare provider behavior and preferences. By leveraging data from various touchpoints, companies can create a more complete picture of each patient's journey and use that information to deliver more targeted and relevant marketing messages.\n\nFor example, if a patient visits a pharmaceutical company's website and searches for information about a specific medication, the company may use that information to send targeted emails providing more information about that medication. If the patient then visits a healthcare provider, the provider can use that same information to make personalized recommendations based on the patient's online behavior.\n\nTake for example the ZING Engagement Suite, which help break down communication barriers within the life sciences industry by facilitating customizable, on-demand communication between healthcare professionals (HCPs) and life sciences companies. For those unfamiliar, ZING is a comprehensive digital-first solution that enables compliant omnichannel HCP engagement by enhancing existing communication channels with features including text messaging, two-way voice and video calling, onscreen collaboration and form sharing, inbound communications with QR code scanning, artificial intelligence (AI) assistance, signature capture, easy access integrations and more.\n\nBy leveraging data from all channels, pharmaceutical companies can create a more personalized and effective marketing experience. This not only improves the patient experience but can also lead to increased adherence to medication regimens and better health outcomes.\n\nWhat are the challenges of omnichannel marketing in pharma?\n\nDespite the benefits of omnichannel marketing in pharma, there are also some challenges that companies need to be aware of. One of the biggest challenges is ensuring that patient data is protected and that all marketing efforts are in compliance with regulations such as HIPAA. This requires a strong focus on data privacy and security, as well as a deep understanding of regulatory requirements.\n\nAnother challenge of omnichannel marketing in pharma is that it requires a significant investment in technology and data analytics. Companies need to have the tools and resources in place to collect, analyze, and act on data from multiple touchpoints in order to create a truly integrated and personalized experience for patients and healthcare providers.\n\nFor More @p360",
      "json_metadata": "{\"tags\":[\"omnichannel\",\"marketing\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "omnichannel",
      "permlink": "implementing-an-omnichannel-marketing-strategy-in-pharma",
      "title": "Implementing an Omnichannel Marketing Strategy in Pharma"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-05-11T18:28:48",
  "trx_id": "af9043858984f606c2856cf2b800d005cf474b81",
  "trx_in_block": 7,
  "virtual_op": 0
}

{
  "block": 74503723,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The Hippocratic Oath is an ancient pledge that physicians take to uphold ethical standards and practices in medicine. The oath was named after the ancient Greek physician Hippocrates, who is considered the father of Western medicine. The Hippocratic Oath has been a guiding principle for physicians for centuries, and its principles have been adopted by many medical schools around the world.\n\nThe Hippocratic Oath is a solemn promise that physicians make to their patients, colleagues, and society. The oath includes a commitment to uphold the highest ethical standards in medical practice, including confidentiality, honesty, and respect for patient autonomy. The oath also includes a promise to use medical knowledge and skills for the benefit of patients and to avoid any actions that may cause harm.\n\nOne of the key principles of the Hippocratic Oath is the principle of non-maleficence, which means to \"first, do no harm.\" This principle requires physicians to prioritize the well-being of their patients and to avoid any actions that may cause harm or unnecessary suffering. The principle of beneficence, which means to \"do good,\" also requires physicians to act in the best interests of their patients and to promote their well-being.\n\nEffective communication is a crucial aspect of the healthcare industry. Healthcare professionals (HCPs) must communicate effectively with their patients to ensure that they receive the appropriate treatment and care. However, communication in healthcare is not always easy. HCPs must navigate complex medical jargon, emotional patients, and time constraints while conveying important information.\n\nOne of the most important aspects of HCP communication is establishing rapport with patients. Building trust and a positive relationship with patients can help ease their anxiety and improve the effectiveness of treatment. HCPs can establish rapport by using open-ended questions, active listening, and empathy. They should avoid interrupting patients, using medical jargon, or appearing rushed.\n\nHCPs must also ensure that their communication is clear and easily understood. Patients may have limited health literacy or language barriers that can make it difficult for them to understand medical terminology. HCPs should use plain language and avoid medical jargon whenever possible. They can also use visual aids such as diagrams or videos to help explain complex medical concepts.\n\nIn addition to communicating with patients, HCPs must also communicate effectively with their colleagues. Good communication between healthcare providers can prevent errors and improve patient outcomes. HCPs should use standardized communication methods, such as the Situation-Background-Assessment-Recommendation (SBAR) framework, to ensure that everyone involved in a patient's care has the same information.\n\nFinally, HCPs must be aware of cultural differences that may affect communication with patients. Cultural differences can impact how patients understand and respond to medical information. HCPs should strive to understand their patients' cultural backgrounds and adapt their communication styles accordingly.\n\nIn conclusion, effective communication is essential for HCPs to provide high-quality care. By establishing rapport with patients, using clear and understandable language, communicating effectively with colleagues, and being aware of cultural differences, HCPs can improve the effectiveness of treatment and ensure positive outcomes for their patients.\n\nObstacles to Effective HCP Communication\n\nIn the current market, PR confronts numerous obstacles in the way of establishing a relationship with HCP and in optimizing HCP engagement. Beyond the ground-level difficulties, PR, by extension, represents their c-suite executives and the public distrust of the elite. These sentiments, valid or not, ultimately come at the expense of the patient and their best clinical outcome. In my experience, these limitations arise when pharmaceutical companies and PR fail to understand my daily routines when constructing physical and digital touchpoints and misalign products with my patient populations or treatment philosophies. We can do better.\n\nFor More Visit@ p360",
      "json_metadata": "{\"tags\":[\"effective\",\"hcp\",\"communication\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "effective",
      "permlink": "the-road-to-effective-hcp-communication-overcoming-obstacles",
      "title": "The Road to Effective HCP Communication: Overcoming Obstacles"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-05-10T17:37:54",
  "trx_id": "09dd3f2edb0fe199071a0238c6e8e66d3303be91",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 74469943,
  "op": [
    "transfer",
    {
      "amount": "0.001 STEEM",
      "from": "alexmove.witness",
      "memo": "Hi, shriyala! If you like contests, then I invite you to take part in a series of contests \"Workplace\" from SelfDevelopment Club. Total prize fund: 375 STEEM. Details in the SelfDevelopment Club community. Have a good day, shriyala! Good luck! 20230509",
      "to": "shriyala"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-05-09T13:21:03",
  "trx_id": "9cf8de792d54b58c870f05c8086e35f60df281aa",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 74469404,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Artificial intelligence (AI) is one central part of Software engineering, which has permeated every field of science and innovation, from engineering to healthcare. AI is being used extensively to improve the design techniques and required time of the drugs. AI is being utilized widely to further develop the plan strategies and called for an investment in medications. Based on the massive pharmaceutical data and machine learning process, AI is a useful tool for data mining. One of the many areas that will benefit greatly from the strategic integration of machine learning is pharmaceutical sales.\n\nMachine learning is a branch of artificial intelligence, which is widely defined as the machine's capability to imitate intelligent human behavior. Artificial intelligence systems are used to perform complicated tasks in a way that is similar to how humans resolve problems.\n\nMachine learning term occurs by giving computer systems access to vast amounts of data that they can process and learn from themselves. It starts with data observation, which could involve examples, experiences, or direct instruction. The machine search for patterns in the data in order to make future commitments. The goal is for this to be an automatic process without human intervention. \n\n4 Ways That Machine Learning is Transforming Pharma Sales\n\nHealthcare has seen huge changes over the course of the last decade, and pharmaceutical reps are not safe from the impacts of that change. More physicians are important for a bigger coordinated medical services bunch. \n\nAI Helps Reps Become a Trusted Advisor \n\"Sales rep\" is actually a misnomer for drug delegates. They are entrusted with turning into an educator, genuine sources, and trusted advisor. Building connections is key to pharmaceutical companies. In addition to knowing about their own products, reps must familiarize themselves with the conditions the drugs treat, as well as competing products. Through machine learning, artificial intelligence can analyze a massive amount of data and make appropriate recommendations about what information and approach will have the most effect on a particular physician. AI-driven chatbots are turning out to be progressively well-known, furnishing your reps with easy-to-use voice and text-based chatbots can build efficiency and admittance to data.\n\nML Provides Dynamic Segmentation\nReps have always used segmentation to personalize engagement with a particular group of physicians. Machine learning can trace incalculable factors that the human brain is only unequipped for doing. AI considers the context of many variables and provides reps with personalized information in real time.\n\nML Enables Reps to Spend More Time in the Field\nThe more time that sales reps spend doing paperwork or other admin tasks, the less time that they are selling and building relationships. Machine learning can provide a virtual assistant model that maximizes a rep's time in the field.\n\nAI Acts Like a Personalized Mentor \nIn general, sales and marketing people prefer to work alone.\n\nThe Sales Cycle is Changing One Sale At A Time\nAmong other things, Artificial Intelligence and Machine Learning are simplifying some of the most time-consuming aspects of the pharma industry:\n\nIncreased productivity.\nSimplify the sales process.\nHave sales teams that are better prepared for anything in the field.\nGive reps more time in the field.\nEnhance cross-team collaboration.\nHave you thought about your AI strategy yet?\n\nWant to learn more about how Microsoft-powered AI and ML can help improve your business and simplify the pharma sales funnel? Get in touch with us @p360",
      "json_metadata": "{\"tags\":[\"learning\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "machine",
      "permlink": "machine-learning-challenges-and-future-directions",
      "title": "Machine Learning: Challenges and Future Directions"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-05-09T12:54:03",
  "trx_id": "128c864b94ded1b64720a11bf5f3834da1f56a11",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 74469367,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Artificial intelligence (AI) is one central part of Software engineering, which has permeated every field of science and innovation, from engineering to healthcare. AI is being used extensively to improve the design techniques and required time of the drugs. AI is being utilized widely to further develop the plan strategies and called for an investment in medications. Based on the massive pharmaceutical data and machine learning process, AI is a useful tool for data mining. One of the many areas that will benefit greatly from the strategic integration of machine learning is pharmaceutical sales.\n\nMachine learning is a branch of artificial intelligence, which is widely defined as the machine's capability to imitate intelligent human behavior. Artificial intelligence systems are used to perform complicated tasks in a way that is similar to how humans resolve problems.\n\nMachine learning term occurs by giving computer systems access to vast amounts of data that they can process and learn from themselves. It starts with data observation, which could involve examples, experiences, or direct instruction. The machine search for patterns in the data in order to make future commitments. The goal is for this to be an automatic process without human intervention. \n\n4 Ways That Machine Learning is Transforming Pharma Sales\n\nHealthcare has seen huge changes over the course of the last decade, and pharmaceutical reps are not safe from the impacts of that change. More physicians are important for a bigger coordinated medical services bunch. \n\nAI Helps Reps Become a Trusted Advisor \n\"Sales rep\" is actually a misnomer for drug delegates. They are entrusted with turning into an educator, genuine sources, and trusted advisor. Building connections is key to pharmaceutical companies. In addition to knowing about their own products, reps must familiarize themselves with the conditions the drugs treat, as well as competing products. Through machine learning, artificial intelligence can analyze a massive amount of data and make appropriate recommendations about what information and approach will have the most effect on a particular physician. AI-driven chatbots are turning out to be progressively well-known, furnishing your reps with easy-to-use voice and text-based chatbots can build efficiency and admittance to data.\n\nML Provides Dynamic Segmentation\nReps have always used segmentation to personalize engagement with a particular group of physicians. Machine learning can trace incalculable factors that the human brain is only unequipped for doing. AI considers the context of many variables and provides reps with personalized information in real time.\n\nML Enables Reps to Spend More Time in the Field\nThe more time that sales reps spend doing paperwork or other admin tasks, the less time that they are selling and building relationships. Machine learning can provide a virtual assistant model that maximizes a rep's time in the field.\n\nAI Acts Like a Personalized Mentor \nIn general, sales and marketing people prefer to work alone.\n\nThe Sales Cycle is Changing One Sale At A Time\nAmong other things, Artificial Intelligence and Machine Learning are simplifying some of the most time-consuming aspects of the pharma industry:\n\nIncreased productivity.\nSimplify the sales process.\nHave sales teams that are better prepared for anything in the field.\nGive reps more time in the field.\nEnhance cross-team collaboration.\nHave you thought about your AI strategy yet?\n\nWant to learn more about how Microsoft-powered AI and ML can help improve your business and simplify the pharma sales funnel? Get in touch with us @p360",
      "json_metadata": "{\"tags\":[\"machine\",\"learning\"],\"users\":[\"p360\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "machine",
      "permlink": "machine-learning-challenges-and-future-directions",
      "title": "Machine Learning: Challenges and Future Directions"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-05-09T12:52:12",
  "trx_id": "52c3a51769fd5b0a07ce2fac54f45f8c110e8557",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 73704099,
  "op": [
    "transfer",
    {
      "amount": "0.001 STEEM",
      "from": "alexmove.witness",
      "memo": "Please support me @alexmove.witness as witness on site https://steemitwallet.com/~witnesses. I send daily Witness vote STEEM reward and developing a learning project SelfDevelopment Club. Your vote is very important to me, shriyala! Good luck! 20230412",
      "to": "shriyala"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-04-12T18:00:09",
  "trx_id": "560205f1953a013cde383b28881f1b5878682235",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 73703865,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Artificial Intelligence is beneficial in many different sectors. Some studies have shown its potential advantages not just in technology, but also in education and the business sector. Additionally, artificial intelligence has been proven to provide a massive impact on the healthcare industry. As to everyone’s knowledge, healthcare relies on more than just tips and tricks. \n\nThe applications of AI in the pharmaceutical industry\n\nArtificial Intelligence in the pharmaceutical industry(AI) can be implemented in almost every aspect, right from drug discovery and development to manufacturing and marketing. By leveraging and implementing AI systems in the core workflows, pharma companies can make all business operations efficient, cost-effective, and hassle-free. The best part is that AI systems are designed to deliver better outcomes as they continually learn from new data and experience, making them a powerful tool in the research and development wing of the pharmaceutical industry. \n\nArtificial Intelligence is rapidly changing the healthcare industry, and the pharmaceutical sector is no exception. The potential for artificial intelligence to revolutionize drug discovery, development, and personalized medicine is immense.  The use of AI in pharma can lead to improved efficiency, accuracy, and speed in drug development, resulting in better treatments for patients.\n\nArtificial intelligence can be categorized into the following types:\n\nReactive Machines: These are the most basic types of artificial intelligence systems and are purely reactive and have the ability neither to form memories nor to use past experiences to inform current decisions. Some examples of Reactive Machines are Siri and Alexa. \n\nLimited Memory Artificial Intelligence: These refer to artificial intelligence systems that are capable of using past experiences to inform current decisions but have a limited ability to store and access those experiences. A very practical example that can be used here could be self-driving cars.\n\nTheory of Mind Artificial Intelligence: Theory of Mind Artificial Intelligence refers to AI systems that are designed to understand and reason about the mental states of other agents, including humans and other AI systems. A Theory of Mind AI system is capable of inferring the beliefs, desires, and intentions of other agents based on their observed behavior and the context of the situation.\n\nSelf-Aware Artificial Intelligence: This refers to a hypothetical type of AI that possesses consciousness, the ability to perceive its own existence, and the capacity for introspection. Self-aware AI would be able to recognize its own thoughts and feelings and have a sense of identity and self-awareness similar to that of humans.\n\nWhile AI has the potential to revolutionize the pharmaceutical industry, there are also challenges that need to be addressed. One challenge is the lack of high-quality data. To train machine learning algorithms, large amounts of high-quality data are needed. However, much of the data in healthcare is unstructured and difficult to analyze. Additionally, data privacy concerns need to be addressed to ensure that patient data is protected.\n\nAnother challenge is the lack of regulatory guidance. As AI is a relatively new technology, there is a lack of regulatory guidance on how it should be used in healthcare. Regulatory bodies need to develop guidelines on how AI can be used safely and effectively in drug development and personalized medicine.\n\nArtificial intelligence has the potential to revolutionize the pharmaceutical industry by improving efficiency, accuracy, and speed in drug discovery, development, and personalized medicine. While there are challenges that need to be addressed, the benefits of AI in pharma are immense. By using AI, we can identify new drug targets and candidates more efficiently, predict drug efficacy and toxicity more accurately and personalize medicine based on an individual's unique characteristics. The use of AI in pharma is not just about improving efficiency and reducing costs, but about developing better treatments for patients.\n\nTo learn more about all of P360’s innovative products, visit P360.com.",
      "json_metadata": "{\"tags\":[\"artificial\",\"intelligence\",\"in\",\"pharmaceutical\",\"industry\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "artificial",
      "permlink": "the-role-of-artificial-intelligence-in-pharmaceutical-industry-improving-quality-and-efficiency",
      "title": "The Role of Artificial Intelligence in Pharmaceutical Industry: Improving Quality and Efficiency"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-04-12T17:48:27",
  "trx_id": "8e08c4607328a048964084c7dc5d52da0b619786",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 71232436,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "high-purity-methane-gas-market-outlook-to-2027-capacity-and-capital-expenditure-forecasts-with-details-of-all-active",
      "voter": "drizzy254",
      "weight": 10000
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2023-01-16T12:08:45",
  "trx_id": "87ecf0d219bd67232066372ef097914894dc862a",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 69120863,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "shriyala",
      "delegator": "steem",
      "vesting_shares": "8965.309173 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-11-03T18:04:06",
  "trx_id": "a99ba829cb0f69f3534e3b473bf84384d7053ebb",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 65305651,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global Computer-Aided Engineering market was valued at over US$8,632million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 7.6% between 2022 and 2029. The growth can be attributed to the rising demand for integrated software solutions, eliminating the need to create multiple prototypes and reducing product recalls among various industry verticals.\n\nComputer-Aided Engineering (CAE) is a process of developing and simulating the product performance or resolving engineering problems for various industries using software tools and virtual platforms.\n\nAgileIntel’s global Computer-Aided Engineering market study is a 157 pages report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, type, application, and end-user perspective.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Computer-Aided-Engineering-Market-/47#popup\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nInsights on Type:\n\nThe computer-Aided Engineering (CAE) market has been segmented into Finite Element Analysis (FEA), Computational Fluid Dynamics (CFD) and Multibody Dynamics, Optimization & Simulation, depending on the type.\n\nFAE is a computational analysis tool that helps analyze the stress and dynamics of components and assemblies under real-world conditions. The FEA segment dominated the CAE market with a global revenue share of around 55% in 2021. It is expected to continue its dominance during the forecast period due to its large-scale implementation in manufacturing industries such as the automotive sector.\n\nFurthermore, the Computational Fluid Dynamics (CFD) is expected to drive the market growth during the forecast period due to its widespread application in aerospace engineering, Heating, Air conditioning, and Ventilation (HVAC) engineering, electronics manufacturing, turbo machinery, etc. CFD uses mathematical modeling and software tools to qualitatively predict the fluid flow.\n\nInsights on Deployment:\n\nThe CAE software can be deployed on-premise or on the cloud. The on-premise segment held the largest share of the CAE market, accounting for around 66% of the global revenue in 2021. Several businesses consider the software deployment at the client’s site more convenient and safe. It provides users complete control of the data, hardware and software platforms, upgrades, and system changes, thereby driving the segment growth during the forecast period.\n\nHowever, on-premise systems require huge capital expenditure and maintenance costs to ensure functionality. The could-based deployment is expected to grow considerably during the forecast period as it provides enterprises real-time access to systems and data, vast storage space, and confidentiality. Additionally, cloud computing services offer businesses Infrastructure-as-a-Service (IaaS) and Software-as-a-Service (SaaS) platforms that render application-specific solutions to CAE users.\n\nImpact of COVID-19\n\nThe COVID-19 pandemic has negatively affected the global CAE market. The primary reason for the hindered growth in the short term is the decreased demand for CAE software from automotive and industrial equipment end-use verticals. As the factories and manufacturing plants have halted operations during the pandemic, the vendors witnessed a steep decline in new orders and CAE software purchases.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Computer-Aided-Engineering-Market-/47\n\nHowever, as the people are settling in remote work culture, the designing, modelling, and other related operations in the market are resuming. To assist the transition to remote working, numerous software vendors are offering discounts, trial extensions, temporary free access, and licensing changes to support the migration from office to home.\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"computer-aided\",\"engineering\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Computer-Aided-Engineering-Market-/47#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Computer-Aided-Engineering-Market-/47\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-computer-aided-engineering-market-cumulative-impact-for-covid-19-recovery-research-report-2029",
      "title": "Global Computer-Aided Engineering Market  Cumulative Impact for COVID-19 Recovery Research Report 2029"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-06-23T10:19:21",
  "trx_id": "fbf19273c41bff32d4d58b016e3483d024fede77",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 65304073,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "global-contact-center-software-market-size-2021-analysis-by-top-companies-and-forecast-to-2029",
      "voter": "defrag",
      "weight": 1500
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-06-23T09:00:03",
  "trx_id": "02744edde27a7f995963c8790d364c4edab12432",
  "trx_in_block": 8,
  "virtual_op": 0
}

{
  "block": 65304069,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global contact center software market was valued at US$23,174.75 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 19.1% between 2022 and 2029. This can be attributed to rising adoption of contact center technologies in customer-service industries such as BFSI, retail, healthcare and telecom to ensure accurate, consistent and timely queries resolution.\n\nAgileIntel’s global contact center software market study is a 157 pages report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, business solution, and vertical perspective.\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Contact-Center-Software-Market-/15#popup\n\nInsights on Vertical:\n\nThe contact center software market is classified into BFSI, FMCG and retail, government, healthcare, telecom and IT, travel and hospitality, and others, based on vertical.\n\nThe telecom and IT segment dominated the contact center software market in 2021, mainly due to the presence of many telecom and IT companies in the overall customer base. Intense competition has made it imperative for telecom and IT players to enhance their service quality, increasing the demand for contact center solutions. Additionally, the growing adoption of cloud-based contact center solutions has resulted in quick access to customer information, resulting in timely query resolution.\n\nThe rise in online shopping customers has created a need for retailers to deploy a dedicated team to handle online queries. Moreover, the retail segment is gradually incorporating social media management tools for customer feedback and engagement, which requires the deployment of contact center platforms.\n\nThe demand for contact center solutions is anticipated to increase in the healthcare sector. It can perform various functions such as scheduling appointments, conveying doctors' availability, scheduling surgeries, receiving management feedback, and maintaining a customer database. Likewise, banking, finance, and insurance industries are implementing contact center solutions due to the increasing demand for personalized and streamlined customer interactions while conducting financial transactions.\n\nInsights on Business Solution:\n\nThe contact center software market is segmented based on business solution into Automatic Call Distribution (ACD), call recording, Computer Telephony Integration (CTI), customer collaboration, dialer, Interactive Voice Response (IVR), reporting and analytics, workforce optimization, and Others.\n\nContact centers use ACD systems to increase employee productivity and enhance customer satisfaction. These systems answer the incoming calls and route them to the concerned department based on the type of query. The ACD systems help organizations to streamline the communication process by ensuring even distribution of workload among the agents and simultaneously improve the service quality.\n\nSimilarly, call recordings help improve the quality monitoring of the performance and analyze the improvements required by the contact center agents, enables to retrieve information and help assess the time required to solve a particular query.\n\nContact centers are adopting the CTI technology to synchronize the functions of the telephone system and the computer system that will allow contact center representatives to monitor, record, and route the incoming calls to the most appropriate person in the department.\n\nFurthermore, the IVR segment accounted for 21% of the contact center software market in 2021. The IVR feature allows automating customer support by providing customized greetings and messages and also guiding them during a call. This reduces the time required to address queries and enables to handle higher call volumes per day.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Contact-Center-Software-Market-/15\n\nInsights on Regional Growth:\n\nNorth America is the largest market accounting for a 37% share during the forecast period. This can be attributed to the growing omnichannel approach to sales and the region's rising e-commerce industry.  Several organizations are rapidly investing in emerging technologies, such as big data, analytics, and cloud-based platforms, which is likely to drive the demand for contact center software solutions in the region.\n\nMeanwhile, Europe is expected to witness steady growth due to the increased adoption of contact center systems in the healthcare industry due to the growing number of multi-specialty hospitals. Likewise, the rise in the aging population in Germany and the advancement in medical technologies has increased the demand for services such as telehealth and telemedicine, which is likely to drive the market growth.\n\nThe Asia Pacific is expected to be the fastest-growing regional market, with the number of contact centers in the region estimated to reach 36,350 by 2028. This can be attributed to the initiatives taken by the governments in countries such as India, China, and Japan to encourage the digitization of business processes. Moreover, the deployment of cloud-based systems across various organizations is also expected to boost the demand for contact centers in the region during the forecast period.\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"contact\",\"center\",\"software\",\"market\",\"size\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Contact-Center-Software-Market-/15#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Contact-Center-Software-Market-/15\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-contact-center-software-market-size-2021-analysis-by-top-companies-and-forecast-to-2029",
      "title": "Global Contact Center Software Market Size 2021 Analysis by Top Companies, And Forecast to 2029"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-06-23T08:59:51",
  "trx_id": "33ec9b75715f2d99b1da25eb2d9ce506638c8dd2",
  "trx_in_block": 7,
  "virtual_op": 0
}

{
  "block": 65276782,
  "op": [
    "vote",
    {
      "author": "shriyala",
      "permlink": "global-digital-marketing-software-market-growth-trends-covid-19-impact-and-forecasts-2021-2029",
      "voter": "defrag",
      "weight": 1500
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-06-22T10:07:48",
  "trx_id": "d1b339b9496826644e7fd123cdbe13cbade764be",
  "trx_in_block": 4,
  "virtual_op": 0
}

{
  "block": 65276779,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global Digital Marketing Software market was valued at over US$55,391million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 16.3% between 2022 and 2029. The growing popularity of social media and e-commerce platforms due to the proliferation of smartphones is expected to drive the growth of the Digital Marketing Software market.\n\nDigital Marketing Software helps businesses measure the performance of their campaigns and ensures their marketing campaigns are launched and tested quickly and efficiently.\n\nAgileIntel’s global Digital Marketing Software market study is a 162 pages report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, software, service, and end-user perspective.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Digital-Marketing-Software-Market-/51#popup\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nInsights on End-User:\n\nThe end-users of the Digital Marketing Software market include automotive, BFSI, education, government, healthcare, manufacturing, media and entertainment, and others.\n\nThe BFSI segment dominated the market accounting for a global revenue share of around 21% in 2021. This can be attributed to the large-scale adoption of Digital Marketing Software in the BFSI industry for various applications, including statement generation, automatic notification, investment advisory, etc. Additionally, banks and other financial institutions are using location-based advertising for improving consumer engagement and sending tailored messages through the most preferred channels of a customer.\n\nFurther, the media and entertainment segment is witnessing an upsurge as companies are developing online advertising strategies owing to the proliferation of smartphones and the continued rollout of high-speed data networks. Media and entertainment companies such as Star, The Walt Disney Company, and Netflix use social media advertising to update people about their upcoming shows and film releases. Likewise, gaming companies are adopting digital marketing software solutions such as Search Engine Optimization (SEO), App Store Optimization (ASO), video marketing, marketing automation, etc., to create personalized real-time campaigns for the target audience and increase customer engagement. For instance, in January 2022, Rovio Entertainment Corporation, a Finish gaming company, announced a new fully animated, long-form series of Angry Birds on Netflix.\n\nInsights on Software:\n\nThe Digital Marketing Software market is classified into CRM Software, Email Marketing, Social Media, Search Marketing, Content Management, Marketing Automation, Campaign Management, and Others based on software.\n\nThe Customer Relationship Management (CRM) software segment held the largest share of 21%, accounting for a global revenue of over US$7,768 million in 2021. The growing demand by businesses to efficiently manage customer interactions has resulted in the widespread adoption of CRM software in recent years. CRM software helps companies understand customer preferences streamline processes, and improve profitability.\n\nFurthermore, the social media segment is anticipated to grow significantly during the forecast period. This can be attributed to the growing use of social media platforms such as Facebook, Instagram, Snapchat, Twitter, and Pinterest in the retail and e-commerce industry for marketing products in an engaging and entertaining manner. Additionally, the integration of advanced technologies such as artificial intelligence (AI) and big data analytics into social media platforms is expected to propel market growth during the forecast period. For instance, Chatbots are being aggressively used by companies to engage with customers.\n\nImpact of COVID-19\n\nThe outbreak of the COVID-19 pandemic has had a positive impact on the digital marketing software market. The pandemic has triggered a paradigm shift in the behavior of individuals when it comes to using different apps. Advertising companies are increasingly following digital marketing channels and providing publishers with advanced advertising capabilities. The outbreak of the coronavirus and the ensuing economic downturn has presented app developers with lucrative opportunities to review their advertising set-ups and improve their capabilities to push for more accountability and transparency with partners.\n\nThe pandemic has resulted in a rise in the number of people staying indoors, consequently leading to the high internet consumption for entertainment purposes. This is likely to impact the way companies market their products. Moreover, as governments across the globe have urged their citizens to stay home and mandated social distancing, people are socializing through online networking, thus leading to rising social media marketing activities.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Digital-Marketing-Software-Market-/51\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"digital\",\"marketing\",\"software\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Digital-Marketing-Software-Market-/51#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Digital-Marketing-Software-Market-/51\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-digital-marketing-software-market-growth-trends-covid-19-impact-and-forecasts-2021-2029",
      "title": "Global Digital Marketing Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2029)"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-06-22T10:07:39",
  "trx_id": "e721feb9ef1ec72053fe997b00463f68b8790944",
  "trx_in_block": 4,
  "virtual_op": 0
}

{
  "block": 65274601,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global e-commerce fulfillment services market was valued at US$84.72 billion in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 8.4% between 2022 and 2029. The upsurge of e-commerce and the resulting rise in the number of online buyers, specifically in emerging economies, drive the demand for e-commerce fulfillment services.\n\nFulfillment service centers help e-commerce vendors outsource logistical services such as warehousing, bundling, shipping, and other value-added services such as delivery speed and return management.\n\nAgileIntel’s global e-commerce fulfillment services market study is a 157 pages report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, data type, industry, and end-user perspective.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-E-commerce-Fulfillment-Services-Market-/52#popup\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nInsights by Service Type:\n\nThe e-commerce fulfillment services market is classified into warehousing and storage services, shipping services, bundling services, and others based on the service type.\n\nThe shipping segment held the largest revenue share of over 40% in 2021. The boom in the e-commerce industry has resulted in many e-commerce companies outsourcing shipping services to third-party fulfillment service providers, thereby driving the shipping fulfillment services market. Moreover, the increase in disposable incomes, the growing inclination among consumers towards international brands, and the high internet penetration rate, coupled with the rise in the number of social media users, are expected to boost the demand for shipping fulfillment services during the forecast period.\n\nFurthermore, the warehouse and storage segment held a considerable revenue share in 2021 and is expected to continue doing so during the forecast period. The deployment of automated mobile robots (AMR) and augmented reality (AR) technology in warehouses helps in improving operational efficiency. E-commerce companies worldwide outsource these services to reduce the delivery time, consequently contributing to the segment growth. For instance, in January 2020, Ship fusion, a U.S.-based fulfillment service provider, opened a new 3,81,000 sq. ft. fulfillment center in Chicago, which includes a temperature-controlled warehouse and is equipped with an efficient conveyer and automated racking system.\n\nInsights on Product Type:\n\nThe e-commerce fulfillment services market is classified into automotive, beauty and personal care, books and stationery, consumer electronics, healthcare, clothing and footwear, home and kitchen application, sports and leisure, and others based on product type.\n\nThe clothing and footwear segment dominated the e-commerce fulfillment services market accounting for a 27% revenue share in 2021. This segment's high growth can be attributed to the growing interest among consumers towards buying clothing and footwear through online channels. This trend witnessed an upsurge during the COVID-19 pandemic, where people were forced to stay indoors due to the government lockdown policies. Additionally, the home and kitchen segment is also anticipated to grow considerably during the forecast period due to the rising incidence of work-from-home situations worldwide owing to the ongoing pandemic.\n\nFurthermore, consumer electronics is projected to be the fastest-growing segment during the forecast period. The growth can be attributed to the rising demand for consumer electronics such as mobile phones, tablets, televisions, etc. often need special care while packaging. Additionally, The COVID-19 pandemic has resulted in huge demand for electronics products, such as headsets, routers, laptops, etc. These consumer electronics being extremely fragile, require appropriate packaging to prevent moisture and reduce the risk of damage. The e-commerce fulfillment centers manage the specific packaging requirements and offer bundling and assembly services for electronic products' accessories such as controllers, extra cables, headphones, and speakers that the consumer may wish to order together as a complete set.\n\nImpact of COVID-19\n\nThe e-commerce fulfillment services market has been adversely affected due to the COVID-19 pandemic. The government-imposed lockdowns and closure of international borders to curtail the spread of the virus has caused severe disruptions in the supply chain and logistical operations and labor shortages, resulting in the stagnation of manufacturing activities in several countries globally. The uncertainty in the movement of goods amid lockdowns has caused a decline in the demand for international fulfillment services for e-commerce activities worldwide.\n\nHowever, relaxations and resumption of logistics and transportation services for essential products are expected to revive the e-commerce fulfillment services market. Additionally, despite the opening of shops and retail stores across the globe towards the end of 2021, consumers prefer the e-commerce channel to buy essential or non-essential products. This trend is expected to drive the demand for fulfillment services to meet the growing demand for shipping, warehousing, and other services during the forecast period.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-E-commerce-Fulfillment-Services-Market-/52\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"e\",\"commerce\",\"fulfillment\",\"services\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-E-commerce-Fulfillment-Services-Market-/52#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-E-commerce-Fulfillment-Services-Market-/52\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-e-commerce-fulfillment-services-market-upcoming-trends-growth-drivers-and-challenges",
      "title": "Global E commerce Fulfillment Services Market Upcoming Trends, Growth Drivers and Challenges"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-06-22T08:18:21",
  "trx_id": "ba789067ad3df5e38af4471542a931c570edea55",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 65273591,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global Engineering Services Outsourcing (ESO) market was valued at US$798.7billion in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 18.9% between 2022 and 2029. The growing collaboration between Engineering Service Providers (ESPs) and Original Equipment Manufacturers (OEMs) is expected to increase the adoption of engineering services outsourcing (ESO) during the forecast period.\n\nEngineering Services Outsourcing (ESO) refers to outsourcing technology and services related to engineering activities such as designing, prototyping, system integration, testing, and consultation to specialized vendors or ESPs.\n\nAgileIntel’s global Engineering Services Outsourcing market study is a 157 pages report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, application, service type, and location perspective.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Engineering-Services-Outsourcing-Market-/53#popup\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nKey insights from the Global Engineering Services Outsourcing report\n\nInsights on Service Type:\n\nThe ESO market service type includes designing, prototyping, system integration, testing, and others.\n\nThe testing segment held the largest share of over 31% of the global revenue in 2021. The growing demand to reduce turnaround time by minimizing manual intervention is expected to drive the growth of the testing segment in recent years. Also, OEMs hire software testing services from ESPs to develop and redesign product models with higher compatibility and bug-free operations.\n\nFurthermore, the designing segment is anticipated to grow significantly during the forecast period. The growing design complexities and the need to reduce costs by outsourcing design to a skilled and low-cost workforce drive the growth of design engineering outsourcing. The increasing demand for architectural, visual, graphic, and industrial designing for advanced equipment and mobility solutions is expected to increase the demand for design engineering during the forecast period. Additionally, the rising demand for consumer electronics has propelled the growth of outsourcing engineering services for prototyping cost-efficient products. Countries like the USA, Canada, Japan, and China are driving the prototyping segment's growth globally.\n\nInsights on Application:\n\nThe end-use application of the ESO market includes aerospace, automotive, industrial, consumer electronics, semiconductors, healthcare, telecom, and others.\n\nThe industrial segment dominated the ESO market, registering a revenue share of over 61% in 2021, and is expected to continue doing so during the forecast period. Digitization in exploration services, including drilling, blasting, crushing, and tunneling, is increasing the adoption of ESO in this sector. The industrial sector extensively implements cloud infrastructure to modernize its IT infrastructure, drive automation, and streamline processes. Additionally, the deployment of the industrial internet of things (IIoT) to reduce downtimes, detect and prevent errors, and cut maintenance costs is expected to drive the industrial segment growth.\n\nFurthermore, the healthcare segment is estimated to be the fastest-growing segment, with a CAGR of around 30% during the forecast period. The growing investment in advanced medical equipment, laboratories, and medications is driving the segment growth in recent years. The segment witnessed an upsurge in the past few months to develop drugs and vaccines during the COVID-19 pandemic. Healthcare organizations collaborate with the ESPs to increase their clinical proficiency and reduce operational costs. For instance, in August 2020, PRA Health Sciences' data solutions division, Symphony Health, collaborated with Close-Up International, a provider of sales audits and medical prescriptions, to expand its data services worldwide.\n\nImpact of COVID-19\n\nThe COVID-19 pandemic has had a diverse effect on the ESO market as the outsourcing of services was negatively impacted in specific industries such as automotive and industrial. Meanwhile, there was an increase in demand for ESO services from the healthcare sector.\n\nThe COVID-19 pandemic adversely affected some major economies and has undoubtedly disrupted the ESO market's supply chain in these industries. Temporary work shutdowns, travel restrictions, 'shelter-in-place' norms, and disruption in trade activities are certain factors that have subsequently affected the ESO industry. On the contrary, the rapid developments in the healthcare sector, especially in the pharmaceutical and medical device manufacturing domains, witnessed a boom because of the increased efforts to arrest the COVID-19 spread worldwide.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Engineering-Services-Outsourcing-Market-/53\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"engineering\",\"services\",\"outsourcing\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Engineering-Services-Outsourcing-Market-/53#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Engineering-Services-Outsourcing-Market-/53\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-engineering-services-outsourcing-market-demand-analysis-2022-growth-statistics-revenue-estimates-covid-19-impact-global",
      "title": "Global Engineering Services Outsourcing Market Demand Analysis 2022 Growth Statistics, Revenue Estimates, COVID-19 Impact, Global Share, Emerging Trends,"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-06-22T07:27:30",
  "trx_id": "35baf912787f4446618ed37adb369f4e8bdcee7f",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 65044731,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global eSIM market was valued at over US$7,190 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 7.8% between 2022 and 2029. The rapid increase in the number of Internet of Things (IoT) connected devices in consumer electronics and the application of Machine-to-machine (M2M) communications is expected to create new opportunities and influence the market growth during the forecast period.\n\nEmbedded Subscriber Identity Module (eSIM) is a digital hardware chipset that allows consumers to store multiple operator profiles on a single device and switch between them remotely by reprogramming the software settings.\n\nAgileIntel’s global eSIM market study is a 157 pages report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, data type, industry, and end-user perspective.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-eSIM-Market/30#popup\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nKey insights from the Global eSIM report\n\nInsights on Solution:\n\nThe eSIM market is segmented into connectivity services and hardware, based on solution type.\n\nThe connectivity services segment held the largest revenue share of the eSIM market, accounting for around 89% in 2021, and is estimated to grow significantly during the forecast period. This high growth can be attributed to the rise in adoption of eSIM for M2M connections which is expected to create revenue generation opportunities for the network operators by providing subscription services.\n\nMeanwhile, the hardware segment is projected to grow substantially, registering a CAGR of over 31% during the forecast period. The increase in consumer electronics manufacturers is anticipated to fuel the demand and contribute to the segment growth.\n\nMarket dynamics\n\nTrends\n\nThe emerging 5G technology is expected to provide high internet speed and expanded network capacity, which is expected to positively impact the eSIM market, increasing its adoption across several cellular-enabled devices. The need for remote connectivity is rising rapidly to manage these network-connected devices such as smartphones, wearables, smart glasses, connected cars, which is offered by integrating eSIM with consumer electronic products. The advent of 5G is expected to enable faster data communication with lower latency, providing better navigation and more connected devices in smart homes. eSIM usage is likely to be one of the prominent factors supporting consumer 5G use cases, as it can be easily integrated into smaller devices such as fitness bands, wearables, and smartwatches. For enterprises using IoT systems with cellular-enabled devices, the deployment of eSIM presents them with an opportunity to upgrade their systems to accommodate 5G and reap its benefits.\n\nDrivers\n\nThe growing emphasis on remote access for M2M communication systems is expected to drive market growth during the forecast period. M2M systems comprise of wi-fi communication links, Radio Frequency Identification (RFID), sensors, and automatic computing software, which interprets data and transmits it through a network for further processing. Factors such as reduced maintenance costs and downtime, real-time data monitoring, low power consumption, and remote provisioning have resulted in the increased adoption of M2M systems in applications such as connected cars, smart meters, smartphones, smartwatches, and retail POS, among others. These applications require improved network connectivity, wherein eSIM is integrated with M2M systems, thereby driving the demand for eSIMs.\n\nOpportunities\n\nThe rapid adoption of IoT across various products and applications such as home appliances, health monitoring systems, agriculture, utilities, self-driving drones and connected vehicles, and industrial machinery will likely provide growth opportunities for eSIM vendors. The implementation of eSIM technology is more economical than a traditional SIM. It also occupies lesser space, making it easy for the eSIM to be integrated into the hardware. The eSIM technology can be deployed with IoT-enabled systems for large-scale machine-to-machine operations across sectors such as oil & gas, manufacturing plants, power plants, and warehousing facilities. Businesses relying on IoT systems are expected to achieve substantial cost savings with the eSIM technology while also offering the benefit of staying connected with the systems remotely through mobile networks.\n\nChallenges\n\nThe eSIM enabled systems allow automatic interoperability between multiple SIM operators and connectivity platforms, allowing remote provisioning of SIM profiles. With several network service providers involved in the operational chain, preserving the security of these systems has become complex. The credentials Of Mobile Network Operators (MNOs) are collected and stored by the eSIM in an inbuilt device software and are prone to security hacks. Besides, eSIM operation across multiple physical platforms and MNOs exposes it to several risks of the virtual environment. As such, the operational flexibility offered by eSIM may prove futile if the security is compromised, thus hampering the market growth.\n\nImpact of COVID-19\n\nThe eSIM supply chain has been adversely affected because of the COVID-19 pandemic. COVID-19 had a devastating influence on the devices market worldwide, leading to significant disruptions in the supply chains, production lines, inactive logistics, and labor shortages, delaying shipments and slowing down the development of next-generation products which use eSIMs.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-eSIM-Market/30\n\nOver the past few years, eSIM has benefited from increased market demand and active support from different industry stakeholders. During the COVID-19 pandemic, its genuine benefits have been realized, particularly as part of mobile operators’ strategies to digitalize their services. Moreover, consumers were open to starting mobile services using eSIMs, rather than going to a store to activate the physical SIM card. Due to the pandemic, many operators may have decided to delay their eSIM implementation plans on many of their mobile phone models to focus on critical priorities, such as mobile network resiliency.\n\nHowever, the number of eSIM devices commercially available for purchase across smartwatches, smartphones, tablets, and laptops increased in 2021. As the share of eSIM-enabled consumer device shipments continues to grow, eSIM activations are expected to rise sharply, providing avenues for the eSIM market growth in the coming years.\n\nAbout Us:\n\nChemIntel360, part of AgileIntel’s broader research offering, provides an integrated portfolio of quantitative and qualitative research reports on the chemicals sector. Our studies make use of credible market intelligence.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"esim\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-eSIM-Market/30#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-eSIM-Market/30\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-esim-market-trends-size-share-segments-emerging-audience-and-forecast-to-2029",
      "title": "Global eSIM Market  Trends, Size, Share, Segments, Emerging Audience and Forecast to 2029"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-06-14T07:41:57",
  "trx_id": "595cdd5ba33f2c4f548aea5ec9e8394284315010",
  "trx_in_block": 8,
  "virtual_op": 0
}

{
  "block": 65043443,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global 3D Animation market was valued at over US$18,025 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 10.4% between 2022 and 2029. The growing preference for high-definition (HD) content for video marketing and the rising usage of visual effects technology (VFX) in movies and games drive the global 3D Animation market.\n\n3D Animation is a graphic technique that creates an illusion of movement in characters, objects, drawings, and models in TV shows, movies, and games.\n\nAgileIntel’s global 3D Animation market study is a 157 pages report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, application, and printing type, perspective.\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-3D-Animation-Market/37#popup\n\nInsights on Animation Type:\n\nThe 3D Animation market has been segmented based on animation type into 3D Modeling, Motion Graphics, 3D Rendering, and Visual Effects.\n\nThe 3D Modeling segment held the largest revenue share of over 31% of the 3D Animation market in 2021 and is expected to maintain its dominance during the forecast period. Industry players are extensively using the 3D Modeling technique for designing and creating fully animated digital objects used in special effects and character animation. 3D Modeling techniques use different methods such as polygon modeling, 3D sculpting, 3D garment visualization, 3D laser scanning, etc., to create 3D images of different objects.\n\nOn the other hand, the Visual Effects segment is expected to be the fastest-growing segment registering a CAGR of around 13% during the forecast period. The extensive use of VFX technology in applications such as media and entertainment, marketing, visual analytics, product visualization, system visualization, information visualization, and scientific visualization is expected to propel segment growth in the coming years.\n\nFurthermore, the Motion Graphics segment is projected to observe substantial growth during the forecast period. The high growth in this segment can be attributed to its wide use in creating animated videos. Motion Graphics can digitally track human actions, such as lip movement and facial expressions, thereby offering viewers a sound, visual experience.\n\nMarket dynamics\n\nTrends\n\nEvolving 3D Rendering and facial animation techniques are likely to remain a key trend, driving the 3D Animation market growth. The 3D Rendering techniques have evolved from non-realistic wireframe rendering to more advanced techniques, including ray tracing, radiosity, and scanline rendering. The rendering techniques may be real-time rendering or photo-realistic rendering. Real-time rendering is ideal for applications in interactive media such as simulations, games, mapping, and medical applications. In contrast, photo-realistic rendering is suitable for applications in non-interactive media such as feature videos and films, which are rendered at a slower rate. Furthermore, the 3D facial animation techniques have also evolved to create improved facial animation. To improve animation technology, academic systems or small standalone systems are gradually shifting to modern performance-driven technologies such as lip synchronization, expression coding, muscle simulation, etc.\n\nDrivers\n\nThe increasing adoption of Visual effects (VFX) in the media and entertainment industry, including films, games, and commercials, is driving the 3D Animation market growth. VFX creates live-action imagery by using computer-generated graphics. It is executed in the post-production stage with the use of multiple tools such as animation, graphics design, and modelling. The use of VFX has made shooting convenient and economical as it reduces production costs. The rising trend of outsourcing VFX from developed countries to cost-effective developing countries has adversely affected the VFX artists in developed countries. To overcome the offshoring, governments in countries such as the U.K. and Canada are offering subsidies, grants, and tax relaxations to companies operating in the 3D animation sector. For instance, In November 2021, British Film Institute (BFI) - run U.K. Global Screen Fund (UKGSF) was allocated GBP42 million by the government to provide grants for film and television. The funds were aimed to support various screen content, such as documentaries, interactive narrative games, animation, and television.\n\nOpportunities\n\nThe increasing use of 3D Animation technology in other segments such as chemical, energy, power, forensics, and travel and hospitality is slowly gaining traction, creating immense growth opportunities for the 3D Animation market. Forensic animation involves using full-motion Computer Graphics (CG) to explain the internal functioning of a process or device. It is also used to recreate an event such as architectural, industrial, vehicular accidents, and crime scene re-constructions. Similarly, 3D Animation is gaining prominence in the healthcare industry for teaching and understanding the mechanism of the human body. The biotech, medical device, and pharmaceutical industry have leveraged the benefits of 3D Animation by creating dynamic content and high-end visuals.\n\nChallenges\n\nIn many countries, such as the U.S, the growth of the 3D Animation market is hindered by copyright infringement. Fan communities have released and renamed animation series as ‘fansubs’, which are gaining popularity in the absence of official releases. Many animation studios and distributors have a working partnership with these fan clubs, allowing them to even download and produce fansubs, which implies that even the copyright holders encourage and accept this copyright infringement, despite these being illegal. Moreover, the availability of digital platform to the fansubs has affected the profit share of animation distributors, as content can be copied without any limit, and their quality is similar to the official products.\n\nImpact of COVID-19\n\nThe 3D Animation market has been positively affected because of the COVID-19 pandemic. As the COVID-19 global pandemic continues to induce physical movement and gathering restrictions, the demand for high-quality entertainment at home could become a competitive advantage for content creators. Due to the current work-from-home norms, the demand for cloud-based 3D Animation solutions has witnessed an upsurge from various industries. The adoption of simulation technology is allowing media and entertainment companies to offer viewers an advanced visualization experience.\n\nAdditionally, several industry players have undertaken strategic initiatives to help individuals during the ongoing crisis. For instance, in March 2020, Viacom International’s Nickelodeon introduced #KidsTogether, an initiative to support families and kids in fun and engaging activities. Likewise, in March 2020, NVIDIA expanded GPU licensing to 500 licenses to support companies in helping their employees. Furthermore, the 3D animation solutions have helped the healthcare sector by offering an enhanced mode of communication between doctors and patients, a training and learning platform for medical students, and marketing services for patients. For instance, in March 2020, Fusion Animation, an action medical animation video maker, unveiled a 3D model of the surface of the COVID-19 virus, which will enable scientists to research possible treatments to combat the pandemic.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-3D-Animation-Market/37\n\nAbout Us:\n\nChemIntel360, part of AgileIntel’s broader research offering, provides an integrated portfolio of quantitative and qualitative research reports on the chemicals sector. Our studies make use of credible market intelligence.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"animation\",\"market\",\"kidstogether\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-3D-Animation-Market/37#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-3D-Animation-Market/37\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-3d-animation-market-2021-industry-development-analysis-of-driving-factors-and-growth-forecast-to-2029",
      "title": "Global 3D Animation Market  2021 Industry Development, Analysis of Driving Factors and Growth Forecast to 2029"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-06-14T06:37:21",
  "trx_id": "49e7bf370b19e5c9bcf2f278c1a64fc1dfc73cd4",
  "trx_in_block": 7,
  "virtual_op": 0
}

{
  "block": 65013517,
  "op": [
    "delegate_vesting_shares",
    {
      "delegatee": "shriyala",
      "delegator": "steem",
      "vesting_shares": "27217.736963 VESTS"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-06-13T05:32:57",
  "trx_id": "004f1a344459028e903d4f7fa52bee1b16d70e55",
  "trx_in_block": 6,
  "virtual_op": 0
}

{
  "block": 64443607,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global data annotation tools market was valued at US$ 616.91million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 25.62% during the forecast period. This can be attributed to the growing adoption of image data annotation in the automotive, retail, and healthcare sectors. Data annotation is the process of adding attributes or labeling to the datasets, which helps users manage the data definition at a single location and eliminate the need to rewrite similar rules in multiple places.\n\nAgileIntel’s global data annotation tools market study is a 157 report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, annotation type, and data type perspective.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Data-Annotation-Tools-Market/12#popup\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nInsights by Annotation Type:\n\nData annotation tools are software solutions that use labeled/tagged training datasets for machine learning. The data annotation tool market is segmented into manual, semi-automatic, and automatic based on the annotation type.\n\nThe manual data annotation segment accounted to US$ 505.09 million in 2021. Manual data annotation is the process where human annotators examine vast amounts of datasets and build a comprehensive, quality AI training data. This approach is mainly preferred due to the high-level of accuracy, minimal data annotation efforts, and possibility of extracting accurate business insights from the data which can then be integrated into an algorithm.\n\nOn the other hand, automatic data annotation tools reduce human involvement. They can handle most easily identified annotations using annotation techniques such as bounding box annotation, polygon and polylines annotation, semantic segmentation, panoramic segmentation, net entity relationships (NER), parts of speech (POS),  Audio labelling, etc. The growing demand for ML in automated data analytics is expected to boost the automatic data annotation tools in various data-specific applications.\n\nInsights by Data Type:\n\nThe data annotation tools market is segmented on type as text, image/video, and audio annotations.\n\nThe text segment accounted for a 37% market share in 2021, mainly due to its growing application in the e-commerce and clinical sector. For instance, e-commerce sites utilize data and information from social media platforms to influence buyers. Text data annotation is widely used in social media monitoring to design systems for recommendation and endorsement based on consumer sentiment analysis. Additionally, the increasing adoption of Electronic Health Record (EHR) systems has resulted in large repositories of structured and unstructured patient data. The use of data annotation tools and Natural Language Processing (NLP) models will help valuable insights from the patient data that would assist in the patient treatment.\n\nFurthermore, the image/video annotation segment is anticipated to witness significant growth during the forecast period. The image segment is driving the market growth mainly due to the increasing use of computer vision in industries such as automotive, healthcare, and media and entertainment. For example, medical imaging is one of the fastest-growing and prominent image labeling applications in the healthcare sector. Moreover, the rising trend of gathering insights from large volumes of data sets for surveillance and national security is bolstering the video annotation market growth.\n\nInsights on Regional Growth:\n\nNorth America is the largest market for data annotation tools accounting for 37% of the global revenue share in 2021, mainly due to the growing adoption of image data annotation tools in the automotive, healthcare, financial services and retail sectors. Additionally, growing investments in AI and machine learning solutions by North American enterprises is expected to drive the market positively.\n\nMeanwhile, Europe is anticipated to grow at a CAGR of 29% during the forecast period, mainly due to the growing implementation of biometric solutions in the region which is expected to drive the use of the image-based data annotation tools. For instance, in January 2020, biometric applications were deployed at 14 airports and 134 railway stations in Germany to enhance security operations. Additionally, implementation of automobile obstacle detection technologies are expected to drive the adoption of data annotation tools in the automobile sector.\n\nThe Asia Pacific is projected to witness prominent growth in data annotation tools usage during the forecast period, mainly due to rapid adoption of smart devices, technological advancements and increasing usage of social networking in developing countries such as India and China. The growing use of smart devices is expected to lead to a surge in personal data, thus, driving the requirement data collection and data annotation. The growth of the healthcare industry in the region is marked by the increasing adoption of technology and innovative healthcare access programs. These factors are anticipated to boost the demand for image-based data annotation tools in this region in the near future.\n\nInsights on Key Markets:\n\nThe U.S data annotation market was valued at US$153.6 million in 2021. The growth in the U.S. is driven by the adoption of AI and machine learning applications of data annotation tools. Moreover, in the U.S., AI-based investment advisory consumer applications are getting traction to improve investment decisions.\n\nMeanwhile, China’s data annotation market was valued at US$48.3 million in 2021, primarily driven by the increased penetration of data collection and annotation tools in applications such as face recognition in surveillance and security systems in the region. For instance, the Chinese government has imposed real-name registering policies across the country, under which citizens should link their official government ID with an online account. Implementation of such policies has spurred the growth in usage of data annotation tools in the country.\n\nImpact of COVID-19\n\nThe COVID-19 pandemic had a positive impact on the data annotation tools market. The growth in the adoption of big data and artificial intelligence tools is expected to increase the use of data annotation tools.\n\nFurthermore, the healthcare sector is under immense pressure during the pandemic due to the unprecedented wave of new COVID-19 variants and the near-full hospitals still dealing with existing patients. Under such circumstances, data annotation tools can help healthcare service providers to detect COVID-19 hotspots, predict patient inflow, and ensure an uninterrupted supply of critical medicines and medical care equipment.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Data-Annotation-Tools-Market/12\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"digital\",\"signage\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Data-Annotation-Tools-Market/12#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Data-Annotation-Tools-Market/12\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-digital-signage-market-may-set-epic-growth-story-in-future",
      "title": "Global Digital Signage Market May Set Epic Growth Story in Future"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-05-24T08:23:36",
  "trx_id": "7a75c06fa0fcc9cbdf7535dfdfa25c6419227b9c",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 64442880,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global e-cigarette and vape market was valued at US$18,103 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 25% during the forecast period. This can be attributed to the growing preference among smokers to adopt a safer tobacco alternative. The continuous innovation in e-cigarette technology and introduction of new products is expected to drive their adoption during the forecast period.\n\nAgileIntel’s global e-cigarette and vape market study is a 166 pages report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, product type, and component perspective.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-E-cigarette-and-Vape-Market-/14#popup\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029. Insights by Product Type:\n\nThe e-cigarette and vape market is segmented into disposable, rechargeable and modular devices based on product type.\n\nRechargeable e-cigarette was the largest segment in 2021, accounting for 43% of the market share. These e-cigarettes can be recharged for prolonged usage and comprise an internal battery. The demand for rechargeable e-cigarettes is growing since they are economical, and users do not have to re-purchase cartridges. Also, customers making DIY e-liquid need not purchase pre-filled cartridges. Seasoned vapers particularly find it economical to buy rechargeable e-cigarettes.\n\nMeanwhile, the disposable variants of e-cigarettes come with an internal battery, compact, and pre-filled with cartomizers, suitable for one-time use only. Further, the growth in modular devices is driven by demand from users who seek advanced and customizable functionalities in their devices. These devices are expensive, highly advanced, and have programmable functions, such as temperature control and variable wattage control. They are also preferred by individuals participating in professional vape competitions.\n\nInsights by Component:\n\nThe e-cigarette and vape market is segmented into Vape Mod, Atomizer, E-liquid, and Cartomizer, based on component type.\n\nVape Mods are key components of the e-cigarette device and held the largest market share in 2021. The availability of numerous customization options and price ranges is driving the adoption of Vape Mods. They have evolved over the years incorporating features such as temperature control, variable wattage, and custom atomizer power delivery, giving users multiple options to change the flavor and vapor output. Vape mods are expected to get more advanced by connecting to the internet and mobile phones.\n\nMeanwhile, the atomizer segment accounted for 28% market share in 2021 and is expected to grow over the forecast period because different types of coils used in e-cigarettes require atomizers of different configurations, such as Rebuildable Atomizer (RBA) and Rebuildable Dripping Atomizer (RDA). Furthermore, the customizable nature of Atomizers is also driving their sales as they can be manufactured in different styles and sizes to serve different purposes, such as competition vaping, casual vaping, and high flavor output.\n\nMoreover, the demand for Cartomizers is driven by the sales trend in the disposable e-cigarettes segment. This one-time use component is cheap, comes in standard flavor, holds a small amount of e-liquid, and has to be re-purchased upon consumption.\n\nInsights on Regional Growth:\n\nNorth America is the largest market accounting for 44% of the global revenue share in 2021, mainly due to the presence of prominent players such as Altria Group and Philip Morris International, who hold a significant market share in the region. The growing demand for disposable e-cigarettes due to their low-cost and easy availability has contributed to the market growth in the region. Moreover, events such as vape conventions and competitions are regularly organized in the region, thereby raising the demand for modular devices in North America.\n\nEurope accounted for 27% of the global e-cigarettes and vape market in 2021. Some countries such as the U.K. have legalized the consumption of e-cigarettes which is expected to significantly boost market growth in the region. Moreover, European countries have established vape shops where customers can visit and test the devices and e-liquid flavors before purchasing.\n\nAsia Pacific is the largest manufacturer of e-cigarettes in the world. The region has been witnessing a significant demand for modular e-cigarette devices, which is expected to drive market growth.\n\nInsights on Key Markets:\n\nThe U.S. was the largest market for e-cigarette and vape products, capturing a 40% market share and was valued at US$7.28 billion. The market growth was driven by a high demand for rechargeable e-cigarettes, whereas E-liquid is expected to emerge as the fastest-growing segment in the U.S. The presence of various small-scale e-cigarette companies in the U.S. has resulted in the development of customized products for niche customers. These companies are also developing atomizers that can provide a high vapor and flavor output.\n\nThe e-cigarette and vape market in China was pegged at US$1.38 billion in 2021. The increase in disposable income and availability of low-priced vape products are expected to drive the demand for e-cigarettes in China. Moreover, small companies are outsourcing the manufacturing of e-cigarettes to China to price their products competitively.\n\nImpact of COVID-19\n\nThe COVID-19 pandemic had a mixed impact on the e-cigarette and vape market. Supply chain disruptions caused by the temporary closure of manufacturing plants and trade restrictions in many countries have adversely affected the global tobacco industry. Additionally, many reports indicated that people using e-cigarettes and vapes are five to seven times more susceptible to being infected by COVID-19. Smoking damages the lungs, making it difficult for the body to fight off COVID-19 and other diseases. These factors have impacted the market during the pandemic.\n\nOn the other hand, the government-imposed lockdowns, social distancing norms, and stay-at-home orders have resulted in a significant rise in the sales of e-cigarettes. The general perception that e-cigarettes and vapes are safer than conventional tobacco products is expected to drive the demand for these products during the forecast period. Moreover, E-cigarette and vape vendors have resorted to aggressive marketing strategies and offering their products through online platforms as supplies of e-cigarette and vape devices became scarce in physical stores. Many vaping brands such as MyVapery, One Drop Vape, and Podsalt offer hand sanitizers and masks as gifts on purchase of their products.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-E-cigarette-and-Vape-Market-/14\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"e\",\"cigarette\",\"and\",\"vape\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-E-cigarette-and-Vape-Market-/14#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-E-cigarette-and-Vape-Market-/14\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-e-cigarette-and-vape-market-cumulative-impact-for-covid-19-recovery-research-report-2029",
      "title": "Global E-cigarette and Vape Market Cumulative Impact for COVID-19 Recovery Research Report 2029"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-05-24T07:46:54",
  "trx_id": "4946e5c4fb950a78a698bec22daaffdedf0d29d4",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 64299602,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global Automated Guided Vehicle (AGV) market was valued at US$3,872million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 10.6% between 2022 and 2029, mainly driven by the increasing demand for automation solutions in material handling processes across industries.\n\nAGVs, that are controlled using software and sensor-based guidance systems, are primarily used to transport products along the floor of a facility.\n\nAgileIntel’s global AGV market study is a 160 slide report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, vehicle type, and navigation perspective.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Automated-Guided-Vehicle-Market/7#popup\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nInsights on Navigation:\n\nThe AGV market is classified into laser guidance, magnetic guidance, inductive guidance, vision guidance, natural navigation, and others, based on navigation.\n\nThe laser guidance segment dominated the market with a revenue share of over 36% in 2021. The technology conceptualizes the area and stores the guide path in the vehicle’s memory which can be easily amended and expanded whenever required.\n\nThe use of vision guidance technology is currently limited as it happens to be sensitive to light. However, it is anticipated to witness a steady growth during the forecast period, mainly due to their growing deployment in the warehouses and distribution centres. AGVs make use of camera-based vision together with Light Detection and Ranging (LiDAR) sensors and computer systems, to create a 3D image of the operational area that helps in the precise manoeuvring of production areas and warehouses.\n\nInsights on Regional Growth:\n\nEurope dominated the AGV market with a revenue share of 31.2% in 2021 and is expected to continue doing so during the forecast period. This can be attributed to the presence of major manufacturers and exporters of AGV in this region. Moreover, rising investments in advanced technologies in the manufacturing sector and increasing productivity of the automotive and logistics industries in the region is driving the demand for AGVs in the European market.\n\nMeanwhile, Asia Pacific is estimated to witness remarkable growth with India and China being the key countries. The rapid growth of e-commerce has resulted in a large-scale deployment of AGVs in the warehouses. A good example is Flipkart’s deployment of 340 small AGVs at its warehouse in India, in 2019. Additionally, the rapidly growing manufacturing and automotive industries in the region are also expected to drive the demand for AGVs during the forecast period. The automotive industry uses AGVs mainly in the assembly lines for auto components, engines, and transmissions.\n\nImpact of COVID-19\n\nThe COVID-19 pandemic has significantly impacted the global economy. Labor shortage and complete disruption of supply chain and logistics operations due to the government-imposed lockdowns forced many manufacturing industries to shut operations. However, the deployment of automation and robotics such as AGVs and autonomous mobile robots (AMRs) has helped businesses to sustain their production levels with minimum employee involvement. Logistics and warehouse AGVs have ensured continuity of services amidst the global lockdown\n\nAdditionally, there has been a significant rise in the deployment of AGVs in hospitals during the COVID-19 pandemic,to deliver medicines to patients while reducing human interventions. For instance, in March 2020, Homagama Base Hospital in Sri Lanka deployed AGVs to treatCOVID-19 patients.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Automated-Guided-Vehicle-Market/7\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"automated\",\"guided\",\"vehicle\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Automated-Guided-Vehicle-Market/7#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Automated-Guided-Vehicle-Market/7\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "automated",
      "permlink": "global-automated-guided-vehicle-market-to-2029-size-share-analysis-by-key-vendors-growth-rate-and-industry-outlook-report",
      "title": "Global Automated Guided Vehicle Market To 2029, Size, Share Analysis by Key Vendors, Growth Rate & Industry Outlook Report"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-05-19T07:55:36",
  "trx_id": "8440747e7abb071cff8e6d16662c00cc16d5ab63",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 64228080,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global Private 5G Network market was valued at US$1348 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 38.8% between 2022 and 2029, mainly due to the increased adoption of Unified Communication & Collaboration (UC&C) and video conferencing. Private 5G Network platforms offer enterprises a cost-efficient and time-saving way to connect, address, and deliver information to their audience.\n\nAgileIntel’s global Private 5G Network market study is a 168 slide report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, component, and end-user industry perspective.\n\nPrivate 5G Network was available for commercial use since 2020. Hence, the base year is 2021for the study with historical data till 2020.The data forecast has been provided for the years between 2022 and 2029.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Private-5G-Network-Market/9#popup\n\nInsights on End-User Industry:\n\nThe Private 5G Network market is classified into manufacturing, transportation and logistics, enterprises and institutions, energy and utilities, smart cities, mining, defense, and others based on end-user industry.\n\nThe manufacturing sector accounted for a market size of US$263.6 million in 2021, which is expected to increase to US$5,107 million by 2029, at a CAGR of 41.7% during the forecast period. This strong growth is mainly due to the rising demand for private 5G services for various industrial use cases, such as Ultra-HD cameras, extended reality headsets, and Automated Guided Vehicles (AGVs). Additionally, the increasing demand for uninterrupted communication among machines is expected to drive segment growth over the long term.\n\nThe automotive segment is being driven by the surge in deployment of private 5G networks by leading automotive manufacturers such as Mercedes-Benz, Audi and Robert Bosch.\n\nThe demand for private 5G networks is expected to rise across enterprises and institutions primarily due to the growing need to securely manage data at their premises.\n\nAdditionally, the energy and utilities sector is expected to grow significantly due to the adoption of secured private networks for high-speed internet connectivity during energy generation and distribution.\n\nInsights on Regional Growth:\n\nNorth America is the largest market accounting for a 31% share during the forecast period. This can be attributed to the increasing investments in deploying private 5G network infrastructure by key service providers such as AT&T, Qualcomm Technologies and Verizon Communications, among others. Additionally, the increasing deployment of industrial sensors by automotive manufacturers such as Ford Motor and General Motors is expected to create considerable market opportunities in the region.\n\nMeanwhile, the Asia Pacific is expected to witness the highest growth rate of 42% from 2021 to 2029, due to the presence of several manufacturers and a significant rise in investments to build automated factories in the region. Additionally, considerable investments to acquire the 5G spectrum in key countries such as China, Japan, South Korea, and Australia are also expected to contribute to the region’s growth.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Private-5G-Network-Market/9\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"private\",\"network\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Private-5G-Network-Market/9#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Private-5G-Network-Market/9\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "private",
      "permlink": "private-5g-network-market-cumulative-impact-for-covid-19-recovery-research-report-2029",
      "title": "Private 5G Network Market Cumulative Impact for COVID-19 Recovery Research Report 2029"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-05-16T20:06:51",
  "trx_id": "62adb8ddd469dc8f8299e51a7c083f6775e389ca",
  "trx_in_block": 2,
  "virtual_op": 0
}

{
  "block": 64211661,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global Virtual Production market was valued at US$1,568.88 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 15% between 2022 and 2029. Significant increases in movie production budgets and the high usage of visual effects (VFX) in theatre, film, television, and video games are driving market growth.\n\nVirtual Production uses VFX and other technologies that allow filmmakers to visualize digital scenes in three-dimensional (3D) graphics, realistic virtual characters, and a real-time virtual interactive background.\n\nAgileIntel’s global Virtual Production market study is a 158-slide report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, production stage, and end-user perspective.\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Virtual-Production-Market/10#popup\n\nInsights on Production Stage:\n\nThe Virtual Production market is classified into pre-production, production, and post-production, based on the stages of production.\n\nThe post-production segment leads the Virtual Production market with over 52% revenue share in 2021, mainly due to its increasing importance in editing and collaborating post-shoot videos with graphics and VFX. The segment is expected to grow considerably during the forecast period as there is a constant rise in new video production projects on various video platforms globally. Additionally, the rising application of Virtual Production in commercial ads is expected to drive market growth during the forecast period.\n\nThe production segment is anticipated to grow considerably during the forecast years. Combining high-quality visual graphics with a 3D motion-captured imagery character is gaining traction and is likely to positively affect the market growth during the forecast period. By capturing an actor’s movements using virtual cameras, the videographers can show images of a character’s action on screen. The scene can be projected side by side in a realistic graphics environment generated through the computer or a live LED screen in the background.\n\nInsights on Key Markets:\n\nThe U.S. is the largest market for Virtual Production with market size of around US$350 million in 2021. The implementation of advanced VFX and Virtual Production technologies and the growing adoption of Virtual Production by movie studios, such as Viacom CBS, Walt Disney Studios, NBC Universal, and Warner Media, are expected to positively influence growth in the region.\n\nThe Virtual Production market in China was pegged at over US$130 million in 2021. The market is expected to grow rapidly during the forecast period, driven by Chinese production firms' growing adoption of the technology to reduce visual effects costs in the local productions.\n\nImpact of COVID-19\n\nThe Virtual Production market has been positively affected because of the COVID-19 pandemic. As the COVID-19 global pandemic continues to induce physical movement and gathering restrictions, virtual production levels could become a competitive advantage for content creators.\n\nThe global outbreak has disrupted film and series production, and this pause in content creation leading to the non-availability of fresh content. Governments worldwide are carefully considering reopening after putting in place new safety measures. Virtual sets move crews from the risks of travel and on-location shooting to the controlled atmosphere of a sound stage, which is a safer way of video production. Digital character development and motion capture, enabled by Virtual Production technologies, could allow for totally remote productions during the pandemic period. However, as the restrictions ease, content production resumes, and the OTT platform is expected to become the preferred channel of new content release, thereby supporting growth in content consumption as well as the virtual production market growth.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Virtual-Production-Market/10\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"virtual\",\"production\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Virtual-Production-Market/10#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Virtual-Production-Market/10\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-virtual-production-market-size-share-report-by-player-type-application-and-region-2021-2029",
      "title": "Global Virtual Production Market Size, Share, Report By Player, Type, Application and Region 2021-2029"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-05-16T06:23:06",
  "trx_id": "cc0d29c0806fc5864606697a142be6c74a1cfa3f",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 64209870,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global digital signage market was valued at US$22.57 billion in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 6.6% during the forecast period. This can be attributed to the growing adoption for digitized promotion and widespread infrastructure development in emerging countries.\n\nAgileIntel’s global digital signage market study is a 157 pages report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, display type, and vertical perspective.\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Digital-Signage-Market-/13#popup\n\nInsights on Vertical:\n\nThe digital signage market is segmented into retail, hospitality, entertainment, sports, enterprise, banking, healthcare, education, and transportation based on vertical.\n\nThe retail sector is likely to witness considerable growth opportunities during the forecast period as leading industry players use digital signage solutions to make new product launch announcements and promotions to lure customers to visit their stores.\n\nThe adoption of digital signage solutions in the transportation vertical is witnessing significant growth in sectors such as airports, metros, railway stations, subways, roadways, bus depots, and other public transport systems. Digital displays are used to deliver information related to travel schedules, routes, and advertisement purposes.\n\nFurthermore, digital signage solutions are used to display informative content for the staff, doctors, patients, and visitors in the healthcare sector. The installation of digital signage at baking and other financial institutions is focused on enhancing customer experience, attracting new clients, display different offers and notifications.\n\nInsights on Display Type:\n\nThe digital signage market is segmented into video walls, kiosks, digital posters, transparent LED screens, and others according to the display type.\n\nThe video wall segment accounted for the largest market share of 27% in 2021 and is expected to continue doing so during the forecast period. Video walls offer large-scale, high-resolution displays and are very versatile. Together, video walls and screens held a significant share of the digital signage market and are used extensively in shopping malls and other public places. On the other hand, kiosks are primarily used for advertising and providing information in institutes and retail verticals.\n\nTransparent LED screens integrated with LED lights offer a high resolution and transparency level of about 80%. Additionally, they are energy efficient and therefore are cost-effective. The transparent LED display segment held a market share of 12% in 2021 and is expected to witness significant demand during the forecast period.\n\nImpact of COVID-19\n\nThe digital signage market has been negatively affected by the COVID-19 pandemic due to disruptions in the supply chain caused by the temporary closure of manufacturing plants and trade restrictions affecting material flow in many countries.\n\nGovernment imposed lockdowns, social distancing, stay-at-home orders, and travel restriction have resulted in the temporary closure of many hospitality businesses. The restrictions on social gatherings have impacted the revenues of stadiums and playgrounds, thereby infrastructure upgrades such as new signage installations, have been cancelled or put on hold, affecting the digital signage market negatively.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Digital-Signage-Market-/13\n\nInsights on Key Markets:\n\nThe U.S. is the largest market for digital signage products and services, capturing 23% of the global market share and was valued at US$5.18 billion in 2021. The demand for wider displays, interactive and real-time content, is expected to drive the growth of digital signage products in the U.S. For instance, Starbucks implemented digital signage technology provided by BrightSign and its integrator OSM Solutions to install outdoor digital menu boards at various drive-through facilities in the U.S. The digital board displays menu content and the videos of drinks preparation in real-time.\n\nThe digital signage market in China accounted for US$1.01 billion in 2021. The growing demand from the country’s transportation, healthcare, education, and enterprise verticals is expected to drive digital signage market growth during the forecast period.\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"digital\",\"signage\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Digital-Signage-Market-/13#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Digital-Signage-Market-/13\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-digital-signage-market-outlook-to-2029-capacity-and-capital-expenditure-forecasts-with-details-of-all-active",
      "title": "Global Digital Signage Market  Outlook to 2029- Capacity and Capital Expenditure Forecasts with Details of All Active"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-05-16T04:53:15",
  "trx_id": "736e921ad78ae8fc00608e4c0a0f6a1ee494904b",
  "trx_in_block": 8,
  "virtual_op": 0
}

{
  "block": 64068437,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global contact center software market was valued at US$23,174.75 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 19.1% between 2022 and 2029. This can be attributed to rising adoption of contact center technologies in customer-service industries such as BFSI, retail, healthcare and telecom to ensure accurate, consistent and timely queries resolution.\n\nAgileIntel’s global contact center software market study is a 157 pages report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, business solution, and vertical perspective.\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Contact-Center-Software-Market-/15#popup\n\nInsights on Vertical:\n\nThe contact center software market is classified into BFSI, FMCG and retail, government, healthcare, telecom and IT, travel and hospitality, and others, based on vertical.\n\nThe telecom and IT segment dominated the contact center software market in 2021, mainly due to the presence of many telecom and IT companies in the overall customer base. Intense competition has made it imperative for telecom and IT players to enhance their service quality, increasing the demand for contact center solutions. Additionally, the growing adoption of cloud-based contact center solutions has resulted in quick access to customer information, resulting in timely query resolution.\n\nThe rise in online shopping customers has created a need for retailers to deploy a dedicated team to handle online queries. Moreover, the retail segment is gradually incorporating social media management tools for customer feedback and engagement, which requires the deployment of contact center platforms.\n\nThe demand for contact center solutions is anticipated to increase in the healthcare sector. It can perform various functions such as scheduling appointments, conveying doctors' availability, scheduling surgeries, receiving management feedback, and maintaining a customer database. Likewise, banking, finance, and insurance industries are implementing contact center solutions due to the increasing demand for personalized and streamlined customer interactions while conducting financial transactions.\n\nInsights on Business Solution:\n\nThe contact center software market is segmented based on business solution into Automatic Call Distribution (ACD), call recording, Computer Telephony Integration (CTI), customer collaboration, dialer, Interactive Voice Response (IVR), reporting and analytics, workforce optimization, and Others.\n\nContact centers use ACD systems to increase employee productivity and enhance customer satisfaction. These systems answer the incoming calls and route them to the concerned department based on the type of query. The ACD systems help organizations to streamline the communication process by ensuring even distribution of workload among the agents and simultaneously improve the service quality.\n\nSimilarly, call recordings help improve the quality monitoring of the performance and analyze the improvements required by the contact center agents, enables to retrieve information and help assess the time required to solve a particular query.\n\nContact centers are adopting the CTI technology to synchronize the functions of the telephone system and the computer system that will allow contact center representatives to monitor, record, and route the incoming calls to the most appropriate person in the department.\n\nFurthermore, the IVR segment accounted for 21% of the contact center software market in 2021. The IVR feature allows automating customer support by providing customized greetings and messages and also guiding them during a call. This reduces the time required to address queries and enables to handle higher call volumes per day.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Contact-Center-Software-Market-/15\n\nInsights on Regional Growth:\n\nNorth America is the largest market accounting for a 37% share during the forecast period. This can be attributed to the growing omnichannel approach to sales and the region's rising e-commerce industry.  Several organizations are rapidly investing in emerging technologies, such as big data, analytics, and cloud-based platforms, which is likely to drive the demand for contact center software solutions in the region.\n\nMeanwhile, Europe is expected to witness steady growth due to the increased adoption of contact center systems in the healthcare industry due to the growing number of multi-specialty hospitals. Likewise, the rise in the aging population in Germany and the advancement in medical technologies has increased the demand for services such as telehealth and telemedicine, which is likely to drive the market growth.\n\nThe Asia Pacific is expected to be the fastest-growing regional market, with the number of contact centers in the region estimated to reach 36,350 by 2028. This can be attributed to the initiatives taken by the governments in countries such as India, China, and Japan to encourage the digitization of business processes. Moreover, the deployment of cloud-based systems across various organizations is also expected to boost the demand for contact centers in the region during the forecast period.\n\nAbout Us:\n\nAgileIntel is a provider of smart and actionable global market research across various sectors. We established the company after identifying a growing demand from clients for a different, more bespoke, considered and personalised approach to market research. Our mission is to help our clients get a better understanding of industries, companies and consumers to make informed business decisions and respond confidently to an evolving marketplace.\n\n \n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"contact\",\"center\",\"software\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Contact-Center-Software-Market-/15#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Contact-Center-Software-Market-/15\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-contact-center-software-market-2021-industry-development-analysis-of-driving-factors-and-growth-forecast-to-2029",
      "title": "Global Contact Center Software Market  2021 Industry Development, Analysis of Driving Factors and Growth Forecast to 2029"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-05-11T06:37:24",
  "trx_id": "0b23094303396c2e32fa9d1b1b49dc3d2973fc41",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 63645819,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "ChemIntel360’s South America Polyethylene market study is a 56 slide report containing in depth analysis on historical and forecasted spending and consumption patterns in the sector. We offer granular value and volume data from end-use industry and applications perspective. Despite the adverse effects of the COVID-19 pandemic, the market is expected to rebound strongly and grow at a CAGR of 1.9% over 2021-2026. The leading factor driving growth is the chemical’s extensive use in packaging industry in the region. This is further bolstered by construction activity in major markets.\n\nRequest for Sample Copy of this Report @ https://www.chemintel360.com/reportdetails/South-America-Polyethylene-Market/62#popup\n\nScope\n\nThis study contains South America market size data - value and volume. The numbers are broken down by end use (Packaging, Automotive, Building and Construction, Electrical and Electronics, Household Appliances, and Others), by application (Films, Blow Molding, Injection Molding, Pipe, Extrusion Coating, Wire and Cable, and Others). The historical period runs through 2015-2020 and the forecasted period from 2021-2026.\n\nMarket Overview\n\nThe South America Polyethylene market, which grew from US$X.X billion in 2015 to US$X.X billion in 2019, dropped marginally to US$11.0 billion in 2020, due to the ongoing COVID-19 pandemic. Spending is expected to recover in 2021 to value US$X.X billion and increase to US$X.X billion in 2026 at a CAGR of X.X%. Cumulatively the South America Polyethylene market is expected to value US$X.X billion during the forecast period as compared to US$X.X billion during the historical period.\n\nFor More Detail @ https://www.chemintel360.com/reportdetails/South-America-Polyethylene-Market/62\n\nAbout Us:\n\nChemIntel360, part of AgileIntel’s broader research offering, provides an integrated portfolio of quantitative and qualitative research reports on the chemicals sector. Our studies make use of credible market intelligence.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"south\",\"america\",\"polyethylene\",\"market\"],\"links\":[\"https://www.chemintel360.com/reportdetails/South-America-Polyethylene-Market/62#popup\",\"https://www.chemintel360.com/reportdetails/South-America-Polyethylene-Market/62\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "south",
      "permlink": "south-america-polyethylene-market-cumulative-impact-for-covid-19-recovery-research-report-2026",
      "title": "South America Polyethylene Market Cumulative Impact for COVID-19 Recovery Research Report 2026"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-04-26T13:11:18",
  "trx_id": "0fd0bc431df4f44d5128f612e3a8517a453dc72b",
  "trx_in_block": 1,
  "virtual_op": 0
}

{
  "block": 63617502,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global optical character recognition (OCR) market was valued at US$8,750.13 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 13.8% during the forecast period. This can be attributed to the growing adoption of OCR technologies across diversified verticals such as banking, financial services and insurance (BFSI), transport and logistics, healthcare, government, education, telecom and IT, manufacturing and retail. OCR technology helps users convert images and documents into a machine-readable form such as PDF, Microsoft Word, RTF, or ASCII, which is further used for data processing like editing or searching.\n\nAgileIntel’s global optical character recognition market study is a 164 slide report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, type, and vertical perspective.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Optical-Character-Recognition-Market/2#popup\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029. Insights on Vertical:\n\nThe OCR market is segmented into BFSI, transport and logistics, healthcare, government, education, telecom and IT, manufacturing, retail, and others, based on verticals.\n\nThe Banking, Financial Services and Insurance (BFSI) sector held the largest share of the OCR market, accounting for over US$1,726.41 million in revenues in 2021. In the banking industry, OCR technology scans documents, receipts, and checks and converts them into a machine-readable format. They are also used to scan and decipher signatures on cheques, print and update passbooks, etc. Additionally, the adoption of OCR technology in various applications such as loan applications, account opening, and compliance-related processes has helped the BFSI sector to increase its processing speed significantly and also educe errors. For instance, in March 2020, Sony Bank, a Japanese commercial bank, launched a new English-language online banking service for non-Japanese clients to make the account opening process fast and easy.\n\nOCR technology in the transport and logistics industry scans the tracking numbers of packages and postal codes of delivery locations instead of manually noting them. This quickens the packages' processing, shipping, and tracking speed and also reduces costs.\n\nFurther, in the healthcare industry, OCR systems are widely used for scanning medical reports, clinical data, prescription forms, and patient records, which is integrated into patient data management software for the digital storage of relevant documents.\n\nImplementing OCR software in the retail industry helps improve customer experience by offering services, such as voucher code scanning, self-service utility meter reading, and tax-free shopping, among others.\n\nMeanwhile, with the rise in digitized workflows in the government and public sector institutions, there has been a rise in electronic transactions such as automatic verification of documents, applications for documents like personal ID cards, drivers’ licenses, etc., driving the need to integrate OCR solutions in their processes.\n\nInsights on Key Markets:\n\nThe U.S. with a market size of US$2,337.10 million in 2021, is the largest market for OCR, capturing 26.7% of the global market share. This can be attributed to a high degree of innovation and the presence of major industry players such as ABBY, Adobe, IBM, Microsoft and Google. For instance, in August 2020, Microsoft introduced its latest OCR technology called Read API to extract printed and handwritten texts and currency symbols from images, digits, and PDF documents.\n\n The OCR market in China accounted for US$714.62 million in 2021. The growing adoption of OCR technology in industries such as transport and logistics, healthcare, BFSI, and education is expected to drive market growth during the forecast period. Additionally, China is also making considerable investments in advanced technologies to drive growth in the region. For instance, in May 2020, DataGrand, a Chinese AI startup, raised funds worth US$38 million to develop natural language processing (NLP), OCR, robotic process automation, and other AI technologies.\n\nImpact of COVID-19\n\nThe COVID-19 pandemic has adversely affected many businesses worldwide due to trade and travel restrictions, government-imposed lockdowns, social distancing, stay-at-home orders and shutdown of manufacturing facilities. However, adoption of OCR products has witnessed an uptick during the pandemic.\n\nAs a safety measure, organizations are adopting advanced technologies such as AI, robotics, OCR, and ML to ensure business continuity and uninterrupted services to their customers. Several businesses, organizations and government bodies are using OCR platforms to combat against the COVID-19 outbreak. For instance, in India, various state police departments implemented OCR and biometrics technology to issue e-passes to individuals based on validation of supporting identity documents to monitor movement during the lockdown. As organizations, move into a COVID-induced digital age, the adoption of OCR products is expected to increase further during the forecast period.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Optical-Character-Recognition-Market/2\n\nAbout Us:\n\nChemIntel360, part of AgileIntel’s broader research offering, provides an integrated portfolio of quantitative and qualitative research reports on the chemicals sector. Our studies make use of credible market intelligence.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"optical\",\"character\",\"recognition\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Optical-Character-Recognition-Market/2#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Optical-Character-Recognition-Market/2\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-optical-character-recognition-market-size-share-report-by-player-type-application-and-region-2021-2029",
      "title": "Global Optical Character Recognition Market  Size, Share, Report By Player, Type, Application and Region 2021-2029"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-04-25T13:30:51",
  "trx_id": "cfa0642810053a64b15f98ea229f3cc526123169",
  "trx_in_block": 9,
  "virtual_op": 0
}

{
  "block": 63473452,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global 5G services market was valued at US$45,680 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 44.1% between 2022 and 2029, mainly driven by the exponential rise in data traffic and growing demand for high-speed data connectivity. The planned deployment of 5G networks in smart cities growing adoption of IoT is also expected to drive the 5G Services market growth.\n\nAgileIntel’s global 5G services market study is a 172 slide report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, communication technology, and vertical perspective.\n\n5G services commercialization started in 2020. Hence, the base year is 2021 for the study with historical data available for 2020. The data forecast has been provided for the years between 2022 and 2029.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-5G-Services-Market/4#popup\n\nKey insights from the Global 5G Services report\n\nInsights on Communication Technology:\n\nThe 5G services market is classified into Enhanced Mobile Broadband (eMBB), Fixed Wireless Access (FWA), Massive Machine Type Communication (mMTC), and Ultra-Reliable Low Latency Communication (uRLLC) based on the communication technology.\n\nThe Enhanced Mobile Broadband (eMBB) segment, also known as extreme mobile broadband, dominated the market in 2021 and is expected to grow considerably over the forecast period. It is the extended version of 4G network services and can deliver ultra-high wireless bandwidth capabilities in applications such as high definition (HD) video streaming and immersive virtual reality (VR)/augmented reality (AR) gaming and video calling, providing faster download speed and improved user experiences.\n\nThe massive Machine-Type Communications (mMTC) segment is expected to grow exponentially during the forecast period. The 5G mMTC technology provides high bandwidth connectivity for heavy density applications such as smart cities, remote asset monitoring, etc. The rising need for high-speed connectivity for all IoT devices deployed in a network is expected to boost the mMTC segment growth during the forecast period.     \n\nInsights on Regional Growth:\n\nAsia Pacific is the largest market for 5G services globally. Market players in APAC region such as China Mobile, China Telecom, SK Telecom, and KT Corporation are making significant investments in rolling out 5G network infrastructure in China, Japan and South Korea. Moreover, manufacturers such as Huawei Technologies, Samsung Electronics, and BBK Electronics Corporation are continuing to launch 5G-enabled smartphones which is likely to drive growth in the region.\n\nMeanwhile, North America accounted for 27% of the 5G services market in 2021. The 5G rollout in North America is delayed due to the escalating trade war between the U.S. and China. The U.S. is one of the largest importers of Infrastructure equipment from China. Due to geopolitical tensions between these two countries, the U.S. government has urged other countries to review the role of Chinese firms in 5G networks, suspecting their equipment is being used for cyberespionage. The absence of major 5G equipment suppliers from the domestic market is expected to reduce price competition and higher deployment costs. The move is expected to increase the CAPEX of operators and delay the 5G rollout in the U.S.\n\nMarket dynamics\n\nTrends\n\nThe deployment of millimeter wave (mmWave) technology based standalone 5G (SA 5G) networks is likely to take precedence over non-standalone 5G (NSA 5G) technology, which has been used in most of the commercial deployments till date. NSA 5G uses new radio technologies, implemented on an underlying 4G core, thus offering better bandwidth and performance than 4G. However, it is nowhere close to the true potential of the mmWave based SA 5G networks, which can reach 10 times the speed of 4G, and unlock several application areas consumers and business. Thus, as the implementation of SA 5G networks gains momentum, the practical application of advanced IoT, robotics, and AR/VR in industrial use cases can finally be a reality.\n\nDrivers\n\nThe growing demand for high-speed data for commercial, industrial, and personal applications is expected to drive the demand for 5G services. The proliferation of smartphones, tablets, and smart TVs has led to increasing internet use for browsing, streaming videos, and video calling, among others. The resultant increase in data traffic has, in turn, created a need for high-speed data connectivity to provide a seamless experience to users. The commercialization of 5G-enabled services is anticipated to create numerous uses ranging from simple applications such as Virtual Reality (VR) & Augmented Reality (AR) gaming and Ultra-High-Definition (UHD) video streaming to more complex applications, including robotic surgeries, autonomous vehicles, and autonomous defense equipment. Thus, the advent of next-generation technologies is expected to drive the demand for high-speed, low latency data connectivity and the demand for 5G services.\n\nOpportunities\n\n5G and cloud are likely to evolve into two interdependent technology platforms that would grow together and support each other during the forecast period. The combination of cloud technologies and 5G services is anticipated to enhance the flexibility, operational capacity, and functionality of many industries. High-speed data connectivity coupled with reduced latency levels that 5G network services offer would encourage organizations to shift toward cloud-based solutions. Moreover, they are expected to pave the way for several investment opportunities for cloud businesses. For instance, 5G technology is anticipated to enable cloud service providers to use their mobile phones for remotely accessing machines, thus making it easier and more reliable for them to offer their services to mobile enterprise customers. Thus, the growing adoption of cloud services is expected to support the 5G market growth during the forecast period.\n\nChallenges\n\nThe increased cost of 5G spectrum coupled with high infrastructure costs associated with the deployment of 5G services is expected to result in higher subscription fees to avail 5G services. Telecom service providers are charged a high fee by the government or telecom regulating authorities to buy the license or rights to transmit signals over specific electromagnetic spectrum bands. Moreover, governments worldwide release only a limited band to be licensed by telecom operators. These factors are expected to hamper the growth of the 5G services market. For instance, the Telecom Regulatory Authority of India (TRAI) has recommended base price of INR 492 per MHz for 5G spectrum within the 3300 MHz to 3600 MHz band. These high spectrum costs are likely to directly affect the consumers and hamper the development of 5G services over the forecast period.\n\nImpact of COVID-19\n\nThe COVID-19 pandemic has significantly impacted the global economyand, subsequently, 5G roll-out and infrastructure deployment. Governments across the world have issued strict lockdowns and travel restrictions leading to labor shortage and complete disruption of supply chain and logistics operations, delaying the deployment of 5G Infrastructure.As a result, there has been a notable decline in the imports and exports of 5G equipment from major manufacturing hubs, including China, the U.S., Korea, Taiwan, and other key European countries. This, in turn, has further delayed the deployment of the next-generation network infrastructure worldwide.\n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-5G-Services-Market/4\n\nAbout Us:\n\nChemIntel360, part of AgileIntel’s broader research offering, provides an integrated portfolio of quantitative and qualitative research reports on the chemicals sector. Our studies make use of credible market intelligence.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"services\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-5G-Services-Market/4#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-5G-Services-Market/4\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-5g-services-market-2021-industry-development-analysis-of-driving-factors-and-growth-forecast-to-2029",
      "title": "Global 5G Services Market  2021 Industry Development, Analysis of Driving Factors and Growth Forecast to 2029"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-04-20T13:01:54",
  "trx_id": "b9f8dabc8d150df661190b5f27ff1aa2b833d697",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 63473083,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "The global cyber security market was valued at US$176.4 billion in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 10.2% between 2022 and 2029, mainly driven by increasing number of data breaches and advanced malware threats. While the adoption of emerging technologies in the BFSI, retail, IT, and manufacturing sectors have offered new capabilities and ease of working, they have also driven the global threat landscape of exploits, vulnerabilities, and malware.\n\nAgileIntel’s global cyber security market study is a 168 slide report containing in-depth analysis on historical and forecasted spending patterns in the sector. The study offers granular value data from a global, regional, component, and security type perspective.\n\nThe base year is 2021 for the study with historical data between 2018 and 2021. The data forecast has been provided for the years between 2022 and 2029.\n\nRequest for Sample Copy of this Report @ https://www.agileintelresearch.com/reportdetails/Global-Cyber-Security-Market/5#popup\n\nKey insights from the Global Cyber Security report\n\nInsights on Components:\n\nCyber security solutions protect the network, system, or applications from cyber-attacks such as ransomware, malware, phishing, etc. The cyber security market is classified into hardware, software, and services based on components.\n\nThe services segment holds the largest market share and is expected to continue doing so during the forecast period, driven mainly by the robust growth in connected devices which are already creating system vulnerabilities. Moreover, the increasing need for automation for efficiency in enterprise Security Operations Centers is also expected to contribute to the growth of this segment.\n\nFurthermore, large and small enterprises face challenges in securing data, thereby increasing the demand for cyber security software and solutions such as anti-malware, anti-spyware, identity management, and network access control (NAC) to protect their IT systems and networks from unauthorized access and intrusions.\n\nAdditionally, the growing adoption of hardware components such as encrypted flash drives, network firewalls, and intrusion prevention system (IPS) equipment that secures IT networks from cyber threats is driving the growth of the hardware segment.\n\nInsights on Key Markets:\n\nThe U.S. cyber security market was valued at US$53.9 billion in 2021. It remains the largest market for cyber security solutions due to increased spending by the government to improve the cyber security infrastructure of the country. An increasing number of SMEs, presence of major IT hubs, and the growing adoption of cloud solutions by the SMEs in the U.S. are expected to lead to new security-related issues concerning the network and security of organizational systems, thereby warranting the need for more effective cyber security measures to be put in place. The government has introduced policies that support, encourage, and regulate businesses to adopt cyber security measures.\n\nInsights on Regional Growth:\n\n \n\nNorth America is expected to remain the largest market, accounting for a 35% share of the global cyber security products and services market during the forecast period. This can be attributed to the rising cyber security spending by the government and public authorities in the region due the increasing instances of security breaches. Further, the increased spending on security solutions and services by large enterprises and SMEs and stringent standards and policies for maintaining data privacy and security contribute to the region's market growth.\n\nMeanwhile, Asia Pacific is expected to be the fastest-growing market during the forecast period, mainly due to growing efforts towards securing endpoints, networks, and cloud infrastructure. Countries such as India and China have strong defense forces, encouraging governments and defense sectors of these countries to adopt advanced technologies to mitigate threats rising from cyber-espionage and to be prepared to ward off any disruptions due to cyber warfare.\n\nMarket dynamics\n\nTrends\n\nBanking and financial institutions are leveraging emerging technologies such as artificial intelligence (AI) and blockchain for thwarting cyberattacks on their systems. Integration of AI capabilities in cyber security solutions such as Security Information and Event Management (SIEM) will help develop a security system that adapts automatically to changing threat patterns, predicts, detects, and neutralizes threats before they can attack the systems.\n\nDrivers\n\nThe main driver of cyber security spending worldwide is not only the sheer increase in the number of cyberattacks over the last few years but also the use of more advanced methods and techniques by hackers, which makes existing solutions redundant. Therefore, governments and providers are under pressure to constantly innovate and develop new solutions, which are then used by all concerned stakeholders to upgrade their security infrastructure.\n\nOpportunities\n\nThe defense/government sector is expected to remain one of the most attractive growth markets for cyber security solution providers. The defense/government sector stores vulnerable information regarding the country’s residents and military strategies, which is always a target for independent hackers, unethical hackers from other countries, and terrorist cells. The growing reliance on digital storage of information using computers and cloud service, coupled with the rapidly changing technology, necessitates the development and deployment of secure systems that remain ahead of the hackers. Thus, countries across the globe are expected to increase their spending on cyber security solutions in the coming years.\n\nChallenges\n\nA shortage of skilled workforce and lack of training to stay abreast with the current cybersecurity trends are significant challenges faced by market participants. This lack of skills can be attributed to the rapidly evolving cybersecurity threat landscape, the growing adoption of IoT, mobile technology, cloud computing, and data centers.\n\nThe use of unlicensed software is also restraining the growth of the cyber security market.\n\nImpact of COVID-19\n\nThe COVID-19 pandemic had a positive impact on the cyber security market.\n\nWith most companies asking their employees to work from home, the number of cyber-attacks on enterprise data and devices has proliferated, thereby driving continuous investments in security solutions. This has exposed vulnerabilities due to the increased use of cloud service via unmanaged devices. Thus, the ongoing pandemic presents an opportunity for enterprises to assess their IT infrastructure and deploy robust cyber security solutions.  \n\nFor More Detail @ https://www.agileintelresearch.com/reportdetails/Global-Cyber-Security-Market/5\n\nAbout Us:\n\nChemIntel360, part of AgileIntel’s broader research offering, provides an integrated portfolio of quantitative and qualitative research reports on the chemicals sector. Our studies make use of credible market intelligence.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"cyber\",\"security\",\"market\"],\"links\":[\"https://www.agileintelresearch.com/reportdetails/Global-Cyber-Security-Market/5#popup\",\"https://www.agileintelresearch.com/reportdetails/Global-Cyber-Security-Market/5\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-cyber-security-market-by-product-applications-geographic-and-key-players",
      "title": "Global Cyber Security Market by Product, Applications, Geographic and Key Players"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-04-20T12:43:21",
  "trx_id": "a0567c28e415e2d6313f948d60ce50b003531eb2",
  "trx_in_block": 0,
  "virtual_op": 0
}

{
  "block": 63472685,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "ChemIntel360’s South America Ethylene Oxide market study is a 54 slide report containing in depth analysis on historical and forecasted spending and consumption patterns in the sector. We offer granular value and volume data from product perspective. Despite the adverse effects of the COVID-19 pandemic, the market is expected to rebound and grow at a CAGR of 1.9% over 2021-2026. The main factors driving growth is the chemical’s growing demand for polyethylene terephthalate (PET) bottles from packaging industries.\n\nRequest for Sample Copy of this Report @ https://www.chemintel360.com/reportdetails/South-America-Ethylene-Oxide-Market/156#popup\n\nScope\n\nThis study contains South America market size data - value and volume. The numbers are broken down by product (Ethylene Glycol, Ethoxylates, Ethanolamines, Glycol Ethers, Polyethylene Glycol, Polyether Polyols, and Others). The historical period runs through 2015-2020 and the forecasted period from 2021-2026.\n\nMarket Overview\n\nThe South America Ethylene Oxide market, which grew from US$X.X billion in 2015 to US$X.X billion in 2019, dropped marginally to US$1.67 billion in 2020, due to the ongoing COVID-19 pandemic. Spending is expected to recover in 2021 to value US$X.X billion and increase to US$X.X billion in 2026 at a CAGR of X.X%. Cumulatively the South America Ethylene Oxide market is expected to value US$X.X billion during the forecast period as compared to US$X.X billion during the historical period.\n\nFor More Detail @ https://www.chemintel360.com/reportdetails/South-America-Ethylene-Oxide-Market/156\n\nAbout Us:\n\nChemIntel360, part of AgileIntel’s broader research offering, provides an integrated portfolio of quantitative and qualitative research reports on the chemicals sector. Our studies make use of credible market intelligence.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"south\",\"america\",\"ethylene\",\"oxide\",\"market\"],\"links\":[\"https://www.chemintel360.com/reportdetails/South-America-Ethylene-Oxide-Market/156#popup\",\"https://www.chemintel360.com/reportdetails/South-America-Ethylene-Oxide-Market/156\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "south",
      "permlink": "south-america-ethylene-oxide-market-outlook-to-2027-capacity-and-capital-expenditure-forecasts-with-details-of-all-active",
      "title": "South America Ethylene Oxide Market  Outlook to 2027 - Capacity and Capital Expenditure Forecasts with Details of All Active"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-04-20T12:23:27",
  "trx_id": "229089132d1ea4cfe8759c2c7435dc1daa13e289",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 63300091,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "Rigid plastic packaging as the name proposes alludes to a sort of packaging method that includes the utilization of plastic material. Rigid plastic material can be characterized as the material that displays no versatile distortion and wonderful plastic twisting and it has a generally unyielding shape or structure. Rigid plastic packaging contains cups, bottles, terminations, pots, and jars. Benefits presented by Rigid plastic packaging are sturdiness, cost, life span, assimilation of flavors, and lightweight. It is overwhelmingly utilized in a wide scope of utilizations in various enterprises like food and drinks, drugs, individual consideration, and some more.\n\nChemIntel360’s global Rigid Plastic Packaging market study is a 170+ slide report containing in depth analysis on historical and forecasted spending and consumption patterns in the sector. We offer granular value and volume data from a global, regional, applications, and end-use industry perspective. Despite the adverse effects of the COVID-19 pandemic, the industry is expected to grow strongly and grow at a CAGR of 5.4% over 2021-2026. The leading factor driving growth is the chemical’s extensive use in food packaging application, the demand for which has witnessed robust growth in light of increasing safety requirements.\n\nRequest for Sample Copy of this Report @ https://www.chemintel360.com/reportdetails/Rigid-Plastic-Packaging/235#popup\n\nRigid packaging better safeguards its substance. Rigid plastic packaging is characterized by its purposes in items, for example, water and soft drink bottles, which are produced using polyethylene terephthalate (PET), the most generally utilized sap, and less significantly in containers, clamshells, tubs, and plate. The utilization of polypropylene (PP) gum in plastic packaging is growing more quickly than different plastics, like PET and PE (polyethylene).\n\nScope\n\nThis study contains global and regional market size data. The numbers are broken down by application (Food and Beverages, Personal Care, Pharmaceuticals, and Others), and by end-use industry (Bottles and Jars, Trays, Rigid Bulk Products, Tubs, Cups and Pots, and Others). The historical period runs through 2015-2020 and the forecasted period from 2021-2026.\n\nMarket Overview\n\nThe global Rigid Plastic Packaging market, which grew from US$X.X billion in 2015 to US$X.X billion in 2019, increased marginally to US$189.97 billion in 2020, due to the ongoing COVID-19 pandemic. Spending is expected to recover in 2021 to value US$X.X billion and increase to US$X.X billion in 2026 at a CAGR of X%. Cumulatively the market is expected to value US$X.X billion during the forecast period as compared to US$X.X billion during the historical period.\n\nOn the basis of Geography, the Global Rigid Plastic Packaging Market is classified into North America, Europe, Asia Pacific, and Rest of the world. Asia-Pacific holds the largest market share.\n\nKey Players\n\nThe “Global Rigid Plastic Packaging Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players are Amcor Limited, Bemis Company, Inc., Tray Pack Corporation, Consolidated Container Company, Lacerta Group, Inc., Coveris Holdings S.A., Plastipak Holdings, Inc., Alpla Wereke, Alwin Lehner GmbH & Co. Kg, RPC Group Plc, and Silgan Holdings, Inc.\n\nFor More Detail @ https://www.chemintel360.com/reportdetails/Rigid-Plastic-Packaging/235\n\nAbout Us:\n\nChemIntel360, part of AgileIntel’s broader research offering, provides an integrated portfolio of quantitative and qualitative research reports on the chemicals sector. Our studies make use of credible market intelligence.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"global\",\"rigid\",\"plastic\",\"packaging\",\"market\"],\"links\":[\"https://www.chemintel360.com/reportdetails/Rigid-Plastic-Packaging/235#popup\",\"https://www.chemintel360.com/reportdetails/Rigid-Plastic-Packaging/235\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "global",
      "permlink": "global-rigid-plastic-packaging-market-upcoming-trends-growth-drivers-and-challenges",
      "title": "Global Rigid Plastic Packaging Market Upcoming Trends, Growth Drivers and Challenges"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-04-14T10:48:36",
  "trx_id": "9557566dcb7387165253a06b5ffec9d61ff7b277",
  "trx_in_block": 3,
  "virtual_op": 0
}

{
  "block": 63271646,
  "op": [
    "comment",
    {
      "author": "shriyala",
      "body": "ChemIntel360’s APAC Bromine market study is a 52 slide report containing in depth analysis on historical and forecasted spending and consumption patterns in the sector. We offer granular value and volume data from the applications perspective. Despite the adverse effects of the COVID-19 pandemic, the market is expected to rebound and grow at a CAGR of 3.2% over 2021-2026. The main factors driving growth is the chemical’s extensive use in flame retardants, the demand for which has witnessed robust growth in light of rising plastic and electronic component manufacturing in the region.\n\nRequest for Sample Copy of this Report @ https://www.chemintel360.com/reportdetails/APAC-Bromine-Market/142#popup\n\nScope\n\nThis study contains APAC market size data - value and volume. The numbers are broken down by application (Brominated Flame Retardants, Clear Brine Fluids, Water Treatment, Hydrogen Bromide, Methyl Bromide and others). The historical period runs through 2015-2020 and the forecasted period from 2021-2026.\n\nMarket Overview\n\nThe APAC Bromine market, which grew from US$X.X billion in 2015 to US$X.X billion in 2019, dropped marginally to US$1.5 billion in 2020, due to the ongoing COVID-19 pandemic. Spending is expected to recover in 2021 to value US$X.X billion and increase to US$X.X billion in 2026 at a CAGR of X.X%. Cumulatively the APAC Bromine market is expected to value US$X.X billion during the forecast period as compared to US$X.X billion during the historical period.\n\nFor More Detail @ https://www.chemintel360.com/reportdetails/APAC-Bromine-Market/142\n\nAbout Us:\n\nChemIntel360, part of AgileIntel’s broader research offering, provides an integrated portfolio of quantitative and qualitative research reports on the chemicals sector. Our studies make use of credible market intelligence.\n\nContact Us:\n\nMr. Jason Victor\n\nSkype ID: ChemIntel360\n\nmail Id: [email protected]",
      "json_metadata": "{\"tags\":[\"apac\",\"bromine\",\"market\"],\"links\":[\"https://www.chemintel360.com/reportdetails/APAC-Bromine-Market/142#popup\",\"https://www.chemintel360.com/reportdetails/APAC-Bromine-Market/142\"],\"app\":\"steemit/0.2\",\"format\":\"markdown\"}",
      "parent_author": "",
      "parent_permlink": "apac",
      "permlink": "apac-bromine-market-analysis-investigation-growth-by-top-companies-consumption-by-regional-data-trends-by-types-and-application",
      "title": "APAC Bromine Market Analysis Investigation Growth by Top Companies, consumption by Regional data, Trends by Types and Application"
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-04-13T11:00:36",
  "trx_id": "97c40aea471f22785d5ed33ea14bf5285613f178",
  "trx_in_block": 5,
  "virtual_op": 0
}

{
  "block": 63271122,
  "op": [
    "comment",
    {
      "author": "scitech",
      "body": "Chondroitin sulfate is suggested as a helpful mediation in the complex treatment of Osteoarthritis on the board.",
      "json_metadata": "{\"app\":\"steemit/0.2\"}",
      "parent_author": "shriyala",
      "parent_permlink": "global-chondroitin-sulfate-market-outlook-to-2027-capacity-and-capital-expenditure-forecasts-with-details-of-all-active",
      "permlink": "ra9xd8",
      "title": ""
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-04-13T10:34:21",
  "trx_id": "0e527601cf23249f3a6fe76c39c6145ea3974c19",
  "trx_in_block": 6,
  "virtual_op": 0
}

{
  "block": 63271115,
  "op": [
    "comment",
    {
      "author": "scitech",
      "body": "It is used as an intermediate for synthesizing several chemical compounds.",
      "json_metadata": "{\"app\":\"steemit/0.2\"}",
      "parent_author": "shriyala",
      "parent_permlink": "research-report-on-global-phenol-market-size-2021-2027-industry-share-and-demand-analysis-of-key-players",
      "permlink": "ra9xcn",
      "title": ""
    }
  ],
  "op_in_trx": 0,
  "timestamp": "2022-04-13T10:34:00",
  "trx_id": "8536603af83688c8703bab8359eb9966a2a0707b",
  "trx_in_block": 6,
  "virtual_op": 0
}